
<html lang="en"     class="pb-page"  data-request-id="474026b8-daf1-4c4d-9ef8-e04fd250d96e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.0c00046;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-4;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design" /></meta><meta name="dc.Creator" content="Gergő  Dargó" /></meta><meta name="dc.Creator" content="Dávid  Bajusz" /></meta><meta name="dc.Creator" content="Kristóf  Simon" /></meta><meta name="dc.Creator" content="Judit  Müller" /></meta><meta name="dc.Creator" content="György T.  Balogh" /></meta><meta name="dc.Description" content="The knowledge on human serum albumin (HSA) binding is of utmost importance as it affects pharmacokinetic behavior and bioavailability of drugs. In this article, we report a novel method to screen f..." /></meta><meta name="Description" content="The knowledge on human serum albumin (HSA) binding is of utmost importance as it affects pharmacokinetic behavior and bioavailability of drugs. In this article, we report a novel method to screen f..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 29, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00046" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00046" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00046" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00046" /></link>
        
    
    

<title>Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00046" /></meta><meta property="og:title" content="Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0002.jpeg" /></meta><meta property="og:description" content="The knowledge on human serum albumin (HSA) binding is of utmost importance as it affects pharmacokinetic behavior and bioavailability of drugs. In this article, we report a novel method to screen for ionizable molecules with high HSA binding affinity based on pKa shifts using UV-pH titration. We investigated the HSA binding of 27 drugs and compared the results to experimental data from conventional methods. In most cases, significant shifts (ΔpKa &gt; 0.1) were observed for drugs with high HSA binding, while no change could be detected for low-affinity binders. We showed the pivotal role of ionization centers in the formation of strong interactions between drug and HSA using molecular docking studies. We also verified our findings by testing five modified analogues designed by structural considerations. Significant decreases in their HSA binding proved that the UV-pH titration method combined with an in silico support can be used as a medicinal chemistry tool to assist rational molecular design." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00046"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00046">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00046&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00046&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00046&amp;href=/doi/10.1021/acs.jmedchem.0c00046" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1763-1774</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00033" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00140" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Gergő Dargó</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gergő Dargó</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Műegyetem rakpart 3, 1111 Budapest, Hungary</div><div class="loa-info-affiliations-info">Chemistry Department, Gedeon Richter Plc., Gyömrői út. 19-21, 1107 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gerg%C5%91++Darg%C3%B3">Gergő Dargó</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dávid Bajusz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dávid Bajusz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Research Group, Research Centre for Natural Sciences, Magyar tudósok krt. 2, 1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=D%C3%A1vid++Bajusz">Dávid Bajusz</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4277-9481" title="Orcid link">http://orcid.org/0000-0003-4277-9481</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kristóf Simon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristóf Simon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, Műegyetem rakpart 3, 1111 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Krist%C3%B3f++Simon">Kristóf Simon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Judit Müller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Judit Müller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Laboratory II, Gedeon Richter Plc., Gyömrői út. 19-21, 1107 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Judit++M%C3%BCller">Judit Müller</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">György T. Balogh</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">György T. Balogh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Műegyetem rakpart 3, 1111 Budapest, Hungary</div><div class="loa-info-affiliations-info">Chemistry Department, Gedeon Richter Plc., Gyömrői út. 19-21, 1107 Budapest, Hungary</div><div class="loa-info-affiliations-info">Department of Pharmacodynamics and Biopharmacy, University of Szeged, 6720 Szeged, Hungary</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#97f0eee3f5f6fbf8f0ffd7faf6fefbb9f5faf2b9ffe2"><span class="__cf_email__" data-cfemail="15726c617774797a727d5578747c793b7778703b7d60">[email protected]</span></a>. Phone: +36 1 463 2174.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gy%C3%B6rgy+T.++Balogh">György T. Balogh</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8273-1760" title="Orcid link">http://orcid.org/0000-0001-8273-1760</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00046&amp;href=/doi/10.1021%2Facs.jmedchem.0c00046" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1763–1774</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 29, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 January 2020</li><li><span class="item_label"><b>Published</b> online</span>29 January 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00046" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00046</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00046"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3448</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00046" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gergő&quot;,&quot;last_name&quot;:&quot;Dargó&quot;},{&quot;first_name&quot;:&quot;Dávid&quot;,&quot;last_name&quot;:&quot;Bajusz&quot;},{&quot;first_name&quot;:&quot;Kristóf&quot;,&quot;last_name&quot;:&quot;Simon&quot;},{&quot;first_name&quot;:&quot;Judit&quot;,&quot;last_name&quot;:&quot;Müller&quot;},{&quot;first_name&quot;:&quot;György&quot;,&quot;last_name&quot;:&quot;T. Balogh&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;1763-1774&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00046&quot;},&quot;abstract&quot;:&quot;The knowledge on human serum albumin (HSA) binding is of utmost importance as it affects pharmacokinetic behavior and bioavailability of drugs. In this article, we report a novel method to screen for ionizable molecules with high HSA binding affinity based on pKa shifts using UV-pH titration. We investigated the HSA binding of 27 drugs and compared the results to experimental data from conventional methods. In most cases, significant shifts (ΔpKa &gt; 0.1) were observed for drugs with high HSA binding, while no change could be detected for low-affinity binders. We showed the pivotal role of ionization centers in the formation of strong interactions between drug and HSA using molecular docking studies. We also verified our findings by testing five modified analogues designed by structural considerations. Significant decreases in their HSA binding proved that the UV-pH titration method combined with an in silico support can be used as a medicinal chemistry tool to assist rational molecular design.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00046&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00046" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00046&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00046" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00046&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00046" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00046&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00046&amp;href=/doi/10.1021/acs.jmedchem.0c00046" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00046" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00046" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00046%26sid%3Dliteratum%253Aachs%26pmid%3D31995375%26genre%3Darticle%26aulast%3DDarg%25C3%25B3%26date%3D2020%26atitle%3DHuman%2BSerum%2BAlbumin%2BBinding%2Bin%2Ba%2BVial%253A%2BA%2BNovel%2BUV-pH%2BTitration%2BMethod%2BTo%2BAssist%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D4%26spage%3D1763%26epage%3D1774%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292580" title="Binding modes">Binding modes</a>,</li><li><a href="/action/doSearch?ConceptID=291309" title="Reaction mechanisms">Reaction mechanisms</a>,</li><li><a href="/action/doSearch?ConceptID=291342" title="Absorption">Absorption</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=292219" title="Titration">Titration</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/jmcmar.2020.63.issue-4/20200227/jmcmar.2020.63.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The knowledge on human serum albumin (HSA) binding is of utmost importance as it affects pharmacokinetic behavior and bioavailability of drugs. In this article, we report a novel method to screen for ionizable molecules with high HSA binding affinity based on p<i>K</i><sub>a</sub> shifts using UV-pH titration. We investigated the HSA binding of 27 drugs and compared the results to experimental data from conventional methods. In most cases, significant shifts (Δp<i>K</i><sub>a</sub> > 0.1) were observed for drugs with high HSA binding, while no change could be detected for low-affinity binders. We showed the pivotal role of ionization centers in the formation of strong interactions between drug and HSA using molecular docking studies. We also verified our findings by testing five modified analogues designed by structural considerations. Significant decreases in their HSA binding proved that the UV-pH titration method combined with an in silico support can be used as a medicinal chemistry tool to assist rational molecular design.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24182" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24182" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Active pharmaceutical ingredients (API) entering the systematic circulation may interact with various components of the blood, which directly affects their pharmacokinetic and pharmacodynamic behaviors.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> Blood plasma consists of approximately 7–9% of plasma proteins (albumins, glycoproteins, and fibrinogen), which contribute a major part to API-specific interactions. Among them, human serum albumin (HSA) is the most abundant (about 54–60% of blood proteins),<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> which is present in the blood at particularly high concentrations (35–50 g/L).<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8−11)</a> It plays an important role in maintaining the osmotic pressure of the blood, serves as a transport protein for endogenous substances (e.g., fatty acids and steroid hormones), and it is also the main contributor to the binding of drug molecules.<a onclick="showRef(event, 'ref5 ref7 ref8 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref7 ref8 ref10">(5,7,8,10)</a> The protein’s heart-shaped structure is composed of three main domains (I–III), each containing two subdomains (A and B).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> Besides the several recently identified low- to high-affinity binding sites of HSA,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> the two specific drug binding sites (site I: warfarin site on the IIA subdomain and site II: indole-benzodiazepine site on the IIIA subdomain) are considered to be the most significant, regarding plasma protein binding.<a onclick="showRef(event, 'ref8 ref11 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref8 ref11 ref14 ref15 ref16 ref17 ref18">(8,11,14−18)</a> Drug molecules usually form reversible complexes with HSA by electrostatic and hydrophobic interactions. These HSA–API complexes cannot cross biological membranes; therefore, they become therapeutically inactive.<a onclick="showRef(event, 'ref5 ref19'); return false;" href="javascript:void(0);" class="ref ref5 ref19">(5,19)</a> Moreover, strong binding may also have a significant effect on the pharmacokinetic (PK) behavior of APIs (e.g., altered clearance,<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> distribution,<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> drug–drug interactions,<a onclick="showRef(event, 'ref19 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref23">(19,23)</a> and toxicity<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>). The HSA binding affinity shows wide diversity for drug-like compounds; thus, it is essential to predict the unbound fraction of APIs from the early stages of drug discovery for the estimation of PK behavior.</div><div class="NLM_p">For the measurement of HSA-binding properties of APIs, several in vitro methods exist,<a onclick="showRef(event, 'ref18 ref19 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref25 ref26 ref27">(18,19,25−27)</a> including equilibrium dialysis (ED),<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> ultrafiltration (UF),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> ultracentrifugation,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> chromatographic methods,<a onclick="showRef(event, 'ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35">(32−35)</a> NMR spectroscopy,<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> X-ray crystallography,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> capillary electrophoresis (CE),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> etc. These methods differ in throughput and time of the measurement have different sample requirements and limitations, and each has its advantages and disadvantages (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.). Also, most of the methods are able to provide information solely about the APIs’ affinity to HSA, while structural information regarding the interactions between HSA and APIs can be acquired by only a few timely and expensive techniques (e.g., NMR and X-ray diffraction). Besides the experimental methods, in silico models can be used to predict HSA binding, while molecular modeling studies can also be used to explore possible binding modes between HSA and APIs, providing additional structural information on complex formation.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> To give a thoroughly detailed description of the complexes, data from orthogonal methods are needed to be evaluated and compared simultaneously.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of Commonly Used Experimental Methods for the Investigation of HSA–API binding<a onclick="showRef(event, 'ref18 ref19 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref25 ref26 ref27">(18,19,25−27)</a><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">method type</th><th class="colsep0 rowsep0" align="center">measurement time/throughput</th><th class="colsep0 rowsep0" align="center">pros</th><th class="colsep0 rowsep0" align="center">cons</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">Quantitative Binding Data</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left">chromatography and capillary electrophoresis<a onclick="showRef(event, 'ref32 ref33 ref34 ref35 ref39'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35 ref39">(32−35,39)</a></td><td class="colsep0 rowsep0" rowspan="5" align="left">0.5 h/API HT</td><td class="colsep0 rowsep0" align="left">accurate results</td><td class="colsep0 rowsep0" align="left">nonbiological systems</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">no NSB, volume shift, or membrane leakage</td><td class="colsep0 rowsep0" align="left">calibration of immobilized HSA column is needed before measurements</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">high solvent consumption and waste generation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">poor sensitivity for low-binding APIs</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">expensive chiral columns</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">membrane separation methods</td><td class="colsep0 rowsep0" rowspan="4" align="left"> </td><td class="colsep0 rowsep0" rowspan="4" align="left">reliable results</td><td class="colsep0 rowsep0" align="left">Gibbs–Donnan effects</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NSB on filter membranes and plastic devices</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">possible leakage of membrane</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">subsequent HPLC measurements</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">equilibrium dialysis (ED)</td><td class="colsep0 rowsep0" rowspan="3" align="left">3 to 24 h</td><td class="colsep0 rowsep0" rowspan="3" align="left"> </td><td class="colsep0 rowsep0" align="left">long time to reach equilibrium</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">volume shifts during incubation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dilution effects</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">rapid equilibrium dialysis (RED)<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a></td><td class="colsep0 rowsep0" rowspan="3" align="left">2–7 h HT</td><td class="colsep0 rowsep0" align="left">reaching equilibrium faster than ED</td><td class="colsep0 rowsep0" align="left">possible leakage of membrane</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">small volumes can be measured</td><td class="colsep0 rowsep0" rowspan="2" align="left">plate accessories can be expensive (although inexpensive devices have been developed<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NSB and volume shifts minimalized</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">ultrafiltration (UF)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></td><td class="colsep0 rowsep0" rowspan="3" align="left">1–2 h HT</td><td class="colsep0 rowsep0" align="left">fast separation of free and protein-bound API</td><td class="colsep0 rowsep0" align="left">NSB on filter membrane and device</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">small volumes can be measured</td><td class="colsep0 rowsep0" align="left">possibility of molecular sieving</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">good approximation of physiological conditions</td><td class="colsep0 rowsep0" align="left">pH and temperature controls are more difficult</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left">ultracentrifugation<a onclick="showRef(event, 'ref31 ref42'); return false;" href="javascript:void(0);" class="ref ref31 ref42">(31,42)</a></td><td class="colsep0 rowsep0" rowspan="5" align="left">10–24 h MT</td><td class="colsep0 rowsep0" rowspan="5" align="left">moderate NSB and Donnan effect</td><td class="colsep0 rowsep0" align="left">time-consuming, careful pH and temperature controls are needed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">errors due to the Johnston–Ogston effect</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sedimentation of unbound API may occur</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sample harvesting is difficult due to the floating lipid layer</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">expensive instrumentation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">Structural Information</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">X-ray crystallography<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></td><td class="colsep0 rowsep0" rowspan="4" align="left">days to months, LT</td><td class="colsep0 rowsep0" align="left">yields the most accurate structural information</td><td class="colsep0 rowsep0" align="left">impurities of the protein may hinder crystallization</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">binding sites can be identified</td><td class="colsep0 rowsep0" align="left">difficulty to determine correct crystallization conditions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility problems of API may arise</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">precipitation or growth of tiny crystals may occur</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">Binding and Structural Information</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">NMR<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a></td><td class="colsep0 rowsep0" rowspan="2" align="left">hours to days, LT</td><td class="colsep0 rowsep0" align="left">noninvasive technique</td><td class="colsep0 rowsep0" rowspan="2" align="left">APIs with low aqueous solubility cannot be measured in physiological buffers</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no separation step or subsequent measurement needed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">UV-pH titration</td><td class="colsep0 rowsep0" rowspan="3" align="left">0.5 h<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> to 1–2 h MT</td><td class="colsep0 rowsep0" align="left">fast method for screening</td><td class="colsep0 rowsep0" align="left">only ionizable molecules can be measured</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">may provide additional structural information of binding</td><td class="colsep0 rowsep0" rowspan="2" align="left">absorbance of HSA may interfere</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APIs with low aqueous solubility can be measured</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">API, active pharmaceutical ingredient; NSB, nonspecific binding; HT, high throughput; MT, medium throughput; and LT, low throughput.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">If aqueous p<i>K</i><sub>a</sub> values without HSA have already been determined.</p></div></div></div><div class="NLM_p">This study aims to present a UV-pH titration method as a novel approach to screen for high-affinity HSA-binding ionizable APIs. By means of the method, additional structural information might also be gathered, and the role of ionization centers in the interaction between HSA and APIs can be further elucidated to help medicinal chemists in their efforts toward rational molecular design.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Theoretical Basis of UV-pH Titration</h3><div class="NLM_p">Spectrophotometry can be applied for the measurement of proton dissociation constants (p<i>K</i><sub>a</sub>) provided that the compound has a chromophore in proximity to the ionization center and the absorbance changes sufficiently as a function of pH. In aqueous solutions, the dissociation equilibrium of a monoprotic acid and the acid dissociation constant (<i>K</i><sub>a</sub>) can be written as<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m001.gif" alt="" id="_i5" /></img><span class="labelSpan">(1)</span></span><span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m002.gif" alt="" id="_i6" /></img><span class="labelSpan">(2)</span></span>where HA and A<sup>–</sup> are the neutral and dissociated forms of the acid, respectively. After rearrangement of <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a> and taking logarithms, we acquire the Henderson–Hasselbalch equation<span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m003.gif" alt="" id="_i7" /></img><span class="labelSpan">(3)</span></span></div><div class="NLM_p">If there is a pH-dependent change in absorbance, the ratio of HA and A<sup>–</sup> can be determined spectrophotometrically.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> At a pH where the molecule exists entirely in its neutral form, its absorbance at a given wavelength is given by<span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m004.gif" alt="" id="_i8" /></img><span class="labelSpan">(4)</span></span>where ε<sub>HA</sub> and [HA] are the molar absorption coefficient and concentration of HA, respectively, and <i>l</i> is the optical path length. At a pH where the molecule exists entirely in its dissociated form, the absorbance of A<sup>–</sup> is given by<span class="NLM_disp-formula" id="eq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m005.gif" alt="" id="_i9" /></img><span class="labelSpan">(5)</span></span>where ε<sub>A<sup>–</sup></sub> and [A<sup>–</sup>] are the molar absorption coefficient and concentration of A<sup>–</sup>, respectively. At an intermediate pH where both species are present, the absorbance is given as<span class="NLM_disp-formula" id="eq6"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m006.gif" alt="" id="_i10" /></img><span class="labelSpan">(6)</span></span></div><div class="NLM_p">Combining <a class="ref internalNav" href="#eq4" aria-label="eqs 4">eqs 4</a>–<a class="ref internalNav" href="#eq6" aria-label="6">6</a>, the ratio of HA and A<sup>–</sup> can be written as<span class="NLM_disp-formula" id="eq7"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m007.gif" alt="" id="_i11" /></img><span class="labelSpan">(7)</span></span></div><div class="NLM_p">Combining <a class="ref internalNav" href="#eq3" aria-label="eqs 3">eqs 3</a> and <a class="ref internalNav" href="#eq7" aria-label="7">7</a> provides a modified Henderson–Hasselbalch equation, which can be used to calculate p<i>K</i><sub>a</sub> values based on absorbance changes<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><span class="NLM_disp-formula" id="eq8"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m008.gif" alt="" id="_i12" /></img><span class="labelSpan">(8)</span></span></div><div class="NLM_p">If the conditions for UV-pH measurements coincide, then this method is the fastest way for the determination of p<i>K</i><sub>a</sub> values (approximately 20–25 min/3 parallel measurements). Furthermore, the sample requirement of built-in UV-pH methods of the SiriusT3 instrument is also minuscule, and only 5 μL of a 10 mM stock solution (DMSO, MeCN, etc.) of the API is needed in a titration volume of 1 mL. Also, measurements in the presence of co-solvents, macromolecules, or additives may be possible, making it an ideal choice for complexation studies as well.</div><div class="NLM_p">Upon complexation with macromolecules (e.g., cyclodextrins, crown ethers, proteins, etc.), the dissociation equilibrium and the acid dissociation constant can be written as<span class="NLM_disp-formula" id="eq9"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m009.gif" alt="" id="_i13" /></img><span class="labelSpan">(9)</span></span><span class="NLM_disp-formula" id="eq10"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m010.gif" alt="" id="_i14" /></img><span class="labelSpan">(10)</span></span>where G is the guest molecule, and <i>K</i><sub class="stack">a</sub><sup class="stack">*</sup> is the apparent proton dissociation constant of the complexed API. Due to different absorption properties of the complexed species, a significant spectral change may occur.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> If absorption of the guest molecule is negligible and addition of absorbances is assumed, then the absorbances of the molecular species can be given as<span class="NLM_disp-formula" id="eq11"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m011.gif" alt="" id="_i15" /></img><span class="labelSpan">(11)</span></span><span class="NLM_disp-formula" id="eq12"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m012.gif" alt="" id="_i16" /></img><span class="labelSpan">(12)</span></span><span class="NLM_disp-formula" id="eq13"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_m013.gif" alt="" id="_i17" /></img><span class="labelSpan">(13)</span></span></div><div class="NLM_p last">Substituting <a class="ref internalNav" href="#eq11" aria-label="eqs 11">eqs 11</a>–<a class="ref internalNav" href="#eq13" aria-label="13">13</a> into <a class="ref internalNav" href="#eq8" aria-label="eq 8">eq 8</a>, the apparent p<i>K</i><sub>a</sub> values (p<i>K</i><sub>a,app</sub>) can be calculated with shifts from p<i>K</i><sub>a</sub> values that are proportional to the ratio of bound and unbound fractions.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> HSA-Binding Measurements by UV-pH Titration</h3><div class="NLM_p">We investigated the possibility of measuring HSA binding of APIs based on changes of proton dissociation constants of their free and complexed molecular forms using UV-pH titration. First, we collected UV–vis absorbance data of HSA during the UV-pH titration assay to determine if the presence of HSA would interfere with the signal of APIs. As can be seen in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> (left), HSA has two p<i>K</i><sub>a</sub> values (p<i>K</i><sub>a1</sub> = 3.87 and p<i>K</i><sub>a2</sub> = 11.56), which are measurable by UV-pH titration. If we add HSA to the blank UV-pH titration assay (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, right), it annuls the spectral changes belonging to the first p<i>K</i><sub>a</sub> value; however, the second p<i>K</i><sub>a</sub> value remains detectable even after blank correction. Therefore, even though the intensity of the signals of the second p<i>K</i><sub>a</sub> value is decreased, we must consider the presence of overlapping absorption bands during titrations of APIs.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. pH-dependent UV–vis absorbance changes and detectable p<i>K</i><sub>a</sub> values of HSA in the absence (left) and in the presence (right) of blank correction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we investigated HSA binding of APIs by measuring their p<i>K</i><sub>a</sub> values in aqueous medium in the absence of HSA and in the presence of HSA (p<i>K</i><sub>a,HSA</sub>). <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> shows some examples of the acquired spectra and experimental p<i>K</i><sub>a</sub> values in the presence and absence of HSA. We observed significant p<i>K</i><sub>a</sub> shifts (Δp<i>K</i><sub>a</sub>) for several APIs, while others showed no change of p<i>K</i><sub>a</sub> values upon addition of HSA (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_001.pdf" class="ext-link">Table S1</a>, Supporting Information). In the case of molecules with multiple protonation centers, their p<i>K</i><sub>a</sub> values changed to varying extent; we proposed that this might indicate which part of the molecule contributes more to the binding to HSA. This was later confirmed by molecular docking studies (see the next section for further details). In some cases, absorption bands of HSA suppressed the absorbance of the API; therefore, p<i>K</i><sub>a,HSA</sub> could not be determined. This usually occurred in the case of APIs with only minuscule pH-dependent absorbance changes in their spectrum in aqueous medium (e.g., diltiazem, imipramine, indomethacin, and propranolol) or in the case of p<i>K</i><sub>a</sub> values higher than ∼10 (e.g., furosemide p<i>K</i><sub>a2</sub> and amodiaquine p<i>K</i><sub>a3</sub>) where the signals of p<i>K</i><sub>a2</sub> of HSA interfered. We could avoid this latter problem if the API had significant absorption at wavelengths higher than 320 nm (e.g., chloroquine p<i>K</i><sub>a2</sub>, nitrazepam p<i>K</i><sub>a2</sub>, and oxazepam p<i>K</i><sub>a2</sub>), where no interference with HSA absorption bands was observed and thus evaluation of data was possible.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Absorbance spectra and detectable p<i>K</i><sub>a</sub> values of diclofenac (DIC), phenylbutazone (PHB), piroxicam (PIR), and procaine (PRC) in the presence and absence of HSA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Literature Data and Experimental Values of HSA Binding by Chromatographic, Rapid Equilibrium Dialysis (RED), and UV-pH Titration Measurements</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">literature data</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">experimental data</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">UV-pH titration</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">API name</th><th class="colsep0 rowsep0" align="center">PPB%<a onclick="showRef(event, 'ref4 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref4 ref45 ref46 ref47">(4,45−47)</a></th><th class="colsep0 rowsep0" align="center" char=".">HSA% (HPLC)<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a></th><th class="colsep0 rowsep0" align="center" char=".">HSA% (HPLC)</th><th class="colsep0 rowsep0" align="center">HSA% (RED)</th><th class="colsep0 rowsep0" align="center">Δp<i>K</i><sub>a1</sub></th><th class="colsep0 rowsep0" align="center">Δp<i>K</i><sub>a2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amodiaquine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">78.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.12 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.64 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cefuroxime</td><td class="colsep0 rowsep0" align="left">33 ± 3; 31.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">40.1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">chloroquine</td><td class="colsep0 rowsep0" align="left">(<i>S</i>): 66.6 ± 3.3</td><td class="colsep0 rowsep0" rowspan="2" align="char" char="."> </td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">50.5<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" rowspan="2" align="left"> </td><td class="colsep0 rowsep0" rowspan="2" align="left">0.21 ± 0.03</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.75 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>): 42.7 ± 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diazepam</td><td class="colsep0 rowsep0" align="left">98.7 ± 0.2; 99</td><td class="colsep0 rowsep0" align="char" char=".">93.2</td><td class="colsep0 rowsep0" align="char" char=".">89.2</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.09 ± 0.03</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diclofenac</td><td class="colsep0 rowsep0" align="left">>99.5; 99.5</td><td class="colsep0 rowsep0" align="char" char=".">99.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">95.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.47 ± 0.01</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diclofenac ethyl ester</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">98.1</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diflunisal</td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="char" char=".">98.7</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">0.38 ± 0.04</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diflunisal ethyl ester</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">97.5</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diltiazem</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="char" char=".">53.9</td><td class="colsep0 rowsep0" align="char" char=".">56.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">famotidine</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="char" char=".">14.5</td><td class="colsep0 rowsep0" align="char" char=".">25.1</td><td class="colsep0 rowsep0" align="left">4.4 ± 2.6</td><td class="colsep0 rowsep0" align="left">0.02 ± 0.03</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">furosemide</td><td class="colsep0 rowsep0" align="left">98.4</td><td class="colsep0 rowsep0" align="char" char=".">63.8</td><td class="colsep0 rowsep0" align="char" char=".">99.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.10 ± 0.01</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">imipramine</td><td class="colsep0 rowsep0" align="left">90.1 ± 1.4; 92.6</td><td class="colsep0 rowsep0" align="char" char=".">83.1</td><td class="colsep0 rowsep0" align="char" char=".">84.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">indomethacin</td><td class="colsep0 rowsep0" align="left">90; 92–99</td><td class="colsep0 rowsep0" align="char" char=".">99.5</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">95.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">isoniazid</td><td class="colsep0 rowsep0" align="left">∼0</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">10.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.05 ± 0.03</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">isoxicam</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">97.3</td><td class="colsep0 rowsep0" align="left">80.4 ± 0.8</td><td class="colsep0 rowsep0" align="left">0.22 ± 0.05</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lornoxicam</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">98.0 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.87 ± 0.23<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1.00 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">meloxicam</td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">99.9</td><td class="colsep0 rowsep0" align="left">96.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.16 ± 0.23<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.55 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>O</i>-methyl meloxicam</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">84.2</td><td class="colsep0 rowsep0" align="left">65.9 ± 1.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">metronidazole</td><td class="colsep0 rowsep0" align="left">10; 11 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">11.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.00 ± 0.01</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nitrazepam</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">82.3</td><td class="colsep0 rowsep0" align="char" char=".">76.7</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.05 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.98 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oxazepam</td><td class="colsep0 rowsep0" align="left">98.4</td><td class="colsep0 rowsep0" align="char" char=".">94.2</td><td class="colsep0 rowsep0" align="char" char=".">79.9, 89.5</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.06 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.27 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phenylbutazone</td><td class="colsep0 rowsep0" align="left">97.8; 98–99</td><td class="colsep0 rowsep0" align="char" char=".">98.4</td><td class="colsep0 rowsep0" align="char" char=".">99.9</td><td class="colsep0 rowsep0" align="left">96.3 ± 0.5</td><td class="colsep0 rowsep0" align="left">0.53 ± 0.05</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i>-methyl phenylbutazone</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">85.0</td><td class="colsep0 rowsep0" align="left">64.1 ± 1.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>O</i>-methyl phenylbutazone</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">92.9</td><td class="colsep0 rowsep0" align="left">92.9 ± 1.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">physostigmine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">20.0</td><td class="colsep0 rowsep0" align="left">9.7 ± 6.6</td><td class="colsep0 rowsep0" align="left">0.05 ± 0.03</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">piroxicam</td><td class="colsep0 rowsep0" align="left">99; 99</td><td class="colsep0 rowsep0" align="char" char=".">96.8</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">93.3 ± 0.3</td><td class="colsep0 rowsep0" align="left">0.00 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.55 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">procaine</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="char" char=".">36.0</td><td class="colsep0 rowsep0" align="char" char=".">21.0</td><td class="colsep0 rowsep0" align="left">6.4 ± 0.4</td><td class="colsep0 rowsep0" align="left">0.02 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.00 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">propranolol</td><td class="colsep0 rowsep0" align="left">87 ± 6; 87</td><td class="colsep0 rowsep0" align="char" char=".">62.0</td><td class="colsep0 rowsep0" align="char" char=".">62.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sulindac</td><td class="colsep0 rowsep0" align="left">94; 93.5</td><td class="colsep0 rowsep0" align="char" char=".">92.0</td><td class="colsep0 rowsep0" align="char" char=".">98.2</td><td class="colsep0 rowsep0" align="left">64.9 ± 6.9</td><td class="colsep0 rowsep0" align="left">0.16 ± 0.06</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tenoxicam</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="left">96.8 ± 0.0</td><td class="colsep0 rowsep0" align="left">0.13 ± 0.11<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.72 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">trimethoprim</td><td class="colsep0 rowsep0" align="left">37.5; 41.5</td><td class="colsep0 rowsep0" align="char" char=".">37.6</td><td class="colsep0 rowsep0" align="char" char=".">37.3</td><td class="colsep0 rowsep0" align="left">3.1 ± 4.6</td><td class="colsep0 rowsep0" align="left">0.01 ± 0.02</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">warfarin</td><td class="colsep0 rowsep0" align="left">99 ± 1; 99</td><td class="colsep0 rowsep0" align="char" char=".">97.9</td><td class="colsep0 rowsep0" align="char" char=".">99.9, 100.0</td><td class="colsep0 rowsep0" align="left">91.5 ± 0.7</td><td class="colsep0 rowsep0" align="left">0.41 ± 0.05</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Experimental data has been measured using a racemic compound.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">HSA binding could not be determined due to chemical decomposition during incubation.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">HSA suppressed the absorbance of the API, and p<i>K</i><sub>a,HSA</sub> could not be determined.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">High standard deviations originate from extrapolated p<i>K</i><sub>a</sub> values, out of the measurement range of UV-pH titration.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Comparison of the Results with Reference Values</h3><div class="NLM_p">To compare our results with data from orthogonal methods, we also measured HSA binding of the APIs using chromatographic measurements on an immobilized HSA column using rapid equilibrium dialysis (RED) and carried out molecular docking of some APIs (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) into the crystal structure of HSA. We found that in the case of compounds with high HSA binding, significant shifts (Δp<i>K</i><sub>a</sub> > 0.1) could be observed for at least one p<i>K</i><sub>a</sub> value, while no change of p<i>K</i><sub>a</sub> values can be expected for APIs with lower HSA binding (HSA% less than ∼40%). However, in some cases (e.g., diazepam (DZP)), the results of UV-pH titration (Δp<i>K</i><sub>a</sub> = 0.09) contradicted the data from orthogonal methods (HSA binding, >90%).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of APIs investigated by molecular modeling studies. CHQ, chloroquine; DIC, diclofenac; DIF, diflunisal; DZP, diazepam; MEL, meloxicam; NZP, nitrazepam; PHB, phenylbutazone; PIR, piroxicam; and TEN, tenoxicam.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among the studied drugs, p<i>K</i><sub>a</sub> shifts (from free to HSA-bound form) around or greater than 0.4 units were observed for chloroquine (CHQ; Δp<i>K</i><sub>a2</sub>, 0.75), diclofenac (DIC; Δp<i>K</i><sub>a,</sub> 0.47), diflunisal (DIF; Δp<i>K</i><sub>a2</sub>, 0.38), meloxicam (MEL; Δp<i>K</i><sub>a2</sub>, 0.55), nitrazepam (NZP; Δp<i>K</i><sub>a2</sub>, 0.98), phenylbutazone (PHB; Δp<i>K</i><sub>a,</sub> 0.53), piroxicam (PIR; Δp<i>K</i><sub>a2</sub>, 0.55), and tenoxicam (TEN; Δp<i>K</i><sub>a2</sub>, 0.72). In each case, the p<i>K</i><sub>a</sub> shifted toward a more acidic value, favoring the deprotonated form of the APIs when bound to HSA. To understand the structural basis of these changes, the available X-ray structures of human serum albumin (HSA) were scrutinized. From the mentioned APIs, co-crystallized structures with HSA exist for DIC (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z69">4Z69</a><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>), DIF (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXE">2BXE</a><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a>), and PHB (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXC">2BXC</a><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a>). Notably, DIC and PHB bind to drug site I (“warfarin site”), while DIF binds to drug site II (indole-benzodiazepine site). Although the exact hydrogen positions are not available at the resolution of these structures, the immediate vicinity of the ligand protonatable groups to positively charged amino acids (such as the K195-K199-R218-R222 cluster in drug site I or R410-K414 in drug site II) strongly implies the preference toward the deprotonated forms of the APIs. The experimental binding modes were evaluated with the extra precision (XP) mode of Glide for both the protonated and deprotonated forms (refinement only): per-residue Coulomb interaction scores between the ligands and the mentioned charged residues confirm this implication (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Refined experimental binding modes for the deprotonated (green) and protonated (magenta) forms of (A) diclofenac, (B) phenylbutazone, and (C) diflunisal (C). Coulomb interaction scores with the most important interacting residues are shown in matching colors, the smaller the better. (While in phenylbutazone, formally, the ring CH gets deprotonated, and practically, the negative charge is located on one of the oxo groups due to tautomerization).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the remaining five APIs, Glide XP was used to predict their binding modes in the two drug sites of HSA by docking to the X-ray structures <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXC">2BXC</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXE">2BXE</a>. The poses were inspected with regard to the vicinity of the protonatable groups (specifically, the ones with the significant p<i>K</i><sub>a</sub> shifts) to potential ionic interaction partners. For four APIs, such a binding pose was identified in drug site I (as the most favorable binding pose in each case), and the differences of the Coulomb interaction scores confirm the preference toward the deprotonated forms (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). For CHQ (the only API with a formal positive charge in its protonated form), no such binding mode was identified in either drug site. We propose that in the case of CHQ, the deprotonated form is favored because ligand entry to both drug sites is hindered for the protonated form due to the repulsive interactions with the positively charged residue clusters at the entry points of the sites (K195-K199-R218-R222 in drug site I and R410-K414 in drug site II, see also <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Refined predicted binding modes for the deprotonated (green) and protonated (magenta) forms of (A) meloxicam, (B) nitrazepam, (C) piroxicam, and (D) tenoxicam. Coulomb interaction scores with the most important interacting residues are shown in matching colors, the smaller the better.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Due to the contradictory UV-pH titration results of DZP, to find possible explanations, we compared X-Ray structures (where available) and predicted binding modes of DZP and its structural analogue NZP (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). In the X-ray structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXD">2BXD</a>, DZP occupies drug site II (A), with its only protonatable nitrogen being too far from the R485 residue to make direct contact. Although its predicted binding mode in site I (B) would justify a p<i>K</i><sub>a</sub> shift (the same nitrogen being only 3.0 Å away from R257), binding to this site is not observed in the crystal structure, suggesting that site II is clearly preferred. Thus, the protonatable nitrogen will not be able to directly interact with HSA, which can explain the smaller than expected p<i>K</i><sub>a</sub> shift. On the contrary, in the predicted binding mode of NZP to drug site II (C), the deprotonatable amide nitrogen is too far from R410 to make direct contact, but the predicted binding mode in drug site I (D) nicely supports the observed p<i>K</i><sub>a</sub> shift of 0.56 units (by placing the amide nitrogen 3.4 Å away from R257), suggesting the preference of NZP toward drug site I.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of crystallographic and predicted binding modes of (A, B) diazepam and (C, D) nitrazepam, with distances of the relevant protonatable groups to the closest charged residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Use of UV-pH Titration To Assist Medicinal Chemistry</h3><div class="NLM_p">As the previous examples show, UV-pH titration combined with molecular modeling can be used to identify the role of ionization centers in the formation of strong API–HSA interactions. The information gathered this way might be used to help chemists to design molecules with decreased HSA binding, which might improve the API pharmacokinetics and increase their bioavailability. For validation purposes, some of the APIs with considerable p<i>K</i><sub>a</sub> shifts (DIC, DIF, MEL, and PHB) were modified by ester formation or alkylation to neutralize their protonatable groups; these analogues were evaluated with the same protocols as described above.</div><div class="NLM_p">The chromatographic measurements showed a significant decrease in retention time for each modified API, indicating a lower HSA binding affinity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). We observed moderate decreases in binding for DIC ethyl ester (100% → 98.1%) and DIF ethyl ester (100% → 97.5%) and extensive decreases in the case of <i>O</i>-methyl MEL (99.9% → 84.2%), <i>O</i>-methyl PHB (99.9% → 92.9%), and <i>C</i>-methyl PHB (99.9% → 85.0%). RED measurements also showed significant decreases in the binding of modified MEL (99.9% → 65.9%) and PHB (99.9% → 92.9% (<i>O</i>-methyl PHB) and 99.9% → 85.0% (<i>C</i>-methyl PHB)), while HSA binding could not be determined this way for the esters of DIC and DIF due to their instability under the measurement conditions of RED (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Chromatograms of diclofenac (DIC), diflunisal (DIF), meloxicam (MEL), phenylbutazone (PHB), and their modified forms with neutralized ionization centers. (Due to low absorbance of <i>O</i>-methyl MEL, its extracted ion chromatogram (EIC) (<i>m/z</i> = 366.0) was also used for peak identification).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further support the experimental results, molecular docking studies have also been carried out to compare binding modes of the analogues. For the ethyl ester of DIF, the <i>O</i>- and <i>C</i>-methylated PHB, and the ethyl ester of DIC, the top binding modes predicted by Glide XP docking were closely similar to their respective unmodified counterparts. Nonetheless, the Coulomb interaction scores against the charged residues were small, as expected (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). For <i>O</i>-methyl MEL, unrestrained Glide XP docking could not identify a binding mode similar to that of the unmodified API. When restricted to the reference binding mode of meloxicam, the modified analogue exhibits repulsive Coulomb interaction scores, while in its unrestricted binding mode, the interaction scores confer slightly and in one case (K199), moderately attractive contributions, similar to the other analogues.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Predicted binding modes for (A) diflunisal ethyl ester, (B) <i>C</i>-methyl phenylbutazone, (C) <i>O</i>-methyl phenylbutazone, (D) <i>O</i>-methyl meloxicam, and (E) diclofenac ethyl ester. For methoxy-meloxicam, the binding mode with the core position restricted to the binding mode of meloxicam is shown in orange. Coulomb interaction scores with the most important charged residues are shown in matching colors (the smaller the better): these are mostly slightly attractive (and in some cases, slightly repulsive), similar to the protonated forms of the original APIs. By comparison, the deprotonated forms of the APIs exhibit large negative (strongly attractive) Coulomb contributions (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As the results of experimental measurements and molecular modeling show, we succeeded in using UV-pH titration as a screening tool for identifying structural moieties that make major contribution in formation of complexes with strong binding. By the modification of the APIs, the ionization centers responsible for strong interactions with HSA could be neutralized, resulting in a lower HSA binding. Since even a few percent decreases have a considerable effect on the distribution of APIs,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> the observed decreases in HSA binding (from 2–3 to 10–35%) support the technique’s applicability to help the design of novel molecules with favorable pharmacokinetic behavior.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, we demonstrated the applicability of UV-pH titration as an orthogonal method for the identification of APIs with high-affinity binding. This fast and cost-effective method can be used as a screening assay in the case of molecules containing ionization centers, providing binding data faster than conventional methods. We showed that the observed p<i>K</i><sub>a</sub> shifts (Δp<i>K</i><sub>a</sub>) are proportional to HSA binding of APIs. In the case of multiprotic molecules, by means of molecular docking, we demonstrated that the p<i>K</i><sub>a</sub> shifts of different sizes provide structural information on the binding mode of the API. To elucidate the significance of ionization centers of molecules, we also investigated modified analogues with neutralized protonation centers. The results clearly showed that decreased protein binding can be achieved by this approach, resulting in molecules with improved pharmacokinetics. Therefore, the UV-pH titration method combined with an in silico support might be used as a novel medicinal chemistry tool to assist researchers in the rational drug design to decrease the high attrition rate in later stages of drug discovery. In the future, besides screening for APIs with high-affinity binding, this method might also be used for comparison of binding of a specific API with different kinds of modified HSA derivatives or in the case of different formulations of HSA.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Materials</h3><div class="NLM_p last">Analytical grade solvents such as acetonitrile (MeCN), dimethyl sulfoxide (DMSO), ethanol (absolute), formic acid, trifluoroacetic acid (TFA), and potassium hydroxide (KOH) were purchased from Merck KGaA (Darmstadt, Germany). Analytical grade 2-propanol (IPA), 0.5 M hydrochloric acid, and 0.5 M potassium hydroxide were purchased from Honeywell International Inc. (New Jersey, USA). Albumin from human serum (lyophilized powder, ≥97% (agarose gel electrophoresis) cat. no.: A9511), ammonium acetate (NH<sub>4</sub>OAc), dichloromethane (DCM), ethyl acetate (EtOAc), methyl iodide (MeI), phosphate-buffered saline (PBS) powder, potassium chloride, and the reference materials (acetaminophen, amodiaquine dihydrochloride dihydrate, amoxicillin, ampicillin, antipyrine, aspirin, atenolol, captopril, carbamazepine, cefotaxime sodium, cefuroxime sodium, cephalexin, chloroquine diphosphate, chlorothiazide, chlorpromazine hydrochloride, cimetidine hydrochloride, clonidine hydrochloride, diazepam, diclofenac sodium, diflunisal, diltiazem hydrochloride, diphenhydramine hydrochloride, famotidine, furosemide, imipramine hydrochloride, indomethacin, isoniazid, isoxicam, ketoconazole, meloxicam, metronidazole, naproxen, nifedipine, nitrazepam, oxazepam, phenylbutazone, phenytoin, physostigmine, piroxicam, procaine hydrochloride, propranolol hydrochloride, ranitidine hydrochloride, rifampin, sulfamerazine, sulfamethoxazole, sulindac, terbutaline hemisulfate, trimethoprim, and warfarin) were purchased from Sigma-Aldrich Co., Ltd. (Budapest, Hungary). Diclofenac ethyl ester, ketorolac tromethamine, and <i>O</i>-methyl meloxicam were purchased from Toronto Research Chemicals Inc. (North York, Toronto, Canada). Lornoxicam and tenoxicam were purchased from Carbosynth Ltd. (Compton, Berkshire, United Kingdom). <i>O</i>-methyl phenylbutazone was purchased from Ambinter c/o Greenpharma S.A.S. (Orléans, France). Diflunisal ethyl ester and <i>C</i>-methyl phenylbutazone were synthesized at Gedeon Richter Plc. Compounds possessed a purity of >95% by means of HPLC. (Diflunisal ethyl ester: SHIMADZU prominence modular HPLC system equipped with a photodiode array detector (PDA) and a mass spectrometer equipped with an electrospray ionization source (ESI); column: CORTECS C18+, 90 Å, 2.7 μm (3.0 × 50 mm); retention time = 3.89 min; peak area, 98.76%; eluent A, 0.1% (v/v) formic acid in water; eluent B, MeCN/water 95:5 (v/v) with 0.1% (v/v) formic acid; gradient: 0–4.5 min/2–100% B and 4.5–5.6 min/100% B; flow rate of 1.25 mL/min; detection at 220 ± 4 nm; column temperature: 40 °C. <i>C</i>-methyl phenylbutazone: Agilent 1200 liquid chromatography system equipped with a diode array detector and coupled with an Agilent 6410 triple quadrupole mass spectrometer (QQQ-MS) equipped with an ESI source; column: Kinetex EVO C18, 100 Å, 2.6 μm (3.0 × 100 mm); retention time = 8.60 min; peak area, 99.77%; eluent A, 0.1% (v/v) TFA in water; eluent B, MeCN/water 95:5 (v/v) with 0.1% (v/v) TFA; gradient: 0–15 min/0–100% B and 15–18 min/100% B; flow rate of 1 mL/min; detection at 220 ± 4 nm; column temperature: 45 °C.) For detailed information on their syntheses and confirmation of structures (NMR and HRMS), see the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_001.pdf" class="ext-link">Sections 4–6</a>). Neutral linear buffer (NLB) was purchased from Pion Inc. (U.K.) Ltd. (Forrest Row, United Kingdom). In all experiments, distilled water was purified by the Millipore Milli-Q 140 gradient water purification system.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> UV-pH Titration</h3><div class="NLM_p last">The UV-pH titrations were performed using a fully automated SiriusT3 instrument (Pion Inc., Forest Row, U.K.). Spectrophotometric determination of p<i>K</i><sub>a</sub> values was performed using the built-in fast UV p<i>K</i><sub>a</sub> method, the absorbance changes during the titrations were monitored by the dip-probe absorption spectroscopy (D-PAS) method,<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a> and evaluation and calculation of p<i>K</i><sub>a</sub> values were performed by the SiriusT3Refine software (version 1.1.3.0., Pion Inc., Forest Row, U.K.). For the determination of p<i>K</i><sub>a</sub> values in aqueous media, 5 μL of 10 mM DMSO solution of the samples was titrated from pH 2.0 to pH 12.0 in 1.5 mL ionic strength adjusted water (ISA-water: 0.15 M KCl; the initial sample concentration is approximately 33.3 μM). In the case of determination of p<i>K</i><sub>a</sub> values in the presence of HSA (p<i>K</i><sub>a,HSA</sub>), a modified fast UV assay was used: ISA-water solutions containing HSA (33.3 μM, with a 1:1 nominal molar ratio of HSA and APIs) were added manually in advance to the titration vials. All measurements were performed under a nitrogen atmosphere at <i>T</i> = 25.0 ± 0.1 °C. The pH region 2.0–10.0 and the spectral region of 250–450 nm were used in the analysis, and the results were calculated from a minimum of three replicates in each case.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Molecular Docking</h3><div class="NLM_p">Ligand and protein structures were prepared with the standard tools of the Schrödinger software package,<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> based on the OPLS3 force field.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> For ligand docking and the generation of per-residue interaction scores, the extra precision mode (XP) of Glide was used.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> The publicly available PDB structures <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXC">2BXC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXE">2BXE</a>,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z69">4Z69</a><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> were used for evaluating the experimental binding modes of PHB, DIF, and DIC, respectively. For the additional five APIs, the structures 2BXC and 2BXE were used to generate predicted binding modes with Glide XP, after validating them by redocking their cognate ligands into the respective binding pockets. (RMSD values between experimental and predicted poses were 1.40 and 1.01 Å for <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXC">2BXC</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXE">2BXE</a>, respectively, and 5.60 Å for <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z69">4Z69</a>; therefore, this structure was omitted from further use.) The best identified binding pose was refined for both the protonated and deprotonated forms of the APIs.</div><div class="NLM_p last">For detailed description of HSA-binding measurement by RED and biomimetic chromatography, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00046" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00046?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00046</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Results of UV-pH titrations in the presence and absence of HSA, results of HSA-binding measurements by RED and biomimetic chromatography (CHIRALPAK HSA column), comparison of the HPLC systems used for HPLC-HSA measurements, and synthesis and structural confirmation (NMR and HRMS) of diflunisal ethyl ester and <i>C</i>-methyl phenylbutazone (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of different APIs (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_liveslides.mp4">jm0c00046_liveslides.mp4 (6.01 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_001.pdf">jm0c00046_si_001.pdf (510.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_002.csv">jm0c00046_si_002.csv (6.18 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00046" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">György T. Balogh</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Műegyetem rakpart 3, 1111 Budapest, Hungary</span>; 
    <span class="hlFld-Affiliation affiliation">Chemistry
Department, Gedeon Richter Plc., Gyömrői út.
19-21, 1107 Budapest, Hungary</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacodynamics and Biopharmacy, University
of Szeged, 6720 Szeged, Hungary</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8273-1760" title="Orcid link">http://orcid.org/0000-0001-8273-1760</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#44233d302625282b232c0429252d286a2629216a2c31"><span class="__cf_email__" data-cfemail="24435d504645484b434c6449454d480a4649410a4c51">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gergő Dargó</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Műegyetem rakpart 3, 1111 Budapest, Hungary</span>; 
    <span class="hlFld-Affiliation affiliation">Chemistry
Department, Gedeon Richter Plc., Gyömrői út.
19-21, 1107 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dávid Bajusz</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Research Group, Research Centre
for Natural Sciences, Magyar tudósok krt. 2, 1117 Budapest, Hungary</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4277-9481" title="Orcid link">http://orcid.org/0000-0003-4277-9481</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristóf Simon</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry and Technology, Budapest
University of Technology and Economics, Műegyetem rakpart 3, 1111 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judit Müller</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Laboratory II, Gedeon Richter
Plc., Gyömrői út. 19-21, 1107 Budapest, Hungary</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">G.D. thanks the Gedeon Richter Talentum Foundation for the financial support. We are grateful to Gyula Beke for his assistance in synthetizing modified APIs, to Áron Szigetvári and Prof. Csaba Szántay Jr. for NMR measurements, and to János Kóti for HRMS measurements.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CE</td><td class="NLM_def"><p class="first last">capillary electrophoresis</p></td></tr><tr><td class="NLM_term">CHQ</td><td class="NLM_def"><p class="first last">chloroquine</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last">diclofenac</p></td></tr><tr><td class="NLM_term">DIF</td><td class="NLM_def"><p class="first last">diflunisal</p></td></tr><tr><td class="NLM_term">DZP</td><td class="NLM_def"><p class="first last">diazepam</p></td></tr><tr><td class="NLM_term">DAD</td><td class="NLM_def"><p class="first last">diode array detector</p></td></tr><tr><td class="NLM_term">ED</td><td class="NLM_def"><p class="first last">equilibrium dialysis</p></td></tr><tr><td class="NLM_term">EIC</td><td class="NLM_def"><p class="first last">extract ion chromatogram</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HT</td><td class="NLM_def"><p class="first last">high throughput</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">2-propanol</p></td></tr><tr><td class="NLM_term">ISA</td><td class="NLM_def"><p class="first last">ionic strength adjusted</p></td></tr><tr><td class="NLM_term">KOH</td><td class="NLM_def"><p class="first last">potassium hydroxide</p></td></tr><tr><td class="NLM_term">LT</td><td class="NLM_def"><p class="first last">low throughput</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeI</td><td class="NLM_def"><p class="first last">methyl iodide</p></td></tr><tr><td class="NLM_term">MEL</td><td class="NLM_def"><p class="first last">meloxicam</p></td></tr><tr><td class="NLM_term">MT</td><td class="NLM_def"><p class="first last">medium throughput</p></td></tr><tr><td class="NLM_term">NLB</td><td class="NLM_def"><p class="first last">neutral linear buffer</p></td></tr><tr><td class="NLM_term">NSB</td><td class="NLM_def"><p class="first last">nonspecific binding</p></td></tr><tr><td class="NLM_term">NZP</td><td class="NLM_def"><p class="first last">nitrazepam</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photodiode array (detector)</p></td></tr><tr><td class="NLM_term">PHB</td><td class="NLM_def"><p class="first last">phenylbutazone</p></td></tr><tr><td class="NLM_term">PIR</td><td class="NLM_def"><p class="first last">piroxicam</p></td></tr><tr><td class="NLM_term">RED</td><td class="NLM_def"><p class="first last">rapid equilibrium dialysis</p></td></tr><tr><td class="NLM_term">SPME</td><td class="NLM_def"><p class="first last">solid-phase microextraction</p></td></tr><tr><td class="NLM_term">TEN</td><td class="NLM_def"><p class="first last">tenoxicam</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">UF</td><td class="NLM_def"><p class="first last">ultrafiltration</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span></span> <i>Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization</i>; <span class="NLM_publisher-name">Elsevier Inc.</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di&author=E.+H.+Kerns&title=Drug-Like+Properties%3A+Concepts%2C+Structure+Design+and+Methods+from+ADME+to+Toxicity+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DDrug-Like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%2520and%2520Methods%2520from%2520ADME%2520to%2520Toxicity%2520Optimization%26pub%3DElsevier%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fessey, R. E.</span>; <span class="NLM_string-name">Austin, R. P.</span>; <span class="NLM_string-name">Barton, P.</span>; <span class="NLM_string-name">Davis, A. M.</span>; <span class="NLM_string-name">Wenlock, M. C.</span></span> <span> </span><span class="NLM_article-title">The Role of Plasma Protein Binding in Drug Discovery</span>. In  <i>Pharmacokinetic Profiling in Drug Research</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">141</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=119-141&author=R.+E.+Fessey&author=R.+P.+Austin&author=P.+Barton&author=A.+M.+Davis&author=M.+C.+Wenlock&title=Pharmacokinetic+Profiling+in+Drug+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFessey%26aufirst%3DR.%2BE.%26atitle%3DThe%2520Role%2520of%2520Plasma%2520Protein%2520Binding%2520in%2520Drug%2520Discovery%26btitle%3DPharmacokinetic%2520Profiling%2520in%2520Drug%2520Research%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2007%26spage%3D119%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, G. L.</span></span> <span> </span><span class="NLM_article-title">The Importance of Plasma Protein Binding in Drug Discovery</span>. <i>Expert Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1517/17460441.2.1.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1517%2F17460441.2.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=23496037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Sitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=51-64&author=G.+L.+Trainor&title=The+Importance+of+Plasma+Protein+Binding+in+Drug+Discovery&doi=10.1517%2F17460441.2.1.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of plasma protein binding in drug discovery</span></div><div class="casAuthors">Trainor, George L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-64</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Plasma protein binding of drugs is a well-recognized phenomena, but it is only recently that the implications for drug action in vivo have been fully appreciated.  Plasma proteins, by virtue of their high concn., control the free drug concn. in plasma and in compartments in equil. with plasma, thereby, effectively attenuating drug potency in vivo.  The historical background and thermodn. basis for the 'Free Drug Principle' is presented, along with special considerations for intracellular targets, deep compartments and α1-acid glycoprotein binding.  Real and apparent exceptions to the principle are discussed along with a survey of citations from the recent medicinal chem. literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyoyVEZ33iUbVg90H21EOLACvtfcHk0lhKS_7eYyUKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Sitrw%253D&md5=06ed3a7f31e02588cf98e790abdc622f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26atitle%3DThe%2520Importance%2520of%2520Plasma%2520Protein%2520Binding%2520in%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discov.%26date%3D2007%26volume%3D2%26spage%3D51%26epage%3D64%26doi%3D10.1517%2F17460441.2.1.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span> <i>Goodman
& Gilman’s The Pharmacological Basis of Therapeutics, 13th
ed.</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunton, L. L.</span>, <span class="NLM_string-name">Hilal-Dandan, R.</span>, <span class="NLM_string-name">Knollmann, B. C.</span></span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill Education</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+L.+Brunton&author=R.+Hilal-Dandan&author=B.+C.+Knollmann&title=Goodman%0A%26+Gilman%E2%80%99s+The+Pharmacological+Basis+of+Therapeutics%2C+13th%0Aed."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGoodman%250A%2526%2520Gilman%25E2%2580%2599s%2520The%2520Pharmacological%2520Basis%2520of%2520Therapeutics%252C%252013th%250Aed.%26aulast%3DBrunton%26aufirst%3DL.%2BL.%26pub%3DMcGraw-Hill%2520Education%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span>; <span class="NLM_string-name">Zhao, H.</span></span> <span> </span><span class="NLM_article-title">Physiologic Drug Distribution and Protein Binding</span>. In  <i>Applied Biopharmaceutics & Pharmacokinetics</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shargel, L.</span>, <span class="NLM_string-name">Yu, A. B. C.</span></span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill Education</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Sun&author=H.+Zhaoauthor=L.+Shargel&author=A.+B.+C.+Yu&title=Applied+Biopharmaceutics+%26+Pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26atitle%3DPhysiologic%2520Drug%2520Distribution%2520and%2520Protein%2520Binding%26btitle%3DApplied%2520Biopharmaceutics%2520%2526%2520Pharmacokinetics%26aulast%3DShargel%26aufirst%3DL.%26pub%3DMcGraw-Hill%2520Education%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S.</span>, <span class="NLM_string-name">Blood, I.</span></span> <span> </span><span class="NLM_article-title">Heart, and Circulation</span>. In  <i>Human Physiology</i>; <span class="NLM_publisher-name">McGraw-Hill Education</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Fox&author=I.+Blood&title=Human+Physiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DS.%26atitle%3DHeart%252C%2520and%2520Circulation%26btitle%3DHuman%2520Physiology%26pub%3DMcGraw-Hill%2520Education%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Betts, J. G.</span>; <span class="NLM_string-name">Desaix, P.</span>; <span class="NLM_string-name">Johnson, E. W.</span>; <span class="NLM_string-name">Johnson, J. E.</span>; <span class="NLM_string-name">Korol, O.</span>; <span class="NLM_string-name">Kruse, D.</span>; <span class="NLM_string-name">Poe, B.</span>; <span class="NLM_string-name">Wise, J.</span>; <span class="NLM_string-name">Womble, M. D.</span>; <span class="NLM_string-name">Young, K. A.</span></span> <span> </span><span class="NLM_article-title">The Cardiovascular System: Blood</span>. In  <i>Anatomy & Physiology</i>; <span class="NLM_publisher-name">OpenStax</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+G.+Betts&author=P.+Desaix&author=E.+W.+Johnson&author=J.+E.+Johnson&author=O.+Korol&author=D.+Kruse&author=B.+Poe&author=J.+Wise&author=M.+D.+Womble&author=K.+A.+Young&title=Anatomy+%26+Physiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBetts%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520Cardiovascular%2520System%253A%2520Blood%26btitle%3DAnatomy%2520%2526%2520Physiology%26pub%3DOpenStax%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fanali, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Masi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trezza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascenzi, P.</span></span> <span> </span><span class="NLM_article-title">Human Serum Albumin: From Bench to Bedside</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1016/j.mam.2011.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.mam.2011.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=22230555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls12hu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=209-290&author=G.+Fanaliauthor=A.+di+Masiauthor=V.+Trezzaauthor=M.+Marinoauthor=M.+Fasanoauthor=P.+Ascenzi&title=Human+Serum+Albumin%3A+From+Bench+to+Bedside&doi=10.1016%2Fj.mam.2011.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Human serum albumin: From bench to bedside</span></div><div class="casAuthors">Fanali, Gabriella; di Masi, Alessandra; Trezza, Viviana; Marino, Maria; Fasano, Mauro; Ascenzi, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-290</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Human serum albumin (HSA), the most abundant protein in plasma, is a monomeric multi-domain macromol., representing the main determinant of plasma oncotic pressure and the main modulator of fluid distribution between body compartments.  HSA displays an extraordinary ligand binding capacity, providing a depot and carrier for many endogenous and exogenous compds.  Indeed, HSA represents the main carrier for fatty acids, affects pharmacokinetics of many drugs, provides the metabolic modification of some ligands, renders potential toxins harmless, accounts for most of the anti-oxidant capacity of human plasma, and displays (pseudo-)enzymic properties.  HSA is a valuable biomarker of many diseases, including cancer, rheumatoid arthritis, ischemia, post-menopausal obesity, severe acute graft-vs.-host disease, and diseases that need monitoring of the glycemic control.  Moreover, HSA is widely used clin. to treat several diseases, including hypovolemia, shock, burns, surgical blood loss, trauma, hemorrhage, cardiopulmonary bypass, acute respiratory distress syndrome, hemodialysis, acute liver failure, chronic liver disease, nutrition support, resuscitation, and hypoalbuminemia.  Recently, biotechnol. applications of HSA, including implantable biomaterials, surgical adhesives and sealants, biochromatog., ligand trapping, and fusion proteins, have been reported.  Here, genetic, biochem., biomedical, and biotechnol. aspects of HSA are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxjvB_5YQuerVg90H21EOLACvtfcHk0lhKS_7eYyUKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls12hu7w%253D&md5=976cbd0c53b93f77bc172f909ba6682a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2011.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2011.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DFanali%26aufirst%3DG.%26aulast%3Ddi%2BMasi%26aufirst%3DA.%26aulast%3DTrezza%26aufirst%3DV.%26aulast%3DMarino%26aufirst%3DM.%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DAscenzi%26aufirst%3DP.%26atitle%3DHuman%2520Serum%2520Albumin%253A%2520From%2520Bench%2520to%2520Bedside%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2012%26volume%3D33%26spage%3D209%26epage%3D290%26doi%3D10.1016%2Fj.mam.2011.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span>; <span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span></span> <span> </span><span class="NLM_article-title">Chapter 14 – Plasma and Tissue Binding</span>. In  <i>Drug-Like Properties</i>; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">228</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2FB978-0-12-801076-1.00014-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=219-228&author=L.+Di&author=E.+H.+Kerns&author=L.+Di&author=E.+H.+Kerns&title=Drug-Like+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-801076-1.00014-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-801076-1.00014-9%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26atitle%3DChapter%252014%2520%25E2%2580%2593%2520Plasma%2520and%2520Tissue%2520Binding%26btitle%3DDrug-Like%2520Properties%26pub%3DAcademic%2520Press%26date%3D2016%26spage%3D219%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. W.</span></span> <span> </span><span class="NLM_article-title">Albumin: Biochemical Properties and Therapeutic Potential</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1219</span>, <span class="refDoi"> DOI: 10.1002/hep.20720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fhep.20720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=15915465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVSntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=1211-1219&author=G.+J.+Quinlanauthor=G.+S.+Martinauthor=T.+W.+Evans&title=Albumin%3A+Biochemical+Properties+and+Therapeutic+Potential&doi=10.1002%2Fhep.20720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin: biochemical properties and therapeutic potential</span></div><div class="casAuthors">Quinlan, Gregory J.; Martin, Greg S.; Evans, Timothy W.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1211-1219</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review highlights current thinking regarding albumin therapy in the crit. care and hepatol. setting and also discusses other potential therapeutic applications for its use based around the complex biochem. of the multifunctional plasma protein.  Potential contraindications are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVfxiwwEwerLVg90H21EOLACvtfcHk0liVTgncmDuWIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVSntb0%253D&md5=37fd91838abb959d6db2db55ac92e8e5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fhep.20720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.20720%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DG.%2BJ.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DEvans%26aufirst%3DT.%2BW.%26atitle%3DAlbumin%253A%2520Biochemical%2520Properties%2520and%2520Therapeutic%2520Potential%26jtitle%3DHepatology%26date%3D2005%26volume%3D41%26spage%3D1211%26epage%3D1219%26doi%3D10.1002%2Fhep.20720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kragh-Hansen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, V. T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otagiri, M.</span></span> <span> </span><span class="NLM_article-title">Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1248/bpb.25.695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1248%2Fbpb.25.695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=12081132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvV2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=695-704&author=U.+Kragh-Hansenauthor=V.+T.+G.+Chuangauthor=M.+Otagiri&title=Practical+Aspects+of+the+Ligand-Binding+and+Enzymatic+Properties+of+Human+Serum+Albumin&doi=10.1248%2Fbpb.25.695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Practical aspects of the ligand-binding and enzymatic properties of human serum albumin</span></div><div class="casAuthors">Kragh-Hansen, Ulrich; Chuang, Victor Tuan Giam; Otagiri, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">695-704</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Recent work with approaches like recombinant mutants and x-ray crystallog. has given much new information about the ligand-binding properties of human serum albumin (HSA).  The information increases the understanding of this unique transport and depot protein and could give a structural basis for the possible construction of therapeutic agents with altered HSA-binding properties.  A tabulation of high-affinity binding sites for both endogenous and exogenous compds. has been made; it could be useful for the above-mentioned purpose, but it could also be of value when trying to predict potential drug interactions at the protein-binding level.  Drug displacement is not always a complication to therapy; it can be used to increase the biol. effect of a drug.  However, due to rebinding at other sites, the increase in the free concn. of a displaced ligand can be less than expected.  Drugs and drug metabolites can also interact covalently with HSA; thiol-contg. drugs often bind to the single free cysteine residue of HSA, and glucuronidated drugs react irreversibly with other residues of the protein.  Reversible binding of ligands is often stereospecific, and therefore immobilized HSA can be used to sep. drug isomers.  Albumin-contg. dialyzates are useful for extracorporeal removal of endogenous toxins and in the treatment of drug overdoses.  HSA has different types of hydrolytic activities, which also can be stereospecific.  The esterase-like property seems esp. useful in converting prodrugs to active drugs in plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrmebO3fPwI7Vg90H21EOLACvtfcHk0liVTgncmDuWIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvV2hu7s%253D&md5=8de11b4e2c17851a6a69485437ab2cb1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1248%2Fbpb.25.695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.25.695%26sid%3Dliteratum%253Aachs%26aulast%3DKragh-Hansen%26aufirst%3DU.%26aulast%3DChuang%26aufirst%3DV.%2BT.%2BG.%26aulast%3DOtagiri%26aufirst%3DM.%26atitle%3DPractical%2520Aspects%2520of%2520the%2520Ligand-Binding%2520and%2520Enzymatic%2520Properties%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2002%26volume%3D25%26spage%3D695%26epage%3D704%26doi%3D10.1248%2Fbpb.25.695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jahanban-Esfahlan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davaran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosavi-Movahedi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dastmalchi, S.</span></span> <span> </span><span class="NLM_article-title">Investigating the Interaction of Juglone (5-Hydroxy-1, 4-Naphthoquinone) with Serum Albumins Using Spectroscopic and in Silico Methods</span>. <i>J. Iran. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1540</span>, <span class="refDoi"> DOI: 10.1007/s13738-017-1094-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1007%2Fs13738-017-1094-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFOitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=1527-1540&author=A.+Jahanban-Esfahlanauthor=S.+Davaranauthor=A.+A.+Moosavi-Movahediauthor=S.+Dastmalchi&title=Investigating+the+Interaction+of+Juglone+%285-Hydroxy-1%2C+4-Naphthoquinone%29+with+Serum+Albumins+Using+Spectroscopic+and+in+Silico+Methods&doi=10.1007%2Fs13738-017-1094-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating the interaction of juglone (5-hydroxy-1, 4-naphthoquinone) with serum albumins using spectroscopic and in silico methods</span></div><div class="casAuthors">Jahanban-Esfahlan, Ali; Davaran, Soodabeh; Moosavi-Movahedi, Ali A.; Dastmalchi, Siavoush</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Iranian Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1527-1540</span>CODEN:
                <span class="NLM_cas:coden">JICSCJ</span>;
        ISSN:<span class="NLM_cas:issn">1735-207X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The interaction between juglone at the concn. range of 10-110 μM and bovine serum albumin (BSA) or human serum albumin (HSA) at the const. concn. of 11 μM was investigated by fluorescence and UV absorption spectroscopy under physiol.-like condition.  Performing the expts. at different temps. showed that the fluorescence intensity of BSA/HSA was decreased in the presence of juglone by a static quenching mechanism due to the formation of the juglone-protein complex.  The binding const. for the interaction was in the order of 103 M-1, and the no. of binding sites for juglone on serum albumins was detd. to be equal to one.  The thermodn. parameters including enthalpy (ΔH), entropy (ΔS) and Gibb's free energy (ΔG) changes were obtained by using the van't Hoff equation.  These results indicated that van der Waals force and hydrogen bonding were the main intermol. forces stabilizing the complex in a spontaneous assocn. reaction.  Moreover, the interaction of BSA/HSA with juglone was verified by UV absorption spectra and mol. docking.  The results of synchronous fluorescence, UV-visible and CD spectra demonstrated that the binding of juglone with BSA/HSA induces min. conformational changes in the structure of albumins.  The increased binding affinity of juglone to albumin obsd. in the presence of site markers (digoxin and ibuprofen) excludes IIA and IIIA sites as the binding site of juglone.  This is partially in agreement with the results of mol. docking studies which suggests sub-domain IA of albumin as the binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprw9dqtZNbn7Vg90H21EOLACvtfcHk0ljau5lGqrDFWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFOitbo%253D&md5=be12c20f539da159534940ef84710ba4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs13738-017-1094-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13738-017-1094-0%26sid%3Dliteratum%253Aachs%26aulast%3DJahanban-Esfahlan%26aufirst%3DA.%26aulast%3DDavaran%26aufirst%3DS.%26aulast%3DMoosavi-Movahedi%26aufirst%3DA.%2BA.%26aulast%3DDastmalchi%26aufirst%3DS.%26atitle%3DInvestigating%2520the%2520Interaction%2520of%2520Juglone%2520%25285-Hydroxy-1%252C%25204-Naphthoquinone%2529%2520with%2520Serum%2520Albumins%2520Using%2520Spectroscopic%2520and%2520in%2520Silico%2520Methods%26jtitle%3DJ.%2520Iran.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D14%26spage%3D1527%26epage%3D1540%26doi%3D10.1007%2Fs13738-017-1094-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roufegarinejad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarowicz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahanban-Esfahlan, A.</span></span> <span> </span><span class="NLM_article-title">Characterizing the Interaction between Pyrogallol and Human Serum Albumin by Spectroscopic and Molecular Docking Methods</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2766</span>– <span class="NLM_lpage">2775</span>, <span class="refDoi"> DOI: 10.1080/07391102.2018.1496854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1080%2F07391102.2018.1496854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=2766-2775&author=L.+Roufegarinejadauthor=R.+Amarowiczauthor=A.+Jahanban-Esfahlan&title=Characterizing+the+Interaction+between+Pyrogallol+and+Human+Serum+Albumin+by+Spectroscopic+and+Molecular+Docking+Methods&doi=10.1080%2F07391102.2018.1496854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F07391102.2018.1496854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2018.1496854%26sid%3Dliteratum%253Aachs%26aulast%3DRoufegarinejad%26aufirst%3DL.%26aulast%3DAmarowicz%26aufirst%3DR.%26aulast%3DJahanban-Esfahlan%26aufirst%3DA.%26atitle%3DCharacterizing%2520the%2520Interaction%2520between%2520Pyrogallol%2520and%2520Human%2520Serum%2520Albumin%2520by%2520Spectroscopic%2520and%2520Molecular%2520Docking%2520Methods%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2018%26volume%3D37%26spage%3D2766%26epage%3D2775%26doi%3D10.1080%2F07391102.2018.1496854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostami-Hodjegan, A.</span></span> <span> </span><span class="NLM_article-title">Prediction of Plasma Protein Binding Displacement and Its Implications for Quantitative Assessment of Metabolic Drug-Drug Interactions from in Vitro Data</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2778</span>– <span class="NLM_lpage">2787</span>, <span class="refDoi"> DOI: 10.1002/jps.20733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fjps.20733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=16937340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSis7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=2778-2787&author=H.+Christensenauthor=M.+Bakerauthor=G.+T.+Tuckerauthor=A.+Rostami-Hodjegan&title=Prediction+of+Plasma+Protein+Binding+Displacement+and+Its+Implications+for+Quantitative+Assessment+of+Metabolic+Drug-Drug+Interactions+from+in+Vitro+Data&doi=10.1002%2Fjps.20733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of plasma protein binding displacement and its implications for quantitative assessment of metabolic drug-drug interactions from in vitro data</span></div><div class="casAuthors">Christensen, Hege; Baker, Mark; Tucker, Geoffrey T.; Rostami-Hodjegan, Amin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2778-2787</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Although displacement from plasma protein binding (dPB) is usually of little clin. significance, it should be taken into account when interpreting changes in total plasma concns. of drugs subject to metabolically based drug-drug interactions (mDDI).  The aim of this study was to develop an approach to predict changes in the free fractions (fu) of pairs of drugs that compete for plasma binding, knowing their binding affinity consts., and to consider the implications of assocd. concn.- and time-dependence of such changes with respect to drug exposure.  Exptl. fu values of valproic acid and phenytoin in the presence of ibuprofen, diflunisal, or naproxen were predicted successfully (within 0.99- to 1.36-fold) by the model.  In addn., the simulation of time-dependent changes in fu of valproic acid following administration of ibuprofen indicated different extents of dPB during 'first-pass' through the liver after oral absorption and on systemic recirculation.  To understand the impact of the time-dependent change in fu, a full physiol. based pharmacokinetic model, that accounts for concn.-time profile of displacee and displacer and their mutual effect on each other, is required.  The approach developed in this study is a first step towards the development of such a model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg7ajyBq6UI7Vg90H21EOLACvtfcHk0ljau5lGqrDFWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSis7zK&md5=8890fb25b5e47b43e36f217e3865d83b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjps.20733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20733%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DH.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DTucker%26aufirst%3DG.%2BT.%26aulast%3DRostami-Hodjegan%26aufirst%3DA.%26atitle%3DPrediction%2520of%2520Plasma%2520Protein%2520Binding%2520Displacement%2520and%2520Its%2520Implications%2520for%2520Quantitative%2520Assessment%2520of%2520Metabolic%2520Drug-Drug%2520Interactions%2520from%2520in%2520Vitro%2520Data%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D2778%26epage%3D2787%26doi%3D10.1002%2Fjps.20733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birkett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudlow, G.</span></span> <span> </span><span class="NLM_article-title">Effects of Fatty Acids on Two Specific Drug Binding Sites on Human Serum Albumin</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=593269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaE1cXlvVamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1977&pages=987-992&author=D.+J.+Birkettauthor=S.+P.+Myersauthor=G.+Sudlow&title=Effects+of+Fatty+Acids+on+Two+Specific+Drug+Binding+Sites+on+Human+Serum+Albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of fatty acids on two specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Birkett, Donald J.; Myers, Shirley P.; Sudlow, Gillian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">987-92</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Two distinct binding sites, I and II, for anionic drugs on human serum albumin have previously been demonstrated using fluorescent probe techniques.  5-Dimethylaminonaphthalene-1-sulfonamide (I)  [1431-39-6] and dansylsarcosine  [1093-96-5] are specific fluorescent probes for sites I and II, resp.  The addn. of fatty acids results in differing effects at the two binding sites, and the specificity of site II is lost.  The order of potency of various fatty acids in causing these changes is oleic  [112-80-1] > stearic  [57-11-4] > linoleic  [60-33-3] ≥ palmitic acid  [57-10-3], and this is the same as the order of assocn. consts. for these fatty acids.  Thus, chain length and degree of unsatn. det. both binding affinity and the extent to which the fatty acids induce configurational adaptations in the albumin mol.  Furthermore, studies with varying ratios of oleic acid to albumin suggest that the conformational changes induced in the protein are different for each mol. of oleic acid added.  Addn. of oleic acid at a 3:1 molar ratio with albumin significantly increased the binding of warfarin  [81-81-2] and I to site I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wn45AHSv97Vg90H21EOLACvtfcHk0licL2oOortd8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXlvVamtg%253D%253D&md5=127ba3c3b26a9f0b6e761ee075faba32</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DMyers%26aufirst%3DS.%2BP.%26aulast%3DSudlow%26aufirst%3DG.%26atitle%3DEffects%2520of%2520Fatty%2520Acids%2520on%2520Two%2520Specific%2520Drug%2520Binding%2520Sites%2520on%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1977%26volume%3D13%26spage%3D987%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sudlow, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, D. N.</span></span> <span> </span><span class="NLM_article-title">Further Characterization of Specific Drug Binding Sites on Human Serum Albumin</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1052</span>– <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1004490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1976&pages=1052-1061&author=G.+Sudlowauthor=D.+J.+Birkettauthor=D.+N.+Wade&title=Further+Characterization+of+Specific+Drug+Binding+Sites+on+Human+Serum+Albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Sudlow, G.; Birkett, D. J.; Wade, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1052-61</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The fluorescent probes, 5-dimethylaminonaphthalene-1-sulfonamide (I) [1431-39-6] and dansylsarcosine [1093-96-5] function as specific markers for 2 distinct binding sites for anionic drugs on human serum albumin (HSA).  The binding of drugs to site I or II was detected by measuring the displacement of these probes.  The results give an indication of some of the structural features required for binding at these sites.  Stearic acid [57-11-4] binding to HSA induced different conformational changes in the albumin at sites I and II, which were detected by changes in the fluorescence and/or strength of binding of probes specific for the 2 sites.  This provides further evidence for qual. differences between the 2 sites.  The specificity of the sites for particular drugs, even at high drug to albumin ratios, was established, and the specificity and characteristics of the 2 sites on human adult and neonatal sera were shown to be similar to those on cryst. HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZMQN1NBrHM7Vg90H21EOLACvtfcHk0licL2oOortd8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D&md5=5286ae0da826f2764eb595b22361fe80</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudlow%26aufirst%3DG.%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DWade%26aufirst%3DD.%2BN.%26atitle%3DFurther%2520Characterization%2520of%2520Specific%2520Drug%2520Binding%2520Sites%2520on%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1976%26volume%3D12%26spage%3D1052%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kragh-Hansen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otagiri, M.</span></span> <span> </span><span class="NLM_article-title">Characterization of Site I on Human Serum Albumin: Concept about the Structure of a Drug Binding Site</span>. <i>Biochim. Biophys. Acta - Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>1295</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/0167-4838(96)00013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2F0167-4838%2896%2900013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=8695640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK28Xkt12ltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1295&publication_year=1996&pages=147-157&author=K.+Yamasakiauthor=T.+Maruyamaauthor=U.+Kragh-Hansenauthor=M.+Otagiri&title=Characterization+of+Site+I+on+Human+Serum+Albumin%3A+Concept+about+the+Structure+of+a+Drug+Binding+Site&doi=10.1016%2F0167-4838%2896%2900013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of site I on human serum albumin: concept about the structure of a drug binding site</span></div><div class="casAuthors">Yamasaki, Keishi; Maruyama, Toru; Kragh-Hansen, Ulrich; Otagiri, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1295</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-157</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) possesses at least three sites or areas for high-affinity binding of drugs.  Of these sites, site I was investigated by series of ultrafiltration and equil. dialysis expts.  Three ligands, acenocoumarol, dansyl-L-asparagine (DNSA) and Bu p-aminobenzoate (Bu p-ABE) were employed as marker ligands.  Each ligand binds to a single high-affinity site on HSA, and binding studies with different pairs of the ligands revealed independent high-affinity binding.  Preliminary displacement studies performed with the typical site I binding drugs warfarin, phenylbutazone and iodipamide showed different displacement patterns of the three marker ligands.  These studies were followed by stringent competition expts. involving all possible combinations of the three test ligands themselves and of these and the three marker ligands.  On the basis of the results obtained it seems that the acenocoumarol and DNSA binding regions correspond to the warfarin and azapropazone binding regions, resp., of site I reported by others.  The new binding region, represented by Bu p-ABE, is probably located adjacent to the acenocoumarol binding region but apart from that of DNSA.  The authors have elaborated a model for binding site I in which the authors propose novel nomenclatures, region Ia, Ib, and Ic for the acenocoumarol, DNSA and Bu p-ABE binding regions, resp.  Furthermore, the relation between these regions and the high-affinity binding sites for other drugs have been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaccaCROuBhLVg90H21EOLACvtfcHk0licL2oOortd8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt12ltb4%253D&md5=7285423eae1f6679e182e3af5fd0cb7c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0167-4838%2896%2900013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4838%252896%252900013-1%26sid%3Dliteratum%253Aachs%26aulast%3DYamasaki%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DKragh-Hansen%26aufirst%3DU.%26aulast%3DOtagiri%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520Site%2520I%2520on%2520Human%2520Serum%2520Albumin%253A%2520Concept%2520about%2520the%2520Structure%2520of%2520a%2520Drug%2520Binding%2520Site%26jtitle%3DBiochim.%2520Biophys.%2520Acta%2520-%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D1996%26volume%3D1295%26spage%3D147%26epage%3D157%26doi%3D10.1016%2F0167-4838%2896%2900013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhivkova, Z.</span></span> <span> </span><span class="NLM_article-title">Studies on Drug – Human Serum Albumin Binding: The Current State of the Matter</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1830</span>, <span class="refDoi"> DOI: 10.2174/1381612821666150302113710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.2174%2F1381612821666150302113710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=25732557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1altbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1817-1830&author=Z.+Zhivkova&title=Studies+on+Drug+%E2%80%93+Human+Serum+Albumin+Binding%3A+The+Current+State+of+the+Matter&doi=10.2174%2F1381612821666150302113710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on Drug - Human Serum Albumin Binding: The Current State of the Matter</span></div><div class="casAuthors">Zhivkova, Zvetanka D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1817-1830</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human serum albumin (HSA) is the major plasma protein with vital functions acting as depot and career for many endogenous (fatty acids, bilirubin, etc.) and exogenous substances (drugs, nutrients, etc.) in the blood.  Binding to HSA controls the free, active concn. of the drug and may affect considerably the overall pharmacodynamic and pharmacokinetic profile.  Studies on drug - protein binding are important from both theor. and practical point of view as they allow better understanding of the processes underlying drug disposition and elimination and the effect of several pathol. states or co-administered drugs on drug delivery and efficacy.  The present review focuses on the current state of drug - HSA binding studies.  The major functions and consequences of drug - protein binding are described.  The X-ray structure of HSA is discussed focusing on the location and the architecture of the primary drug and fatty acids binding sites.  Some of the most commonly used methods for drug - HSA binding assay are presented together with examples for their application.  The most extensive studied topics in the area are discussed including quant. characterization of drug - HSA complexation, identification of the binding sites, stereoselectivity of drug - HSA interactions, and thermodn. characterization of the binding process.  A short section is devoted to in silico prediction of drug - HSA binding as an important step in drug design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Jbm6e8QThLVg90H21EOLACvtfcHk0lhjqqHbqOssAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1altbk%253D&md5=f14822481b5a6e075d3d33f775411c87</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1381612821666150302113710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612821666150302113710%26sid%3Dliteratum%253Aachs%26aulast%3DZhivkova%26aufirst%3DZ.%26atitle%3DStudies%2520on%2520Drug%2520%25E2%2580%2593%2520Human%2520Serum%2520Albumin%2520Binding%253A%2520The%2520Current%2520State%2520of%2520the%2520Matter%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2015%26volume%3D21%26spage%3D1817%26epage%3D1830%26doi%3D10.2174%2F1381612821666150302113710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohnert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L.-S.</span></span> <span> </span><span class="NLM_article-title">Plasma Protein Binding: From Discovery to Development</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">2953</span>– <span class="NLM_lpage">2994</span>, <span class="refDoi"> DOI: 10.1002/jps.23614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fjps.23614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=23798314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVymt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=2953-2994&author=T.+Bohnertauthor=L.-S.+Gan&title=Plasma+Protein+Binding%3A+From+Discovery+to+Development&doi=10.1002%2Fjps.23614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma protein binding: From discovery to development</span></div><div class="casAuthors">Bohnert, Tonika; Gan, Liang-Shang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2953-2994</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The importance of plasma protein binding (PPB) in modulating the effective drug concn. at pharmacol. target sites has been the topic of significant discussion and debate amongst drug development groups over the past few decades.  Free drug theory, which states that in absence of energy-dependent processes, after steady state equil. has been attained, free drug concn. in plasma is equal to free drug concn. at the pharmacol. target receptor(s) in tissues, has been used to explain pharmacokinetics/pharmacodynamics relationships in a large no. of cases.  Any sudden increase in free concn. of a drug could potentially cause toxicity and may need dose adjustment.  Free drug concn. is also helpful to est. the effective concn. of drugs that potentially can ppt. metab. (or transporter)-related drug-drug interactions.  Disease models are extensively validated in animals to progress a compd. into development.  Unbound drug concn., and therefore PPB information across species is very informative in establishing safety margins and guiding selection of First in Human (FIH) dose and human efficacious dose.  The scope of this review is to give an overview of reported role of PPB in several therapeutic areas, highlight cases where PPB changes are clin. relevant, and provide drug metab. and pharmacokinetics recommendations in discovery and development settings. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqobJp8eG98XrVg90H21EOLACvtfcHk0lhjqqHbqOssAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVymt7c%253D&md5=d676f7490c6e0f09c8acf7cce5183b17</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjps.23614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23614%26sid%3Dliteratum%253Aachs%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DGan%26aufirst%3DL.-S.%26atitle%3DPlasma%2520Protein%2520Binding%253A%2520From%2520Discovery%2520to%2520Development%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D2953%26epage%3D2994%26doi%3D10.1002%2Fjps.23614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rolan, P.</span></span> <span> </span><span class="NLM_article-title">Plasma Protein Binding Displacement Interactions-Why Are They Still Regarded as Clinically Important?</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1994.tb04251.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1111%2Fj.1365-2125.1994.tb04251.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=8186058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK2cXivV2htL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=125-128&author=P.+Rolan&title=Plasma+Protein+Binding+Displacement+Interactions-Why+Are+They+Still+Regarded+as+Clinically+Important%3F&doi=10.1111%2Fj.1365-2125.1994.tb04251.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma protein binding displacement interactions - why are they still regarded as clinically important?</span></div><div class="casAuthors">Rolan, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-8</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">A review, with 40 refs., of drug interactions with blood plasma proteins and its clin. significance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJAyQ7NFyJ5bVg90H21EOLACvtfcHk0lhjqqHbqOssAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXivV2htL8%253D&md5=f6285972ac0a53b94e8c1e5e0f91ff57</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1994.tb04251.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1994.tb04251.x%26sid%3Dliteratum%253Aachs%26aulast%3DRolan%26aufirst%3DP.%26atitle%3DPlasma%2520Protein%2520Binding%2520Displacement%2520Interactions-Why%2520Are%2520They%2520Still%2520Regarded%2520as%2520Clinically%2520Important%253F%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D37%26spage%3D125%26epage%3D128%26doi%3D10.1111%2Fj.1365-2125.1994.tb04251.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span> <span> </span><span class="NLM_article-title">An Examination of Protein Binding and Protein-Facilitated Uptake Relating to in Vitro-in Vivo Extrapolation</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2018.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.ejps.2018.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=30098391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2isrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2018&pages=502-514&author=C.+M.+Bowmanauthor=L.+Z.+Benet&title=An+Examination+of+Protein+Binding+and+Protein-Facilitated+Uptake+Relating+to+in+Vitro-in+Vivo+Extrapolation&doi=10.1016%2Fj.ejps.2018.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation</span></div><div class="casAuthors">Bowman, C. M.; Benet, L. Z.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">502-514</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As explained by the free drug theory, the unbound fraction of drug has long been thought to drive the efficacy of a mol.  Thus, the fraction unbound term, or fu, appears in equations for fundamental pharmacokinetic parameters such as clearance, and is used when attempting in vitro to in vivo extrapolation (IVIVE).  In recent years though, it has been noted that IVIVE does not always yield accurate predictions, and that some highly protein bound ligands have more efficient uptake than can be explained by their unbound fractions.  This review explores the evolution of fu terms included when implementing IVIVE, the concept of protein-facilitated uptake, and the mechanisms that have been proposed to account for facilitated uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOnKrgxaIxYbVg90H21EOLACvtfcHk0lhPoU1_bV0hgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2isrjK&md5=72e0905a27915ab3710cfbacd127ecff</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2018.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2018.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DC.%2BM.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26atitle%3DAn%2520Examination%2520of%2520Protein%2520Binding%2520and%2520Protein-Facilitated%2520Uptake%2520Relating%2520to%2520in%2520Vitro-in%2520Vivo%2520Extrapolation%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2018%26volume%3D123%26spage%3D502%26epage%3D514%26doi%3D10.1016%2Fj.ejps.2018.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parton, T.</span></span> <span> </span><span class="NLM_article-title">Kinetic Determinants of Hepatic Clearance: Plasma Protein Binding and Hepatic Uptake</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1110</span>– <span class="NLM_lpage">1134</span>, <span class="refDoi"> DOI: 10.1080/00498250701658296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1080%2F00498250701658296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=17968739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ahu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=1110-1134&author=M.+Bakerauthor=T.+Parton&title=Kinetic+Determinants+of+Hepatic+Clearance%3A+Plasma+Protein+Binding+and+Hepatic+Uptake&doi=10.1080%2F00498250701658296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake</span></div><div class="casAuthors">Baker, M.; Parton, T.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10/11</span>),
    <span class="NLM_cas:pages">1110-1134</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Hepatic clearance prediction, using scaled data obtained from hepatocytes and microsomes, often under-predicts the eventual obsd. clearance.  This occurs commonly where the compd. is highly bound and/or a sinusoidal transporter substrate.  The authors' own lab. observations and those reported in the literature indicate that consideration of transporter effects in vitro is not sufficient to provide a direct, quant. est. of hepatic clearance in vivo.  The physiol. of contributing processes was reviewed and the processes were compiled into a kinetic model of compd. disposition for a hepatocyte compartment.  The model has variables describing the kinetic effects of plasma protein binding, sinusoidal uptake, passive permeability, and cellular disposition.  Parameters were detd. exptl. requiring, in some instances, assays less familiar or routine to Drug metab. and pharmacokinetics (DMPK) labs.  The model accurately fitted data for the hepatic disposition of a UCB-proprietary compd. that did not undergo metab. but was a substrate for protein binding and sinusoidal uptake.  On addn. of bovine serum albumin to the assay, the uptake kinetics approximated neither those for the free fraction nor the total concn.  However, the model accurately predicted the intermediate obsd. kinetics and illustrated the kinetic effects of plasma protein binding and the complex interplay between various competing and collaborating processes.  Through the use of simulations the model illustrated the influence of different combinations and influences of hepatic kinetic processes.  Possible causes behind the extn. of highly bound compds. were identified as (1) low compd. permeability facilitating active uptake and (2) high permeability facilitating the role of intracellular metab.  In almost all circumstances koff is not low enough (<1 s-1) to limit the extn. of plasma protein bound compds.; however, kon still exerts an effect through competition with the uptake process.  Crucially the model indicated the complex nature of the combined processes, whose broad range of effects on hepatic disposition could only be accurately detd. with a kinetic model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrla35qcclCT7Vg90H21EOLACvtfcHk0lhPoU1_bV0hgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ahu7vO&md5=a8462484f955caae8dad03be95375cb1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F00498250701658296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250701658296%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DParton%26aufirst%3DT.%26atitle%3DKinetic%2520Determinants%2520of%2520Hepatic%2520Clearance%253A%2520Plasma%2520Protein%2520Binding%2520and%2520Hepatic%2520Uptake%26jtitle%3DXenobiotica%26date%3D2007%26volume%3D37%26spage%3D1110%26epage%3D1134%26doi%3D10.1080%2F00498250701658296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranter, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. L.</span></span> <span> </span><span class="NLM_article-title">Determination of Drug–Plasma Protein Binding Kinetics and Equilibria by Chromatographic Profiling: Exemplification of the Method Using l–Tryptophan and Albumin</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1021/ac010643c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac010643c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFalsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2002&pages=446-452&author=A.+M.+Talbertauthor=G.+E.+Tranterauthor=E.+Holmesauthor=P.+L.+Francis&title=Determination+of+Drug%E2%80%93Plasma+Protein+Binding+Kinetics+and+Equilibria+by+Chromatographic+Profiling%3A+Exemplification+of+the+Method+Using+l%E2%80%93Tryptophan+and+Albumin&doi=10.1021%2Fac010643c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of Drug-Plasma Protein Binding Kinetics and Equilibria by Chromatographic Profiling: Exemplification of the Method Using L-Tryptophan and Albumin</span></div><div class="casAuthors">Talbert, Ann M.; Tranter, George E.; Holmes, Elaine; Francis, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">446-452</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-plasma protein binding may greatly influence the bioavailability and metab. of a plasma-borne drug, the bound form being partially protected from the metabolic fate of the unbound drug. Traditionally, equil. values (e.g., percentage binding) for drug-protein binding have been measured to rationalize in vivo phenomena. However, such studies overlook the influence of kinetics.  A rapid method of simultaneously detg. kinetic rate consts. and equil. consts. from chromatog. profiles has been developed, based on the use of immobilized protein columns and HPLC.  By measuring the chromatog. profiles (the position and width) of a retained and an unretained compd. one can directly det. both the rate and equil. consts.  Results are presented for the binding of L-tryptophan to human serum albumin to exemplify the method.  The assocn. equil. const. (Ka) and the assocn. and dissocn. rate consts. (ka and kd, resp.) were thereby measured in an aq. pH 7.4 environment at 37° as 0.84 104 M-1, 5.8 104 M-1 s-1, and 6.9 s-1, resp.  These compare favorably with previously published results.  The described method may be used in quant. structure-property relation-based rational drug discovery or for the rationalization of drug pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZXDhb5GpharVg90H21EOLACvtfcHk0lhPoU1_bV0hgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFalsLY%253D&md5=a972e1bf6e0ad4c8d2e9315d191935d4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fac010643c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac010643c%26sid%3Dliteratum%253Aachs%26aulast%3DTalbert%26aufirst%3DA.%2BM.%26aulast%3DTranter%26aufirst%3DG.%2BE.%26aulast%3DHolmes%26aufirst%3DE.%26aulast%3DFrancis%26aufirst%3DP.%2BL.%26atitle%3DDetermination%2520of%2520Drug%25E2%2580%2593Plasma%2520Protein%2520Binding%2520Kinetics%2520and%2520Equilibria%2520by%2520Chromatographic%2520Profiling%253A%2520Exemplification%2520of%2520the%2520Method%2520Using%2520l%25E2%2580%2593Tryptophan%2520and%2520Albumin%26jtitle%3DAnal.%2520Chem.%26date%3D2002%26volume%3D74%26spage%3D446%26epage%3D452%26doi%3D10.1021%2Fac010643c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svennebring, A.</span></span> <span> </span><span class="NLM_article-title">The Connection Between Plasma Protein Binding and Acute Toxicity as Determined by the LD 50 Value</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1002/ddr.21286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fddr.21286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=26686875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCqsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2016&pages=3-11&author=A.+Svennebring&title=The+Connection+Between+Plasma+Protein+Binding+and+Acute+Toxicity+as+Determined+by+the+LD+50+Value&doi=10.1002%2Fddr.21286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The connection Between Plasma Protein Binding and Acute Toxicity as Determined by the LD50 Value</span></div><div class="casAuthors">Svennebring, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-11</span>CODEN:
                <span class="NLM_cas:coden">DDREDK</span>;
        ISSN:<span class="NLM_cas:issn">0272-4391</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Preclin. Research A dataset of three drug classes (acids, bases, and neutrals) with LD50 values in mice was analyzed to investigate a possible connection between high plasma protein binding and acute toxicity.  Initially, it was found that high plasma protein binding was assocd. with toxicity for acids and neutrals, but after compensating for differences in lipophilicity, plasma protein binding was found not to be assocd. with toxicity.  The therapeutic index established by the quotient between mouse LD50 and the defined daily dose was unaffected by both lipophilicity and plasma protein binding.  Drug Dev Res. © 2015 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ALTHnW5jQrVg90H21EOLACvtfcHk0lisi9dqLca-pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCqsLnK&md5=44ed3909d32b40bd84144fe3980e9d84</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fddr.21286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.21286%26sid%3Dliteratum%253Aachs%26aulast%3DSvennebring%26aufirst%3DA.%26atitle%3DThe%2520Connection%2520Between%2520Plasma%2520Protein%2520Binding%2520and%2520Acute%2520Toxicity%2520as%2520Determined%2520by%2520the%2520LD%252050%2520Value%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2016%26volume%3D77%26spage%3D3%26epage%3D11%26doi%3D10.1002%2Fddr.21286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, V.</span>; <span class="NLM_string-name">Vachharajani, N.</span></span> <span> </span><span class="NLM_article-title">Protein Binding in Drug Discovery and Development</span>. In  <i>Evaluation of Drug Candidates for Preclinical Development</i>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ, USA</span>, <span class="NLM_year">2010</span>; Vol.  <span class="NLM_volume">13</span>, pp  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">167</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=135-167&author=V.+Ramanathan&author=N.+Vachharajani&title=Evaluation+of+Drug+Candidates+for+Preclinical+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DV.%26atitle%3DProtein%2520Binding%2520in%2520Drug%2520Discovery%2520and%2520Development%26btitle%3DEvaluation%2520of%2520Drug%2520Candidates%2520for%2520Preclinical%2520Development%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2010%26volume%3D13%26spage%3D135%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laakso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusecker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner-Redeker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delrat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, P.</span></span> <span> </span><span class="NLM_article-title">Bioanalysis for Plasma Protein Binding Studies in Drug Discovery and Drug Development: Views and Recommendations of the European Bioanalysis Forum</span>. <i>Bioanalysis</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.4155/bio.13.338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.4155%2Fbio.13.338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=24620809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktV2nt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=673-682&author=B.+Buscherauthor=S.+Laaksoauthor=H.+Mascherauthor=K.+Puseckerauthor=M.+Doigauthor=L.+Dillenauthor=W.+Wagner-Redekerauthor=T.+Pfeiferauthor=P.+Delratauthor=P.+Timmerman&title=Bioanalysis+for+Plasma+Protein+Binding+Studies+in+Drug+Discovery+and+Drug+Development%3A+Views+and+Recommendations+of+the+European+Bioanalysis+Forum&doi=10.4155%2Fbio.13.338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum</span></div><div class="casAuthors">Buscher, Brigitte; Laakso, Sirpa; Mascher, Hermann; Pusecker, Klaus; Doig, Mira; Dillen, Lieve; Wagner-Redeker, Winfried; Pfeifer, Thomas; Delrat, Pascal; Timmerman, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Bioanalysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">673-682</span>CODEN:
                <span class="NLM_cas:coden">BIOAB4</span>;
        ISSN:<span class="NLM_cas:issn">1757-6180</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Plasma protein binding (PPB) is an important parameter for a drug's efficacy and safety that needs to be investigated during each drug-development program.  Even though regulatory guidance exists to study the extent of PPB before initiating clin. studies, there are no detailed instructions on how to perform and validate such studies.  To explore how PPB studies involving bioanal. are currently executed in the industry, the European Bioanal. Forum (EBF) has conducted three surveys among their member companies: PPB studies in drug discovery (Part I); in vitro PPB studies in drug development (Part II); and in vivo PPB studies in drug development.  This paper reflects the outcome of the three surveys, which, together with the team discussions, formed the basis of the EBF recommendation.  The EBF recommends a tiered approach to the design of PPB studies and the bioanal. of PPB samples: 'PPB screening' expts. in (early) drug discovery vs. qualified/validated procedures in drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgJVlWvZ1xvbVg90H21EOLACvtfcHk0lisi9dqLca-pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktV2nt74%253D&md5=7a0b1f87dcaa6ac4477b43ed7d8c2b30</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Fbio.13.338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fbio.13.338%26sid%3Dliteratum%253Aachs%26aulast%3DBuscher%26aufirst%3DB.%26aulast%3DLaakso%26aufirst%3DS.%26aulast%3DMascher%26aufirst%3DH.%26aulast%3DPusecker%26aufirst%3DK.%26aulast%3DDoig%26aufirst%3DM.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DWagner-Redeker%26aufirst%3DW.%26aulast%3DPfeifer%26aufirst%3DT.%26aulast%3DDelrat%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DP.%26atitle%3DBioanalysis%2520for%2520Plasma%2520Protein%2520Binding%2520Studies%2520in%2520Drug%2520Discovery%2520and%2520Drug%2520Development%253A%2520Views%2520and%2520Recommendations%2520of%2520the%2520European%2520Bioanalysis%2520Forum%26jtitle%3DBioanalysis%26date%3D2014%26volume%3D6%26spage%3D673%26epage%3D682%26doi%3D10.4155%2Fbio.13.338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronzetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baljinnyam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span> <span> </span><span class="NLM_article-title">Testing for Drug-Human Serum Albumin Binding Using Fluorescent Probes and Other Methods</span>. <i>Expert Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.1080/17460441.2018.1534824</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1080%2F17460441.2018.1534824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=30320522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWiu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1005-1014&author=M.+Ronzettiauthor=B.+Baljinnyamauthor=A.+Yasgarauthor=A.+Simeonov&title=Testing+for+Drug-Human+Serum+Albumin+Binding+Using+Fluorescent+Probes+and+Other+Methods&doi=10.1080%2F17460441.2018.1534824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Testing for drug-human serum albumin binding using fluorescent probes and other methods</span></div><div class="casAuthors">Ronzetti, Michael; Baljinnyam, Bolormaa; Yasgar, Adam; Simeonov, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1005-1014</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug plasma protein binding remains highly relevant to research and drug development, making the assessment and profiling of compd. affinity to plasma proteins essential to drug discovery efforts.  Although there are a no. of fully-characterized methods, they lack the throughput to handle large nos. of compds.  As the evaluation of adsorption, distribution, metab., and excretion is addressed earlier in the drug development timeline, the need for higher-throughput methods has grown.  This review will highlight recent developments on methods for profiling drug plasma binding, with an emphasis on fluorescent probes and emerging high-throughput methodologies.  There have been a no. of high-throughput assays developed in recent years to meet the scaled up demands for compd. profiling.  Ultimately, the selection of assay technol. relies on a no. of factors, such as capabilities of the lab. and the breadth and amt. of data required.  Fluorescent probe displacement assays are highly flexible and amenable to high-throughput screening, easily scaling up to handle large compd. libraries.  Recent developments in fluorescence technologies, such as homogenous time-resolved fluorescence and probes utilizing the aggregation-induced emission effect, have improved the sensitivity of these assays.  Other technologies, such as microscale thermophoresis and quant. structure-activity relationship modeling, are gaining popularity as alternative techniques for drug plasma protein binding characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovzgGcjI27gbVg90H21EOLACvtfcHk0liWxsZu2m-kyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWiu7zN&md5=1733f12699a2921d3fcfd9cab1b488d3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F17460441.2018.1534824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2018.1534824%26sid%3Dliteratum%253Aachs%26aulast%3DRonzetti%26aufirst%3DM.%26aulast%3DBaljinnyam%26aufirst%3DB.%26aulast%3DYasgar%26aufirst%3DA.%26aulast%3DSimeonov%26aufirst%3DA.%26atitle%3DTesting%2520for%2520Drug-Human%2520Serum%2520Albumin%2520Binding%2520Using%2520Fluorescent%2520Probes%2520and%2520Other%2520Methods%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discov.%26date%3D2018%26volume%3D13%26spage%3D1005%26epage%3D1014%26doi%3D10.1080%2F17460441.2018.1534824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebille, B.</span></span> <span> </span><span class="NLM_article-title">Methods of Drug Protein Binding Determinations</span>. <i>Fundam. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">151s</span>– <span class="NLM_lpage">161s</span>, <span class="refDoi"> DOI: 10.1111/j.1472-8206.1990.tb00073.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1111%2Fj.1472-8206.1990.tb00073.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=2093626" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=151s-161s&author=B.+Sebille&title=Methods+of+Drug+Protein+Binding+Determinations&doi=10.1111%2Fj.1472-8206.1990.tb00073.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.1990.tb00073.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.1990.tb00073.x%26sid%3Dliteratum%253Aachs%26aulast%3DSebille%26aufirst%3DB.%26atitle%3DMethods%2520of%2520Drug%2520Protein%2520Binding%2520Determinations%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1990%26volume%3D4%26spage%3D151s%26epage%3D161s%26doi%3D10.1111%2Fj.1472-8206.1990.tb00073.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehngren, M.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Screening of Protein Binding by Equilibrium Dialysis Combined with Liquid Chromatography and Mass Spectrometry</span>. <i>J. Chromatogr. A</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1102</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.chroma.2005.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.chroma.2005.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=16266710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlagsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1102&publication_year=2006&pages=125-134&author=H.+Wanauthor=M.+Rehngren&title=High-Throughput+Screening+of+Protein+Binding+by+Equilibrium+Dialysis+Combined+with+Liquid+Chromatography+and+Mass+Spectrometry&doi=10.1016%2Fj.chroma.2005.10.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry</span></div><div class="casAuthors">Wan, Hong; Rehngren, Mikael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography A</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1102</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">125-134</span>CODEN:
                <span class="NLM_cas:coden">JCRAEY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new approach for screening plasma protein binding is presented.  The method is based on equil. dialysis combined with rapid generic LC-MS bioanal. by using a sample pooling approach enabling high-throughput screening of protein binding in the drug discovery phase.  The method is evaluated by a comparison of measured unbound free fractions fu (%) between single and pooled compds. for a test set of structurally diverse compds. with a wide range of unbound fractions.  Test compds. include 1 acidic and 10 basic drug stds. along with 36 new chem. entities.  A good correlation (R2 > 0.95) of fu (%) between the single and pooled compds. is found, suggesting that at least 10 compds. can be simultaneously measured with acceptable accuracy.  A simplified drug-protein binding model is applied to calc. the fu (%) of drugs at various drug and protein concns. and this is applied to elucidate the applicability of the sample pooling approach from a theor. standpoint.  Moreover, pH shifts in the plasma were obsd. after dialysis when using different types of buffers and the impact of that on the fu is illustrated in assocn. with their physicochem. properties, in particular the ionization state of compds. by the profile of effective mobility as a function of pH.  A new buffer is proposed being able to minimize the pH shift of plasma during the dialysis.  In addn., the application of the proposed buffer does not necessarily require adjusting plasma pH before the dialysis and utilizing a CO2 incubator during the dialysis.  The effect of the ionic strengths of different buffers on MS signals is investigated with regard to ion suppression.  The sample pooling method not only significantly reduces the plasma vol. required but also the no. of bioanal. samples as compared to the single compd. measurements by a conventional approach.  The new proposed approach is esp. beneficial for measuring in vitro protein binding in matrixes such as mouse plasma where plasma is available only in limited amts.  The current new development will facilitate the drug discovery process by more rapidly assessing the protein binding potential of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM94QtsMLoELVg90H21EOLACvtfcHk0liWxsZu2m-kyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlagsrzI&md5=53274b3e87826d1be0ac15d9ba758c08</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2005.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2005.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DRehngren%26aufirst%3DM.%26atitle%3DHigh-Throughput%2520Screening%2520of%2520Protein%2520Binding%2520by%2520Equilibrium%2520Dialysis%2520Combined%2520with%2520Liquid%2520Chromatography%2520and%2520Mass%2520Spectrometry%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D2006%26volume%3D1102%26spage%3D125%26epage%3D134%26doi%3D10.1016%2Fj.chroma.2005.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, S.</span></span> <span> </span><span class="NLM_article-title">Comparison of Ultrafiltration Devices for Assessing Theophylline Protein Binding</span>. <i>Ther. Drug Monit.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1097/00007691-199007000-00017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1097%2F00007691-199007000-00017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=2396314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Crt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1990&pages=398-403&author=J.+Blanchardauthor=S.+Harvey&title=Comparison+of+Ultrafiltration+Devices+for+Assessing+Theophylline+Protein+Binding&doi=10.1097%2F00007691-199007000-00017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of ultrafiltration devices for assessing theophylline protein binding</span></div><div class="casAuthors">Blanchard, James; Harvey, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Drug Monitoring</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">398-403</span>CODEN:
                <span class="NLM_cas:coden">TDMODV</span>;
        ISSN:<span class="NLM_cas:issn">0163-4356</span>.
    </div><div class="casAbstract">The ability of two com. available ultrafiltration devices to assess the protein binding of theophylline was compared using human serum albumin in pH 7.4 buffer at 37°.  The devices compared were the Millipore-MC filter units (Catalog no. UFC3LGC00) and the Amicon Centrifree Micropartition System; both rely on centrifugal force to sep. the unbound and bound mols.  The results from each device were essentially identical provided that the Millipore units were centrifuged using conditions that would not allow heat buildup to occur and thereby cause a decrease in the binding.  This problem could be minimized if the Millipore units were available in a low-binding 30,000 dalton cutoff membrane instead of the 10,000 dalton membrane currently available.  The use of the Millipore 30,000 dalton cutoff polysulfone membrane (UFC3TTK00) reduced the centrifugation time necessary to obtain a sufficient vol. of ultrafiltrate for assay, thereby minimizing the possibility of heat generation.  Furthermore, the binding of theophylline to this device was low and comparable to the binding to the Centrifree devices.  Because this low degree of membrane binding may not hold for other drugs, it would be suggested that a Millipore unit supplied with a low-binding, 30,000 dalton cutoff membrane could provide binding data with an efficacy comparable to that achieved with the Centrifree devices.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzy5v26IoOZ7Vg90H21EOLACvtfcHk0liWxsZu2m-kyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Crt7w%253D&md5=d53280d514227bbdef921755b2de6de2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1097%2F00007691-199007000-00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007691-199007000-00017%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DHarvey%26aufirst%3DS.%26atitle%3DComparison%2520of%2520Ultrafiltration%2520Devices%2520for%2520Assessing%2520Theophylline%2520Protein%2520Binding%26jtitle%3DTher.%2520Drug%2520Monit.%26date%3D1990%26volume%3D12%26spage%3D398%26epage%3D403%26doi%3D10.1097%2F00007691-199007000-00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J. L.</span>; <span class="NLM_string-name">Lary, J. W.</span>; <span class="NLM_string-name">Moody, T. P.</span>; <span class="NLM_string-name">Laue, T. M.</span></span> <span> </span><span class="NLM_article-title">Analytical Ultracentrifugation: Sedimentation Velocity and Sedimentation Equilibrium</span>. In  <i>Methods in Cell Biology</i>; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2008</span>; Vol.  <span class="NLM_volume">84</span>, pp  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">179</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=143-179&author=J.+L.+Cole&author=J.+W.+Lary&author=T.+P.+Moody&author=T.+M.+Laue&title=Methods+in+Cell+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DJ.%2BL.%26atitle%3DAnalytical%2520Ultracentrifugation%253A%2520Sedimentation%2520Velocity%2520and%2520Sedimentation%2520Equilibrium%26btitle%3DMethods%2520in%2520Cell%2520Biology%26pub%3DElsevier%26date%3D2008%26volume%3D84%26spage%3D143%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergström, F.</span></span> <span> </span><span class="NLM_article-title">High Throughput Screening of Drug-Protein Binding in Drug Discovery</span>. <i>J. Liq. Chromatogr. Relat. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1080/10826070701190989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1080%2F10826070701190989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVOhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=681-700&author=H.+Wanauthor=F.+Bergstr%C3%B6m&title=High+Throughput+Screening+of+Drug-Protein+Binding+in+Drug+Discovery&doi=10.1080%2F10826070701190989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput screening of drug-protein binding in drug discovery</span></div><div class="casAuthors">Wan, Hong; Bergstroem, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liquid Chromatography & Related Technologies</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">681-700</span>CODEN:
                <span class="NLM_cas:coden">JLCTFC</span>;
        ISSN:<span class="NLM_cas:issn">1082-6076</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Characterization of drug-protein binding is essential, since it has profound effects on pharmacokinetic and pharmacodynamic parameters of new chem. entities.  Although the traditional equil. dialysis method is well established and widely used for drug-protein binding measurement, this assay suffers from its low throughput.  Recent efforts were made in developing and implementing high throughput assays for drug-protein screening in drug discovery.  The present review highlights high-throughput assays, as well as potential new approaches for drug-protein binding screening in drug discovery.  These primarily include automated 96-well plate, sample pooling based equil. dialysis combined with LCMS, immobilized HSA column HPLC, and electrodriven techniques such as frontal anal. combined with capillary electrophoresis (FACE), and affinity capillary electrophoresis (ACE).  Fundamental drug-protein binding models are also discussed to (1) compare and discriminate HSA (human serum albumin) and AGP (alpha 1-acid glycoprotein) binding with regard to the whole plasma protein binding; and (2) elucidate the applicability of high throughput screening (HTS) from the viewpoint of a simplified binding model.  Some strategies and recommendations are proposed in dealing with applications of high throughput assays in different situations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_xre3PNsNMbVg90H21EOLACvtfcHk0lhlbgd5CAOmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVOhtbg%253D&md5=5eb753c9ec9142c2a3d89a3a266dfacf</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1080%2F10826070701190989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10826070701190989%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DF.%26atitle%3DHigh%2520Throughput%2520Screening%2520of%2520Drug-Protein%2520Binding%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Liq.%2520Chromatogr.%2520Relat.%2520Technol.%26date%3D2007%26volume%3D30%26spage%3D681%26epage%3D700%26doi%3D10.1080%2F10826070701190989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-Q.</span></span> <span> </span><span class="NLM_article-title">Rapid Screening of Drug-Protein Binding Using High-Performance Affinity Chromatography with Columns Containing Immobilized Human Serum Albumin</span>. <i>J. Anal. Methods Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1155/2013/439039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1155%2F2013%2F439039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-7&author=Y.-F.+Liauthor=X.-Q.+Zhangauthor=W.-Y.+Huauthor=Z.+Liauthor=P.-X.+Liuauthor=Z.-Q.+Zhang&title=Rapid+Screening+of+Drug-Protein+Binding+Using+High-Performance+Affinity+Chromatography+with+Columns+Containing+Immobilized+Human+Serum+Albumin&doi=10.1155%2F2013%2F439039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1155%2F2013%2F439039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F439039%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.-F.%26aulast%3DZhang%26aufirst%3DX.-Q.%26aulast%3DHu%26aufirst%3DW.-Y.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DP.-X.%26aulast%3DZhang%26aufirst%3DZ.-Q.%26atitle%3DRapid%2520Screening%2520of%2520Drug-Protein%2520Binding%2520Using%2520High-Performance%2520Affinity%2520Chromatography%2520with%2520Columns%2520Containing%2520Immobilized%2520Human%2520Serum%2520Albumin%26jtitle%3DJ.%2520Anal.%2520Methods%2520Chem.%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D7%26doi%3D10.1155%2F2013%2F439039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noctor, T. A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Perez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainer, I. W.</span></span> <span> </span><span class="NLM_article-title">Use of a Human Serum Albumin-Based Stationary Phase for High-Performance Liquid Chromatography as a Tool for the Rapid Determination of Drug–Plasma Protein Binding</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1002/jps.2600820629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fjps.2600820629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=8331550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK3sXkvVGhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1993&pages=675-676&author=T.+A.+G.+Noctorauthor=M.+J.+Diaz-Perezauthor=I.+W.+Wainer&title=Use+of+a+Human+Serum+Albumin-Based+Stationary+Phase+for+High-Performance+Liquid+Chromatography+as+a+Tool+for+the+Rapid+Determination+of+Drug%E2%80%93Plasma+Protein+Binding&doi=10.1002%2Fjps.2600820629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a human serum albumin-based stationary phase for high-performance liquid chromatography as a tool for the rapid determination of drug-plasma protein binding</span></div><div class="casAuthors">Noctor, Terence A. G.; Diaz-Perez, Maria J.; Wainer, Irving W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-6</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">The present investigation evaluated HPLC on a chiral stationary phase (CSP) based on human serum albumins (HSA) for rapid and precise detn. of the extent to which a drug binds to albumin.  Three series of solutes were examd.: a group of 19 1,4-benzodiazepines, a group of 9 coumarins and a series of 24 structurally related triazole derivs.  The percentage of binding of each compd. to HSA (4 g/100 mL) in buffer soln. (100 mM, pH 7.4) was detd. by ultrafiltration (Centrifree) after incubation for 2-3 h at room temp.  The compds. were quantitated photometrically.  In each case, control expts. were performed to ensure that the compd. under study did not adsorb to the ultrafiltration assembly.  Significant and variable amts. of a UV-absorptive material from the ultrafiltration membrane appeared in the ultrafiltrate and interfered with solute anal.  The percentage of solute bound to HSA, as detd. above, was correlated with the retention of the compd. on the HSA CSP (Chiral-Protein 2), as represented by capacity factors (k').  Because the solutes examd. exhibited a very large range of levels of binding to HSA, HSA CSPs of different sizes and different mobile phases were used.  The triazole derivs. were found to exhibit very low levels of binding to HSA and subsequently to be retained in very small amts. on the HSA CSP.  These solutes were therefore chromatographed on a 15-cm HSA column with a mobile phase composed of a simple phosphate buffer (100 mM, pH 6.90) without an org. modifier.  The coumarins showed very high levels of binding to HSA; therefore, a 5-cm HSA column with a mobile phase of sodium phosphate (100 mM, pH 6.90):propan-1-ol (95:5 [vol./vol.]) was used.  For the benzodiazepines, a 15-cm column with the same mobile phase compn. as that used for the coumarins was used.  For the compds. examd., the extent of HSA binding correlated better with the expression k'/(k' + 1) than with k'.  This factor is derived from the fundamental definition of k' as the ratio of solute in the stationary phase to that in the mobile phase and is therefore an expression of the fraction of solute actually adsorbed to the immobilized protein.  Plots of k'/(k' + 1) against percentage of solute bound to HSA are presented.  These studies show that retention of a solute on the HSA CSP is clearly related to its binding affinity for the free protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXYRcOMv9rBbVg90H21EOLACvtfcHk0lhlbgd5CAOmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvVGhtbg%253D&md5=8f9d55337a700c1244017d0e43894d09</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600820629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600820629%26sid%3Dliteratum%253Aachs%26aulast%3DNoctor%26aufirst%3DT.%2BA.%2BG.%26aulast%3DDiaz-Perez%26aufirst%3DM.%2BJ.%26aulast%3DWainer%26aufirst%3DI.%2BW.%26atitle%3DUse%2520of%2520a%2520Human%2520Serum%2520Albumin-Based%2520Stationary%2520Phase%2520for%2520High-Performance%2520Liquid%2520Chromatography%2520as%2520a%2520Tool%2520for%2520the%2520Rapid%2520Determination%2520of%2520Drug%25E2%2580%2593Plasma%2520Protein%2520Binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1993%26volume%3D82%26spage%3D675%26epage%3D676%26doi%3D10.1002%2Fjps.2600820629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Binding of Imipramine to Plasma Proteins: Effect of Hyperlipoproteinemia</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1002/cpt1979253316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fcpt1979253316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=761443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaE1MXhvFOgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1979&pages=316-321&author=A.+Danonauthor=Z.+Chen&title=Binding+of+Imipramine+to+Plasma+Proteins%3A+Effect+of+Hyperlipoproteinemia&doi=10.1002%2Fcpt1979253316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of imipramine to plasma proteins:  effect of hyperlipoproteinemia</span></div><div class="casAuthors">Danon, Abraham; Chen, Zehava</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-21</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">Imipramine (I)  [50-49-7] was highly bound to lipoproteins and to other plasma proteins.  The binding to the lipoproteins was higher in hyperlipoproteinemic patients than in normal subjects and correlated with both plasma cholesterol  [57-88-5] and triglyceride levels.  The overall percent binding of I was higher in hyperlipoproteinemic patients than in normal subjects.  The varying degree of binding of I to plasma proteins as a result of varying lipoprotein concns., as well as the special nature of the binding to lipoproteins, may be of kinetic and clin. significance in hyperlipoproteinemic individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJn2eBR1SVoLVg90H21EOLACvtfcHk0lhlbgd5CAOmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhvFOgtL4%253D&md5=133fa1abb69eb26fae30d6e9b92e4e23</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcpt1979253316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt1979253316%26sid%3Dliteratum%253Aachs%26aulast%3DDanon%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DBinding%2520of%2520Imipramine%2520to%2520Plasma%2520Proteins%253A%2520Effect%2520of%2520Hyperlipoproteinemia%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1979%26volume%3D25%26spage%3D316%26epage%3D321%26doi%3D10.1002%2Fcpt1979253316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larive, C. K.</span></span> <span> </span><span class="NLM_article-title">Measuring Ligand-Protein Binding Using NMR Diffusion Experiments</span>. <i>Concepts Magn. Reson. Part A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>20A</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1002/cmr.a.10094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fcmr.a.10094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20A&publication_year=2004&pages=24-41&author=L.+H.+Lucasauthor=C.+K.+Larive&title=Measuring+Ligand-Protein+Binding+Using+NMR+Diffusion+Experiments&doi=10.1002%2Fcmr.a.10094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring ligand-protein binding using NMR diffusion experiments</span></div><div class="casAuthors">Lucas, Laura H.; Larive, Cynthia K.</div><div class="citationInfo"><span class="NLM_cas:title">Concepts in Magnetic Resonance, Part A</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">20A</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-41</span>CODEN:
                <span class="NLM_cas:coden">CMRPC2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Characterization of ligand-protein interactions is important because many biol. important processes are mediated by the binding of a small mol. to an enzyme or cell-surface receptor.  Pulsed-field gradient NMR (PFG-NMR) spectroscopy measurements of diffusion coeffs. permit noninvasive, quant. anal. of binding over a broad range of dissocn. consts. and ligand:protein concn. ratios.  An arsenal of specific and selective PFG-NMR methods has been developed by exploiting differential behaviors of small mol. ligands and macromol. proteins.  A discussion of several PFG-NMR methods and their relevant applications reveals the anal. value of using PFG-NMR diffusion measurements for studying ligand-protein binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK1JhVnpSLFLVg90H21EOLACvtfcHk0lj-a39NUpvEQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVCjsrc%253D&md5=0ea7637a42793d336c008e3fac5744fe</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcmr.a.10094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmr.a.10094%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DL.%2BH.%26aulast%3DLarive%26aufirst%3DC.%2BK.%26atitle%3DMeasuring%2520Ligand-Protein%2520Binding%2520Using%2520NMR%2520Diffusion%2520Experiments%26jtitle%3DConcepts%2520Magn.%2520Reson.%2520Part%2520A.%26date%3D2004%26volume%3D20A%26spage%3D24%26epage%3D41%26doi%3D10.1002%2Fcmr.a.10094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaimo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsale, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicero, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span> <span> </span><span class="NLM_article-title">A Novel Method Using Nuclear Magnetic Resonance for Plasma Protein Binding Assessment in Drug Discovery Programs</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2019.01.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.jpba.2019.01.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=30738240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC1MXis1Wksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2019&pages=21-29&author=M.+Galloauthor=S.+Matteucciauthor=N.+Alaimoauthor=E.+Pittiauthor=M.+V.+Orsaleauthor=V.+Summaauthor=D.+O.+Ciceroauthor=E.+Monteagudo&title=A+Novel+Method+Using+Nuclear+Magnetic+Resonance+for+Plasma+Protein+Binding+Assessment+in+Drug+Discovery+Programs&doi=10.1016%2Fj.jpba.2019.01.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A novel method using nuclear magnetic resonance for plasma protein binding assessment in drug discovery programs</span></div><div class="casAuthors">Gallo, Mariana; Matteucci, Sara; Alaimo, Nadine; Pitti, Erica; Orsale, Maria V.; Summa, Vincenzo; Cicero, Daniel O.; Monteagudo, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new methodol. based on NMR was developed to det. plasma protein binding (PPB) of drug candidates in drug discovery programs.  A strong correlation was found between the attenuation of NMR signals of diverse drugs in the presence of different plasma concns. and their fraction bound (fb) reported in the literature.  Based on these results, a protocol for a rapid calcn. of fb of small mols. was established.  The advantage of using plasma instead of purified recombinant proteins and the possibility of pool anal. to increase throughput were also evaluated.  This novel methodol. proved to be very versatile, cost-effective, fast and suitable for automation.  As a plus, it contemporarily provides a quality check and soly. of the compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoCa_PAOMXyLVg90H21EOLACvtfcHk0lj-a39NUpvEQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXis1Wksr4%253D&md5=616d2e8af44c5169588cc5599eb6105f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2019.01.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2019.01.049%26sid%3Dliteratum%253Aachs%26aulast%3DGallo%26aufirst%3DM.%26aulast%3DMatteucci%26aufirst%3DS.%26aulast%3DAlaimo%26aufirst%3DN.%26aulast%3DPitti%26aufirst%3DE.%26aulast%3DOrsale%26aufirst%3DM.%2BV.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DCicero%26aufirst%3DD.%2BO.%26aulast%3DMonteagudo%26aufirst%3DE.%26atitle%3DA%2520Novel%2520Method%2520Using%2520Nuclear%2520Magnetic%2520Resonance%2520for%2520Plasma%2520Protein%2520Binding%2520Assessment%2520in%2520Drug%2520Discovery%2520Programs%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2019%26volume%3D167%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.jpba.2019.01.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meehan, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span> <span> </span><span class="NLM_article-title">A New Drug Binding Subsite on Human Serum Albumin and Drug–Drug Interaction Studied by X-Ray Crystallography</span>. <i>J. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.jsb.2007.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.jsb.2007.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=18258455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksleju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2008&pages=40-49&author=L.+Zhuauthor=F.+Yangauthor=L.+Chenauthor=E.+J.+Meehanauthor=M.+Huang&title=A+New+Drug+Binding+Subsite+on+Human+Serum+Albumin+and+Drug%E2%80%93Drug+Interaction+Studied+by+X-Ray+Crystallography&doi=10.1016%2Fj.jsb.2007.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography</span></div><div class="casAuthors">Zhu, Lili; Yang, Feng; Chen, Liqing; Meehan, Edward J.; Huang, Mingdong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Structural Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-49</span>CODEN:
                <span class="NLM_cas:coden">JSBIEM</span>;
        ISSN:<span class="NLM_cas:issn">1047-8477</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">3'-Azido-3'-deoxythymidine (AZT) is the first clin. effective drug for the treatment of human immunodeficiency virus infection.  The drug interaction with human serum albumin (HSA) has been an important component in understanding its mechanism of action, esp. in drug distribution and in drug-drug interaction on HSA in the case of multi-drug therapy.  We present here crystal structures of a ternary HSA-Myr-AZT complex and a quaternary HSA-Myr-AZT-SAL complex (Myr, myristate; SAL, salicylic acid).  From this study, a new drug binding subsite on HSA Sudlow site 1 was identified.  The presence of fatty acid is needed for the creation of this subsite due to fatty acid induced conformational changes of HSA.  Thus, the Sudlow site 1 of HSA can be divided into three non-overlapped subsites: a SAL subsite, an indomethacin subsite and an AZT subsite.  Binding of a drug to HSA often influences simultaneous binding of other drugs.  From the HSA-Myr-AZT-SAL complex structure, we obsd. the coexistence of two drugs (AZT and SAL) in Sudlow site 1 and the competition between these two drugs in subdomain IB.  These results provide new structural information on HSA-drug interaction and drug-drug interaction on HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr02e6NtI1kY7Vg90H21EOLACvtfcHk0lj-a39NUpvEQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksleju7g%253D&md5=b5bb4a6a96bbfa8614c3e2fbe2e00c94</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2007.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2007.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMeehan%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DM.%26atitle%3DA%2520New%2520Drug%2520Binding%2520Subsite%2520on%2520Human%2520Serum%2520Albumin%2520and%2520Drug%25E2%2580%2593Drug%2520Interaction%2520Studied%2520by%2520X-Ray%2520Crystallography%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2008%26volume%3D162%26spage%3D40%26epage%3D49%26doi%3D10.1016%2Fj.jsb.2007.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. A.</span></span> <span> </span><span class="NLM_article-title">Capillary Electrophoresis Technologies for Screening in Drug Discovery</span>. <i>Drug Discov. Today Technol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1016/j.ddtec.2005.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.ddtec.2005.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=24981845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKrtLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=171-178&author=H.+Wanauthor=R.+A.+Thompson&title=Capillary+Electrophoresis+Technologies+for+Screening+in+Drug+Discovery&doi=10.1016%2Fj.ddtec.2005.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Capillary electrophoresis technologies for screening in drug discovery</span></div><div class="casAuthors">Wan, Hong; Thompson, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-178</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The high sepn. efficiency of capillary electrophoresis (CE), combined with the high selectivity and sensitivity of mass spectrometry (MS) detection offers the potential of unique resolving power and high-throughput capacity to the anal. and structural identification of complex mixts.  Recent advances in CE-MS interfaces and com. available 96-capillary instruments have made the implementation of routine CE methods for drug screening feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8caFTtvPpRbVg90H21EOLACvtfcHk0ljbSaywMqT79Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKrtLnL&md5=76359049fc141fe3ea6716647da7962e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2005.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2005.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26atitle%3DCapillary%2520Electrophoresis%2520Technologies%2520for%2520Screening%2520in%2520Drug%2520Discovery%26jtitle%3DDrug%2520Discov.%2520Today%2520Technol.%26date%3D2005%26volume%3D2%26spage%3D171%26epage%3D178%26doi%3D10.1016%2Fj.ddtec.2005.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambrinidis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallianatou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantili-Kakoulidou, A.</span></span> <span> </span><span class="NLM_article-title">In Vitro, in Silico and Integrated Strategies for the Estimation of Plasma Protein Binding. A Review</span>. <i>Adv. Drug Delivery Rev</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2015.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.addr.2015.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=25819487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslCltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2015&pages=27-45&author=G.+Lambrinidisauthor=T.+Vallianatouauthor=A.+Tsantili-Kakoulidou&title=In+Vitro%2C+in+Silico+and+Integrated+Strategies+for+the+Estimation+of+Plasma+Protein+Binding.+A+Review&doi=10.1016%2Fj.addr.2015.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review</span></div><div class="casAuthors">Lambrinidis, George; Vallianatou, Theodosia; Tsantili-Kakoulidou, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-45</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Plasma protein binding (PPB) strongly affects drug distribution and pharmacokinetic behavior with consequences in overall pharmacol. action.  Extended plasma protein binding may be assocd. with drug safety issues and several adverse effects, like low clearance, low brain penetration, drug-drug interactions, loss of efficacy, while influencing the fate of enantiomers and diastereoisomers by stereoselective binding within the body.  Therefore in holistic drug design approaches, where ADME(T) properties are considered in parallel with target affinity, considerable efforts are focused in early estn. of PPB mainly in regard to human serum albumin (HSA), which is the most abundant and most important plasma protein.  The second crit. serum protein α1-acid glycoprotein (AGP), although often underscored, plays also an important and complicated role in clin. therapy and thus the last years it has been studied thoroughly too.In the present review, after an overview of the principles of HSA and AGP binding as well as the structure topol. of the proteins, the current trends and perspectives in the field of PPB predictions are presented and discussed considering both HSA and AGP binding.  Since however for the latter protein systematic studies have started only the last years, the review focuses mainly to HSA.  One part of the review highlights the challenge to develop rapid techniques for HSA and AGP binding simulation and their performance in assessment of PPB.  The second part focuses on in silico approaches to predict HSA and AGP binding, analyzing and evaluating structure-based and ligand-based methods, as well as combination of both methods in the aim to exploit the different information and overcome the limitations of each individual approach.  Ligand-based methods use the Quant. Structure-Activity Relationships (QSAR) methodol. to establish quantitate models for the prediction of binding consts. from mol. descriptors, while they provide only indirect information on binding mechanism.  Efforts for the establishment of global models, automated workflows and web-based platforms for PPB predictions are presented and discussed.  Structure-based methods relying on the crystal structures of drug-protein complexes provide detailed information on the underlying mechanism but are usually restricted to specific compds.  They are useful to identify the specific binding site while they may be important in investigating drug-drug interactions, related to PPB.  Moreover, chemometrics or structure-based modeling may be supported by exptl. data a promising integrated alternative strategy for ADME(T) properties optimization.  In the case of PPB the use of mol. modeling combined with bioanal. techniques is frequently used for the investigation of AGP binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO5Jya4dWQ6LVg90H21EOLACvtfcHk0ljbSaywMqT79Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslCltbo%253D&md5=06b12cb016d725b42c3f59af08919f4e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2015.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2015.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DLambrinidis%26aufirst%3DG.%26aulast%3DVallianatou%26aufirst%3DT.%26aulast%3DTsantili-Kakoulidou%26aufirst%3DA.%26atitle%3DIn%2520Vitro%252C%2520in%2520Silico%2520and%2520Integrated%2520Strategies%2520for%2520the%2520Estimation%2520of%2520Plasma%2520Protein%2520Binding.%2520A%2520Review%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev%26date%3D2015%26volume%3D86%26spage%3D27%26epage%3D45%26doi%3D10.1016%2Fj.addr.2015.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, M. H.</span></span> <span> </span><span class="NLM_article-title">An Inexpensive, In-House-Made, Microdialysis Device for Measuring Drug–Protein Binding</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00316</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00316" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOjurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=279-282&author=Z.+M.+Herbstauthor=S.+Shibataauthor=E.+Fanauthor=M.+H.+Gelb&title=An+Inexpensive%2C+In-House-Made%2C+Microdialysis+Device+for+Measuring+Drug%E2%80%93Protein+Binding&doi=10.1021%2Facsmedchemlett.7b00316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">An Inexpensive, In-House-Made, Microdialysis Device for Measuring Drug-Protein Binding</span></div><div class="casAuthors">Herbst, Zackary M.; Shibata, Sayaka; Fan, Erkang; Gelb, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An inexpensive, inhouse made microdialysis device is described that is suitable for measuring the binding of small mols. including drug candidates to serum proteins or other macromols.  The device is based on the std. equil. dialysis method to measure the fraction of low mol. wt. compd. bound to proteins.  It is constructed from a std. polypropylene 96-well plate, dialysis tubing, and low viscosity epoxy resin.  The device can be readily prepd. for a small fraction of the cost of a com., multichamber microdialysis device.  Drug-protein binding results are provided, which validates the device.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTjiSTHRb7orVg90H21EOLACvtfcHk0lgluYPNat3WFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOjurzF&md5=9a612b4666217cd6356c44679e4f0bda</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00316%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DZ.%2BM.%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DAn%2520Inexpensive%252C%2520In-House-Made%252C%2520Microdialysis%2520Device%2520for%2520Measuring%2520Drug%25E2%2580%2593Protein%2520Binding%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D279%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.7b00316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kieltyka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drexler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Application of Cassette Ultracentrifugation Using Non-Labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding Determination</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_fpage">1036</span>, <span class="refDoi"> DOI: 10.1016/S0022-3549(15)00177-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2FS0022-3549%2815%2900177-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=26886323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=1036&author=K.+Kieltykaauthor=B.+McAuliffeauthor=C.+Cianciauthor=D.+M.+Drexlerauthor=W.+Shouauthor=J.+Zhang&title=Application+of+Cassette+Ultracentrifugation+Using+Non-Labeled+Compounds+and+Liquid+Chromatography-Tandem+Mass+Spectrometry+Analysis+for+High-Throughput+Protein+Binding+Determination&doi=10.1016%2FS0022-3549%2815%2900177-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Cassette Ultracentrifugation Using Non-labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding Determination</span></div><div class="casAuthors">Kieltyka, Kasia; McAuliffe, Brian; Cianci, Christopher; Drexler, Dieter M.; Shou, Wilson; Zhang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1036-1042</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Membrane-based devices typically used for serum protein binding detn. are not fully applicable to highly lipophilic compds. because of nonspecific binding to the device membrane.  Ultracentrifugation, however, completely eliminates the issue by using a membrane-free approach, although its wide application has been limited.  This lack of utilization is mainly attributed to 2 factors: the high cost in acquiring and handling of radiolabeled compds. and low assay throughput owing to the difficulties in process automation.  To overcome these challenges, we report a high-throughput workflow by cassette ultracentrifugation of nonradiolabeled compds. followed by liq. chromatog.-tandem mass spectrometry (LC-MS/MS) anal.  Twenty compds. with diverse physicochem. and protein binding properties were selected for the evaluation of the workflow.  To streamline the working process, approaches of matrix balancing for all the samples for LC-MS/MS anal. and detg. free fraction without anal. calibration curves were adopted.  Both the discrete ultracentrifugation of individual compds. and cassette ultracentrifugation of all the test compds. followed by simultaneous LC-MS/MS anal. exhibited a linear correlation with literature values, demonstrating resp. the validity of the ultracentrifugation process and the cassette approach.  The cassette ultracentrifugation using nonradiolabeled compds. followed by LC-MS/MS anal. has greatly facilitated its application for high-throughput protein binding screening in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrntwsG-p7rDLVg90H21EOLACvtfcHk0lgluYPNat3WFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnu7rI&md5=4f0784b86c5b895763870c40aebc6db0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0022-3549%2815%2900177-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3549%252815%252900177-X%26sid%3Dliteratum%253Aachs%26aulast%3DKieltyka%26aufirst%3DK.%26aulast%3DMcAuliffe%26aufirst%3DB.%26aulast%3DCianci%26aufirst%3DC.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26aulast%3DShou%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520Cassette%2520Ultracentrifugation%2520Using%2520Non-Labeled%2520Compounds%2520and%2520Liquid%2520Chromatography-Tandem%2520Mass%2520Spectrometry%2520Analysis%2520for%2520High-Throughput%2520Protein%2520Binding%2520Determination%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26spage%3D1036%26doi%3D10.1016%2FS0022-3549%2815%2900177-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, L. E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas-Hernández, C.</span></span> <span> </span><span class="NLM_article-title">Spectrophotometric Determination of the PKa, Isosbestic Point and Equation of Absorbance vs. PH for a Universal PH Indicator</span>. <i>Am. J. Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>05</i></span>,  <span class="NLM_fpage">1290</span>– <span class="NLM_lpage">1301</span>, <span class="refDoi"> DOI: 10.4236/ajac.2014.517135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.4236%2Fajac.2014.517135" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=05&publication_year=2014&pages=1290-1301&author=L.+E.+V.+Salgadoauthor=C.+Vargas-Hern%C3%A1ndez&title=Spectrophotometric+Determination+of+the+PKa%2C+Isosbestic+Point+and+Equation+of+Absorbance+vs.+PH+for+a+Universal+PH+Indicator&doi=10.4236%2Fajac.2014.517135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.4236%2Fajac.2014.517135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fajac.2014.517135%26sid%3Dliteratum%253Aachs%26aulast%3DSalgado%26aufirst%3DL.%2BE.%2BV.%26aulast%3DVargas-Hern%25C3%25A1ndez%26aufirst%3DC.%26atitle%3DSpectrophotometric%2520Determination%2520of%2520the%2520PKa%252C%2520Isosbestic%2520Point%2520and%2520Equation%2520of%2520Absorbance%2520vs.%2520PH%2520for%2520a%2520Universal%2520PH%2520Indicator%26jtitle%3DAm.%2520J.%2520Anal.%2520Chem.%26date%3D2014%26volume%3D05%26spage%3D1290%26epage%3D1301%26doi%3D10.4236%2Fajac.2014.517135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Connors, K. A.</span></span> <span> </span><span class="NLM_article-title">Optical Absorption Spectroscopy</span>. In  <i>Binding Constants: The Measurement of Molecular Complex Stability</i>; <span class="NLM_publisher-name">Wiley-Interscience</span>, <span class="NLM_year">1987</span>; pp  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">187</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&pages=141-187&author=K.+A.+Connors&title=Binding+Constants%3A+The+Measurement+of+Molecular+Complex+Stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DConnors%26aufirst%3DK.%2BA.%26atitle%3DOptical%2520Absorption%2520Spectroscopy%26btitle%3DBinding%2520Constants%253A%2520The%2520Measurement%2520of%2520Molecular%2520Complex%2520Stability%26pub%3DWiley-Interscience%26date%3D1987%26spage%3D141%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span> <i>Goodman and Gilman’s The Pharmacological
Basis of Therapeutics,
10th ed.</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardman, J. G.</span>, <span class="NLM_string-name">Limbird, L. E.</span>, <span class="NLM_string-name">Gilman, A. G.</span></span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+G.+Hardman&author=L.+E.+Limbird&author=A.+G.+Gilman&title=Goodman+and+Gilman%E2%80%99s+The+Pharmacological%0ABasis+of+Therapeutics%2C%0A10th+ed."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGoodman%2520and%2520Gilman%25E2%2580%2599s%2520The%2520Pharmacological%250ABasis%2520of%2520Therapeutics%252C%250A10th%2520ed.%26aulast%3DHardman%26aufirst%3DJ.%2BG.%26pub%3DMcGraw-Hill%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span> <span> </span><span class="NLM_article-title">Compilation of 222 Drugs’ Plasma Protein Binding Data and Guidance for Study Designs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">485</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.drudis.2011.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=22210121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslygsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=475-485&author=F.+Zhangauthor=J.+Xueauthor=J.+Shaoauthor=L.+Jia&title=Compilation+of+222+Drugs%E2%80%99+Plasma+Protein+Binding+Data+and+Guidance+for+Study+Designs&doi=10.1016%2Fj.drudis.2011.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Compilation of 222 drugs' plasma protein binding data and guidance for study designs</span></div><div class="casAuthors">Zhang, Fengling; Xue, Jinpin; Shao, Jingwei; Jia, Li</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">475-485</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The binding of a drug to plasma protein reduces free drug in the blood circulation that would otherwise be available for penetration into tissues to reach the therapeutic target or the kidney for elimination.  Therefore, the binding event affects drug elimination from the body, efficacy, duration of action and toxicity.  Co-administration of other drugs, food and pathol. conditions of patients can significantly change percentage binding of the drug and result in serious consequences.  Here, we present the largest and newest information on plasma protein binding for 222 drugs, of which 50% show 90-100% binding, a range that could be considered as a favorable element for future lead selection.  We also provide crit. and comprehensive evaluations on the methods and techniques established to det. plasma protein binding, pinpoint advantages and pitfalls of individual approaches, and offer detailed guidance for exptl. designs, including ultrafiltration, equil. dialysis, ultracentrifugation, charcoal adsorption, high-performance affinity chromatog., high-performance frontal anal., solid-phase microextn. and in vivo microdialysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTcTLPiF2eoLVg90H21EOLACvtfcHk0lgvsRhG9kBLZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslygsbg%253D&md5=3de93a27ff20a113a4ef0724961ab6bc</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DL.%26atitle%3DCompilation%2520of%2520222%2520Drugs%25E2%2580%2599%2520Plasma%2520Protein%2520Binding%2520Data%2520and%2520Guidance%2520for%2520Study%2520Designs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26spage%3D475%26epage%3D485%26doi%3D10.1016%2Fj.drudis.2011.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, J.</span></span> <span> </span><span class="NLM_article-title">Measurement of Drug–Protein Binding by Immobilized Human Serum Albumin-HPLC and Comparison with Ultrafiltration</span>. <i>J. Chromatogr., B</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>834</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.jchromb.2006.02.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.jchromb.2006.02.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=16567134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFOgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=834&publication_year=2006&pages=108-116&author=S.+S.+Singhauthor=J.+Mehta&title=Measurement+of+Drug%E2%80%93Protein+Binding+by+Immobilized+Human+Serum+Albumin-HPLC+and+Comparison+with+Ultrafiltration&doi=10.1016%2Fj.jchromb.2006.02.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration</span></div><div class="casAuthors">Singh, Sonu Sundd; Mehta, Jitendra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">834</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">108-116</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An HPLC method employing CHIRAL-I (150 mm × 3 mm), 5 μm column from Chrom.Tech., immobilized with human serum albumin (HSA), was used to det. in vitro protein binding of several compds.  Exptl. obtained plasma protein data exhibited good correlation with the reported values.  The method was compared with the conventional ultrafiltration technique and both yielded similar results.  Proprietary compds. that could not be analyzed by ultrafiltration due to high non-specific binding to filter membrane were successfully analyzed by HSA-HPLC method.  On the other hand, two proprietary compds. did not elute from HSA column due to strong binding, but were successfully analyzed by ultra filtration.  This proves that both the techniques have their own merits and demerits and should be exploited judiciously as per the requirement.  The plasma protein binding studies conducted on four gyrase inhibitors in rat and human plasma exhibited no interspecies difference via ultra filtration method.  Further, it was also obsd. that the protein binding obtained for the four gyrase inhibitors by HSA-HPLC method was not only similar to that obtained by ultra filtration in human plasma but was also in accordance with ex vivo and in vitro protein binding obtained for rat plasma after ultra filtration because these compds. predominantly bind to HSA.  The binding of several compds. to α1-acid glycoprotein (AGP), another important plasma protein, was also examd. using AGP immobilized column.  However, the data could not be relied upon since some antibacterials and non-steroidal anti-inflammatory drugs (NSAIDS), which are known to predominantly bind to HSA, were also found to bind to AGP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIksVQwwJ-ObVg90H21EOLACvtfcHk0lgvsRhG9kBLZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFOgsbw%253D&md5=92a665ddf0314ab9a3c1114d80789a93</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2006.02.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2006.02.053%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BS.%26aulast%3DMehta%26aufirst%3DJ.%26atitle%3DMeasurement%2520of%2520Drug%25E2%2580%2593Protein%2520Binding%2520by%2520Immobilized%2520Human%2520Serum%2520Albumin-HPLC%2520and%2520Comparison%2520with%2520Ultrafiltration%26jtitle%3DJ.%2520Chromatogr.%252C%2520B%26date%3D2006%26volume%3D834%26spage%3D108%26epage%3D116%26doi%3D10.1016%2Fj.jchromb.2006.02.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunhuck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, D. P.</span></span> <span> </span><span class="NLM_article-title">Fast Gradient HPLC Method to Determine Compounds Binding to Human Serum Albumin. Relationships with Octanol/Water and Immobilized Artificial Membrane Lipophilicity</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">2236</span>– <span class="NLM_lpage">2248</span>, <span class="refDoi"> DOI: 10.1002/jps.10494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fjps.10494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=14603509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=2236-2248&author=K.+Valkoauthor=S.+Nunhuckauthor=C.+Bevanauthor=M.+H.+Abrahamauthor=D.+P.+Reynolds&title=Fast+Gradient+HPLC+Method+to+Determine+Compounds+Binding+to+Human+Serum+Albumin.+Relationships+with+Octanol%2FWater+and+Immobilized+Artificial+Membrane+Lipophilicity&doi=10.1002%2Fjps.10494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity</span></div><div class="casAuthors">Valko, Klara; Nunhuck, Shenaz; Bevan, Chris; Abraham, Michael H.; Reynolds, Derek P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2236-2248</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A fast gradient HPLC method (cycle time 15 min) has been developed to det. Human Serum Albumin (HSA) binding of discovery compds. using chem. bonded protein stationary phases.  The HSA binding values were derived from the gradient retention times that were converted to the logarithm of the equil. consts. (logK HSA) using data from a calibration set of mols.  The method has been validated using literature plasma protein binding data of 68 known drug mols.  The method is fully automated, and has been used for lead optimization in more than 20 company projects.  The HSA binding data obtained for more than 4000 compds. were suitable to set up global and project specific quant. structure binding relationships that helped compd. design in early drug discovery.  The obtained HSA binding of known drug mols. were compared to the Immobilizd Artificial Membrane binding data (CHI IAM) obtained by our previously described HPLC-based method.  The solvation equation approach has been used to characterize the normal binding ability of HSA, and this relationship shows that compd. lipophilicity is a significant factor.  It was found that the selectivity of the "baseline" lipophilicity governing HSA binding, membrane interaction, and octanol/water partition are very similar.  However, the effect of the presence of pos. or neg. charges have very different effects.  It was found that neg. charged compds. bind more strongly to HSA than it would be expected from the lipophilicity of the ionized species at pH 7.4.  Several compds. showed stronger HSA binding than can be expected from their lipophilicity alone, and comparison between predicted and exptl. binding affinity allows the identification of compds. that have good complementarities with any of the known binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr1LUBLdv-t7Vg90H21EOLACvtfcHk0lgvsRhG9kBLZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCrs7Y%253D&md5=14eb1e0f0ad616846a2b5d1428133fa9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjps.10494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10494%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DReynolds%26aufirst%3DD.%2BP.%26atitle%3DFast%2520Gradient%2520HPLC%2520Method%2520to%2520Determine%2520Compounds%2520Binding%2520to%2520Human%2520Serum%2520Albumin.%2520Relationships%2520with%2520Octanol%252FWater%2520and%2520Immobilized%2520Artificial%2520Membrane%2520Lipophilicity%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D2236%26epage%3D2248%26doi%3D10.1002%2Fjps.10494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollósy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valkó, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunhuck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span> <span> </span><span class="NLM_article-title">Estimation of Volume of Distribution in Humans from High Throughput HPLC-Based Measurements of Human Serum Albumin Binding and Immobilized Artificial Membrane Partitioning</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6958</span>– <span class="NLM_lpage">6971</span>, <span class="refDoi"> DOI: 10.1021/jm050957i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050957i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ClurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6958-6971&author=F.+Holl%C3%B3syauthor=K.+Valk%C3%B3author=A.+Herseyauthor=S.+Nunhuckauthor=G.+K%C3%A9riauthor=C.+Bevan&title=Estimation+of+Volume+of+Distribution+in+Humans+from+High+Throughput+HPLC-Based+Measurements+of+Human+Serum+Albumin+Binding+and+Immobilized+Artificial+Membrane+Partitioning&doi=10.1021%2Fjm050957i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of Volume of Distribution in Humans from High Throughput HPLC-Based Measurements of Human Serum Albumin Binding and Immobilized Artificial Membrane Partitioning</span></div><div class="casAuthors">Hollosy, Ferenc; Valko, Klara; Hersey, Anne; Nunhuck, Shenaz; Keri, Gyoergy; Bevan, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6958-6971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The vol. of distribution (VD) in humans of 179 known drug mols. (acids, bases, and neutrals) has been modeled using two biomimetic-binding measurements.  The phospholipid binding (log K (IAM)) and the plasma protein binding (log K (HSA)) have been calcd. from gradient HPLC retention times on immobilized artificial membrane (IAM) and on human serum albumin (HSA) columns, resp.  The log VD values showed good correlation with the compds.' relative binding to IAM and HSA as follows: log VD = 0.44 log K (IAM) - 0.22 log K (HSA) - 0.66; n = 179, r2 = 0.76, s = 0.33, and F = 272.  It was also obsd. that pos. charged mols. bind relatively more to IAM, while neg. charged ones bind more to HSA, in line with the empirical observation that bases tend to have a larger vol. of distribution than acids.  These results suggest that with the help of these two simple high throughput HPLC-based biomimetic binding measurements an important in vivo drug disposition property can be estd. for use in early drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBHWlrSQHQUbVg90H21EOLACvtfcHk0ljZ3Bzcm1q2vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ClurfK&md5=e19a0a058e052287cdca97c2125f9da4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm050957i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050957i%26sid%3Dliteratum%253Aachs%26aulast%3DHoll%25C3%25B3sy%26aufirst%3DF.%26aulast%3DValk%25C3%25B3%26aufirst%3DK.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DBevan%26aufirst%3DC.%26atitle%3DEstimation%2520of%2520Volume%2520of%2520Distribution%2520in%2520Humans%2520from%2520High%2520Throughput%2520HPLC-Based%2520Measurements%2520of%2520Human%2520Serum%2520Albumin%2520Binding%2520and%2520Immobilized%2520Artificial%2520Membrane%2520Partitioning%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6958%26epage%3D6971%26doi%3D10.1021%2Fjm050957i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Non-Steroidal Anti-Inflammatory Drug Diclofenac Binding to Human Serum Albumin</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1178</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1111%2Fcbdd.12583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=25958880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVSksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2015&pages=1178-1184&author=Y.+Zhangauthor=P.+Leeauthor=S.+Liangauthor=Z.+Zhouauthor=X.+Wuauthor=F.+Yangauthor=H.+Liang&title=Structural+Basis+of+Non-Steroidal+Anti-Inflammatory+Drug+Diclofenac+Binding+to+Human+Serum+Albumin&doi=10.1111%2Fcbdd.12583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Non-Steroidal Anti-Inflammatory Drug Diclofenac Binding to Human Serum Albumin</span></div><div class="casAuthors">Zhang, Yao; Lee, Philbert; Liang, Shichu; Zhou, Zuping; Wu, Xiaoyang; Yang, Feng; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1178-1184</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) is the most abundant protein in plasma, which plays a central role in drug pharmacokinetics because most compds. bound to HSA in blood circulation.  To understand binding characterization of non-steroidal anti-inflammatory drugs to HSA, we resolved the structure of diclofenac and HSA complex by X-ray crystallog.  HSA-palmitic acid-diclofenac structure reveals two distinct binding sites for three diclofenac in HSA.  One diclofenac is located at the IB subdomain, and its carboxylate group projects toward polar environment, forming hydrogen bond with one water mol.  The other two diclofenac mols. cobind in big hydrophobic cavity of the IIA subdomain without interactive assocn.  Among them, one binds in main chamber of big hydrophobic cavity, and its carboxylate group forms hydrogen bonds with Lys199 and Arg218, as well as one water mol., whereas another diclofenac binds in side chamber, its carboxylate group projects out cavity, forming hydrogen bond with Ser480.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPjF2KhYkcI7Vg90H21EOLACvtfcHk0ljZ3Bzcm1q2vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVSksrg%253D&md5=7c653f32321cc32aacefc24b0ff4a6fc</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12583%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DStructural%2520Basis%2520of%2520Non-Steroidal%2520Anti-Inflammatory%2520Drug%2520Diclofenac%2520Binding%2520to%2520Human%2520Serum%2520Albumin%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2015%26volume%3D86%26spage%3D1178%26epage%3D1184%26doi%3D10.1111%2Fcbdd.12583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghuman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunszain, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petitpas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otagiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of the Drug-Binding Specificity of Human Serum Albumin</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.07.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.jmb.2005.07.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=16169013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=38-52&author=J.+Ghumanauthor=P.+A.+Zunszainauthor=I.+Petitpasauthor=A.+A.+Bhattacharyaauthor=M.+Otagiriauthor=S.+Curry&title=Structural+Basis+of+the+Drug-Binding+Specificity+of+Human+Serum+Albumin&doi=10.1016%2Fj.jmb.2005.07.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Drug-binding Specificity of Human Serum Albumin</span></div><div class="casAuthors">Ghuman, Jamie; Zunszain, Patricia A.; Petitpas, Isabelle; Bhattacharya, Ananyo A.; Otagiri, Masaki; Curry, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-52</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) is an abundant plasma protein that binds a remarkably wide range of drugs, thereby restricting their free, active concns.  The problem of overcoming the binding affinity of lead compds. for HSA represents a major challenge in drug development.  Crystallog. anal. of 17 different complexes of HSA with a wide variety of drugs and small-mol. toxins reveals the precise architecture of the two primary drug-binding sites on the protein, identifying residues that are key determinants of binding specificity and illuminating the capacity of both pockets for flexible accommodation.  Numerous secondary binding sites for drugs distributed across the protein have also been identified.  The binding of fatty acids, the primary physiol. ligand for the protein, is shown to alter the polarity and increase the vol. of drug site 1.  These results clarify the interpretation of accumulated drug binding data and provide a valuable template for design efforts to modulate the interaction with HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyKWUfReJZ-bVg90H21EOLACvtfcHk0li1XhnVZDj1qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ&md5=d82105920c360292329bf509667df42f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.07.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.07.075%26sid%3Dliteratum%253Aachs%26aulast%3DGhuman%26aufirst%3DJ.%26aulast%3DZunszain%26aufirst%3DP.%2BA.%26aulast%3DPetitpas%26aufirst%3DI.%26aulast%3DBhattacharya%26aufirst%3DA.%2BA.%26aulast%3DOtagiri%26aufirst%3DM.%26aulast%3DCurry%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520of%2520the%2520Drug-Binding%2520Specificity%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D38%26epage%3D52%26doi%3D10.1016%2Fj.jmb.2005.07.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Multiwavelength Spectrophotometric Determination of Acid Dissociation Constants of Ionizable Drugs</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/S0731-7085(98)00010-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2FS0731-7085%2898%2900010-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=9682153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFWhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=699-712&author=R.+I.+Allenauthor=K.+J.+Boxauthor=J.+E.+A.+Comerauthor=C.+Peakeauthor=K.+Y.+Tam&title=Multiwavelength+Spectrophotometric+Determination+of+Acid+Dissociation+Constants+of+Ionizable+Drugs&doi=10.1016%2FS0731-7085%2898%2900010-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs</span></div><div class="casAuthors">Allen, R. I.; Box, K. J.; Comer, J. E. A.; Peake, C.; Tam, K. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4,5</span>),
    <span class="NLM_cas:pages">699-712</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A multiwavelength spectrophotometry was used to det. acid dissocn. consts. (pKa) of sparingly sol. drugs.  UV absorption spectra of the drug solns. were acquired using a versatile device based on a fiber optic dip probe, a light source, and a photodiode array (PDA) detector, while the pH and the ionic strength of the chem. system was manipulated by a com. available titrator.  Target factor anal. (TFA) was applied to deduce the pKa values from the multiwavelength UV absorption data recorded at different pH values.  We call this multiwavelength approach the WApH technique because the pKa values are detd. from changes in Wavelength and Absorbance as a function of pH (WApH).  The WApH technique is exemplified by using pure niflumic acid, nitrazepam, pyridoxine, quinine, and terbutaline.  The WApH pKa values obtained agree well with those derived from pH-metric titrns.  The WApH technique is able to deduce pKa values with high accuracy even if the absorption spectra of the reacting species are very similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqckQEYX9u_PLVg90H21EOLACvtfcHk0li1XhnVZDj1qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFWhtrw%253D&md5=5a1b3d3d724ac3991dc14e571ac92834</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2898%2900010-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252898%252900010-7%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DR.%2BI.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DComer%26aufirst%3DJ.%2BE.%2BA.%26aulast%3DPeake%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DMultiwavelength%2520Spectrophotometric%2520Determination%2520of%2520Acid%2520Dissociation%2520Constants%2520of%2520Ionizable%2520Drugs%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1998%26volume%3D17%26spage%3D699%26epage%3D712%26doi%3D10.1016%2FS0731-7085%2898%2900010-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takács-Novák, K.</span></span> <span> </span><span class="NLM_article-title">Multi-Wavelength Spectrophotometric Determination of Acid Dissociation Constants: A Validation Study</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>434</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1016/S0003-2670(01)00810-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2FS0003-2670%2801%2900810-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt12nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2001&pages=157-167&author=K.+Y.+Tamauthor=K.+Tak%C3%A1cs-Nov%C3%A1k&title=Multi-Wavelength+Spectrophotometric+Determination+of+Acid+Dissociation+Constants%3A+A+Validation+Study&doi=10.1016%2FS0003-2670%2801%2900810-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Multiwavelength spectrophotometric determination of acid dissociation constants: a validation study</span></div><div class="casAuthors">Tam, K. Y.; Takacs-Novak, K.</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The pKa values of 25 structurally diverse drug compds. including mono-, di- and tri-protic mols. were detd. by a recently developed multi-wavelength spectrophotometric technique, called dip-probe absorption spectroscopy (D-PAS), and the traditional spectrophotometric titrn.  All expts. were performed at 25.0 ± 0.5° in an ionic strength of 0.15 M KCl in two labs. (Semmelweis and Sirius), to evaluate the reproducibility and reliability of the spectrophotometric techniques for pKa detn.  It was found that the pKa values detd. by the D-PAS technique are in excellent agreement with values measured by the traditional spectrophotometric method (av. deviation=0.08 units) and are consistent with the literature data where available.  It was demonstrated that the D-PAS approach is a simple, precise and easy-to-use method for pKa detn. of drug mols. with ionizable group(s) in proximity to chromophore(s).  The advantages and limitations of spectrophotometric pKa detn. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtqUXyzEqEh7Vg90H21EOLACvtfcHk0li1XhnVZDj1qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt12nt7w%253D&md5=c601c8e99f5bc15e40047fc9c7bfca71</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0003-2670%2801%2900810-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-2670%252801%252900810-8%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DK.%2BY.%26aulast%3DTak%25C3%25A1cs-Nov%25C3%25A1k%26aufirst%3DK.%26atitle%3DMulti-Wavelength%2520Spectrophotometric%2520Determination%2520of%2520Acid%2520Dissociation%2520Constants%253A%2520A%2520Validation%2520Study%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2001%26volume%3D434%26spage%3D157%26epage%3D167%26doi%3D10.1016%2FS0003-2670%2801%2900810-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madhavi
Sastry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+Madhavi%0ASastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+Ligand+Preparation%3A+Parameters%2C+Protocols%2C+and+Influence+on+Virtual+Screening+Enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0lhQl0iS2d4Tdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520Ligand%2520Preparation%253A%2520Parameters%252C%2520Protocols%252C%2520and%2520Influence%2520on%2520Virtual%2520Screening%2520Enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span> <i>Schrödinger Release 2018–4: Protein
Preparation Wizard</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2018%E2%80%934%3A+Protein%0APreparation+Wizard%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202018%25E2%2580%25934%253A%2520Protein%250APreparation%2520Wizard%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span> <i>Schrödinger Release 2018–4: LigPrep</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2018%E2%80%934%3A+LigPrep%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202018%25E2%2580%25934%253A%2520LigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lhQl0iS2d4Tdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+Precision+Glide%3A+Docking+and+Scoring+Incorporating+a+Model+of+Hydrophobic+Enclosure+for+Protein-Ligand+Complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lhF-UgMuDu87w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520Precision%2520Glide%253A%2520Docking%2520and%2520Scoring%2520Incorporating%2520a%2520Model%2520of%2520Hydrophobic%2520Enclosure%2520for%2520Protein-Ligand%2520Complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span> <i>Schrödinger Release 2018–4: Glide</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2018%E2%80%934%3A+Glide%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202018%25E2%2580%25934%253A%2520Glide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Long-Jin Zhong, Yang Li, De-Lie An, <span class="NLM_string-name hlFld-ContribAuthor">Jin-Heng Li</span>. </span><span class="cited-content_cbyCitation_article-title">Heteroannulation of N-Fluoro-N-alkylsulfonamides with Terminal Alkynes via Remote C(sp3)–H Functionalization. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 383-389. <a href="https://doi.org/10.1021/acscatal.0c03853" title="DOI URL">https://doi.org/10.1021/acscatal.0c03853</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c03853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c03853%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DHeteroannulation%252Bof%252BN-Fluoro-N-alkylsulfonamides%252Bwith%252BTerminal%252BAlkynes%252Bvia%252BRemote%252BC%252528sp3%252529%2525E2%252580%252593H%252BFunctionalization%26aulast%3DZhong%26aufirst%3DLong-Jin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03092020%26date%3D10122020%26date%3D21122020%26volume%3D11%26issue%3D1%26spage%3D383%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dipanjan  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Priya  Singh</span>, <span class="hlFld-ContribAuthor ">Soumendra  Singh</span>, <span class="hlFld-ContribAuthor ">Debanjona Singh  Roy</span>, <span class="hlFld-ContribAuthor ">Subhankar  Singha</span>, <span class="hlFld-ContribAuthor ">Uttam  Pal</span>, <span class="hlFld-ContribAuthor ">Jhimli  Sengupta</span>, <span class="hlFld-ContribAuthor ">Rami J.  Obaid</span>, <span class="hlFld-ContribAuthor ">Saleh A.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Tanusri Saha  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Ranjan  Das</span>, <span class="hlFld-ContribAuthor ">Samir Kumar  Pal</span>. </span><span class="cited-content_cbyCitation_article-title">Host assisted molecular recognition by human serum albumin: Study of molecular recognition controlled protein/drug mimic binding in a microfluidic channel. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>176 </em>, 137-144. <a href="https://doi.org/10.1016/j.ijbiomac.2021.02.002" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2021.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2021.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2021.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DHost%252Bassisted%252Bmolecular%252Brecognition%252Bby%252Bhuman%252Bserum%252Balbumin%25253A%252BStudy%252Bof%252Bmolecular%252Brecognition%252Bcontrolled%252Bprotein%25252Fdrug%252Bmimic%252Bbinding%252Bin%252Ba%252Bmicrofluidic%252Bchannel%26aulast%3DMukherjee%26aufirst%3DDipanjan%26date%3D2021%26volume%3D176%26spage%3D137%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karolina  Wanat</span>, <span class="hlFld-ContribAuthor ">Grażyna  Żydek</span>, <span class="hlFld-ContribAuthor ">Adam  Hekner</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Brzezińska</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Plasma Protein Binding Studies of Selected Group of Drugs Using TLC and HPLC Retention Data. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (3)
                                     , 202. <a href="https://doi.org/10.3390/ph14030202" title="DOI URL">https://doi.org/10.3390/ph14030202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14030202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14030202%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DIn%252BSilico%252BPlasma%252BProtein%252BBinding%252BStudies%252Bof%252BSelected%252BGroup%252Bof%252BDrugs%252BUsing%252BTLC%252Band%252BHPLC%252BRetention%252BData%26aulast%3DWanat%26aufirst%3DKarolina%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D3%26spage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Martínez</span>, <span class="hlFld-ContribAuthor ">Mai  Zahran</span>, <span class="hlFld-ContribAuthor ">Miguel  Gomez</span>, <span class="hlFld-ContribAuthor ">Johnny  Guevara</span>, <span class="hlFld-ContribAuthor ">Rosemary  Pichardo-Bueno</span>, <span class="hlFld-ContribAuthor ">Junaid  Asim</span>, <span class="hlFld-ContribAuthor ">Gabriel  Ortiz</span>, <span class="hlFld-ContribAuthor ">Yaa  Andoh</span>, <span class="hlFld-ContribAuthor ">Sinji  Shibutani</span>, <span class="hlFld-ContribAuthor ">Baljit  Kaur</span>. </span><span class="cited-content_cbyCitation_article-title">Ionophoric polyphenols are permeable to the blood–brain barrier, interact with human serum albumin and Calf Thymus DNA, and inhibit AChE enzymatic activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (11)
                                     , 1956-1975. <a href="https://doi.org/10.1007/s00044-020-02615-3" title="DOI URL">https://doi.org/10.1007/s00044-020-02615-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02615-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02615-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIonophoric%252Bpolyphenols%252Bare%252Bpermeable%252Bto%252Bthe%252Bblood%2525E2%252580%252593brain%252Bbarrier%25252C%252Binteract%252Bwith%252Bhuman%252Bserum%252Balbumin%252Band%252BCalf%252BThymus%252BDNA%25252C%252Band%252Binhibit%252BAChE%252Benzymatic%252Bactivity%26aulast%3DMart%25C3%25ADnez%26aufirst%3DAlberto%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D11%26spage%3D1956%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. pH-dependent UV–vis absorbance changes and detectable p<i>K</i><sub>a</sub> values of HSA in the absence (left) and in the presence (right) of blank correction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Absorbance spectra and detectable p<i>K</i><sub>a</sub> values of diclofenac (DIC), phenylbutazone (PHB), piroxicam (PIR), and procaine (PRC) in the presence and absence of HSA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of APIs investigated by molecular modeling studies. CHQ, chloroquine; DIC, diclofenac; DIF, diflunisal; DZP, diazepam; MEL, meloxicam; NZP, nitrazepam; PHB, phenylbutazone; PIR, piroxicam; and TEN, tenoxicam.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Refined experimental binding modes for the deprotonated (green) and protonated (magenta) forms of (A) diclofenac, (B) phenylbutazone, and (C) diflunisal (C). Coulomb interaction scores with the most important interacting residues are shown in matching colors, the smaller the better. (While in phenylbutazone, formally, the ring CH gets deprotonated, and practically, the negative charge is located on one of the oxo groups due to tautomerization).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Refined predicted binding modes for the deprotonated (green) and protonated (magenta) forms of (A) meloxicam, (B) nitrazepam, (C) piroxicam, and (D) tenoxicam. Coulomb interaction scores with the most important interacting residues are shown in matching colors, the smaller the better.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of crystallographic and predicted binding modes of (A, B) diazepam and (C, D) nitrazepam, with distances of the relevant protonatable groups to the closest charged residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Chromatograms of diclofenac (DIC), diflunisal (DIF), meloxicam (MEL), phenylbutazone (PHB), and their modified forms with neutralized ionization centers. (Due to low absorbance of <i>O</i>-methyl MEL, its extracted ion chromatogram (EIC) (<i>m/z</i> = 366.0) was also used for peak identification).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/medium/jm0c00046_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Predicted binding modes for (A) diflunisal ethyl ester, (B) <i>C</i>-methyl phenylbutazone, (C) <i>O</i>-methyl phenylbutazone, (D) <i>O</i>-methyl meloxicam, and (E) diclofenac ethyl ester. For methoxy-meloxicam, the binding mode with the core position restricted to the binding mode of meloxicam is shown in orange. Coulomb interaction scores with the most important charged residues are shown in matching colors (the smaller the better): these are mostly slightly attractive (and in some cases, slightly repulsive), similar to the protonated forms of the original APIs. By comparison, the deprotonated forms of the APIs exhibit large negative (strongly attractive) Coulomb contributions (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.0c00046/20200407/images/large/jm0c00046_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00046&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04318" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04318" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span></span> <i>Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization</i>; <span class="NLM_publisher-name">Elsevier Inc.</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di&author=E.+H.+Kerns&title=Drug-Like+Properties%3A+Concepts%2C+Structure+Design+and+Methods+from+ADME+to+Toxicity+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DDrug-Like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%2520and%2520Methods%2520from%2520ADME%2520to%2520Toxicity%2520Optimization%26pub%3DElsevier%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fessey, R. E.</span>; <span class="NLM_string-name">Austin, R. P.</span>; <span class="NLM_string-name">Barton, P.</span>; <span class="NLM_string-name">Davis, A. M.</span>; <span class="NLM_string-name">Wenlock, M. C.</span></span> <span> </span><span class="NLM_article-title">The Role of Plasma Protein Binding in Drug Discovery</span>. In  <i>Pharmacokinetic Profiling in Drug Research</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">141</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=119-141&author=R.+E.+Fessey&author=R.+P.+Austin&author=P.+Barton&author=A.+M.+Davis&author=M.+C.+Wenlock&title=Pharmacokinetic+Profiling+in+Drug+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFessey%26aufirst%3DR.%2BE.%26atitle%3DThe%2520Role%2520of%2520Plasma%2520Protein%2520Binding%2520in%2520Drug%2520Discovery%26btitle%3DPharmacokinetic%2520Profiling%2520in%2520Drug%2520Research%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2007%26spage%3D119%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, G. L.</span></span> <span> </span><span class="NLM_article-title">The Importance of Plasma Protein Binding in Drug Discovery</span>. <i>Expert Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1517/17460441.2.1.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1517%2F17460441.2.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=23496037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Sitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=51-64&author=G.+L.+Trainor&title=The+Importance+of+Plasma+Protein+Binding+in+Drug+Discovery&doi=10.1517%2F17460441.2.1.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of plasma protein binding in drug discovery</span></div><div class="casAuthors">Trainor, George L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-64</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Plasma protein binding of drugs is a well-recognized phenomena, but it is only recently that the implications for drug action in vivo have been fully appreciated.  Plasma proteins, by virtue of their high concn., control the free drug concn. in plasma and in compartments in equil. with plasma, thereby, effectively attenuating drug potency in vivo.  The historical background and thermodn. basis for the 'Free Drug Principle' is presented, along with special considerations for intracellular targets, deep compartments and α1-acid glycoprotein binding.  Real and apparent exceptions to the principle are discussed along with a survey of citations from the recent medicinal chem. literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyoyVEZ33iUbVg90H21EOLACvtfcHk0ljfmbDuVtpiFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Sitrw%253D&md5=06ed3a7f31e02588cf98e790abdc622f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26atitle%3DThe%2520Importance%2520of%2520Plasma%2520Protein%2520Binding%2520in%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discov.%26date%3D2007%26volume%3D2%26spage%3D51%26epage%3D64%26doi%3D10.1517%2F17460441.2.1.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span> <i>Goodman
& Gilman’s The Pharmacological Basis of Therapeutics, 13th
ed.</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunton, L. L.</span>, <span class="NLM_string-name">Hilal-Dandan, R.</span>, <span class="NLM_string-name">Knollmann, B. C.</span></span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill Education</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+L.+Brunton&author=R.+Hilal-Dandan&author=B.+C.+Knollmann&title=Goodman%0A%26+Gilman%E2%80%99s+The+Pharmacological+Basis+of+Therapeutics%2C+13th%0Aed."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGoodman%250A%2526%2520Gilman%25E2%2580%2599s%2520The%2520Pharmacological%2520Basis%2520of%2520Therapeutics%252C%252013th%250Aed.%26aulast%3DBrunton%26aufirst%3DL.%2BL.%26pub%3DMcGraw-Hill%2520Education%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span>; <span class="NLM_string-name">Zhao, H.</span></span> <span> </span><span class="NLM_article-title">Physiologic Drug Distribution and Protein Binding</span>. In  <i>Applied Biopharmaceutics & Pharmacokinetics</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shargel, L.</span>, <span class="NLM_string-name">Yu, A. B. C.</span></span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill Education</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Sun&author=H.+Zhaoauthor=L.+Shargel&author=A.+B.+C.+Yu&title=Applied+Biopharmaceutics+%26+Pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26atitle%3DPhysiologic%2520Drug%2520Distribution%2520and%2520Protein%2520Binding%26btitle%3DApplied%2520Biopharmaceutics%2520%2526%2520Pharmacokinetics%26aulast%3DShargel%26aufirst%3DL.%26pub%3DMcGraw-Hill%2520Education%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S.</span>, <span class="NLM_string-name">Blood, I.</span></span> <span> </span><span class="NLM_article-title">Heart, and Circulation</span>. In  <i>Human Physiology</i>; <span class="NLM_publisher-name">McGraw-Hill Education</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Fox&author=I.+Blood&title=Human+Physiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DS.%26atitle%3DHeart%252C%2520and%2520Circulation%26btitle%3DHuman%2520Physiology%26pub%3DMcGraw-Hill%2520Education%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Betts, J. G.</span>; <span class="NLM_string-name">Desaix, P.</span>; <span class="NLM_string-name">Johnson, E. W.</span>; <span class="NLM_string-name">Johnson, J. E.</span>; <span class="NLM_string-name">Korol, O.</span>; <span class="NLM_string-name">Kruse, D.</span>; <span class="NLM_string-name">Poe, B.</span>; <span class="NLM_string-name">Wise, J.</span>; <span class="NLM_string-name">Womble, M. D.</span>; <span class="NLM_string-name">Young, K. A.</span></span> <span> </span><span class="NLM_article-title">The Cardiovascular System: Blood</span>. In  <i>Anatomy & Physiology</i>; <span class="NLM_publisher-name">OpenStax</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+G.+Betts&author=P.+Desaix&author=E.+W.+Johnson&author=J.+E.+Johnson&author=O.+Korol&author=D.+Kruse&author=B.+Poe&author=J.+Wise&author=M.+D.+Womble&author=K.+A.+Young&title=Anatomy+%26+Physiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBetts%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520Cardiovascular%2520System%253A%2520Blood%26btitle%3DAnatomy%2520%2526%2520Physiology%26pub%3DOpenStax%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fanali, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Masi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trezza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascenzi, P.</span></span> <span> </span><span class="NLM_article-title">Human Serum Albumin: From Bench to Bedside</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1016/j.mam.2011.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.mam.2011.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=22230555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls12hu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=209-290&author=G.+Fanaliauthor=A.+di+Masiauthor=V.+Trezzaauthor=M.+Marinoauthor=M.+Fasanoauthor=P.+Ascenzi&title=Human+Serum+Albumin%3A+From+Bench+to+Bedside&doi=10.1016%2Fj.mam.2011.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Human serum albumin: From bench to bedside</span></div><div class="casAuthors">Fanali, Gabriella; di Masi, Alessandra; Trezza, Viviana; Marino, Maria; Fasano, Mauro; Ascenzi, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-290</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Human serum albumin (HSA), the most abundant protein in plasma, is a monomeric multi-domain macromol., representing the main determinant of plasma oncotic pressure and the main modulator of fluid distribution between body compartments.  HSA displays an extraordinary ligand binding capacity, providing a depot and carrier for many endogenous and exogenous compds.  Indeed, HSA represents the main carrier for fatty acids, affects pharmacokinetics of many drugs, provides the metabolic modification of some ligands, renders potential toxins harmless, accounts for most of the anti-oxidant capacity of human plasma, and displays (pseudo-)enzymic properties.  HSA is a valuable biomarker of many diseases, including cancer, rheumatoid arthritis, ischemia, post-menopausal obesity, severe acute graft-vs.-host disease, and diseases that need monitoring of the glycemic control.  Moreover, HSA is widely used clin. to treat several diseases, including hypovolemia, shock, burns, surgical blood loss, trauma, hemorrhage, cardiopulmonary bypass, acute respiratory distress syndrome, hemodialysis, acute liver failure, chronic liver disease, nutrition support, resuscitation, and hypoalbuminemia.  Recently, biotechnol. applications of HSA, including implantable biomaterials, surgical adhesives and sealants, biochromatog., ligand trapping, and fusion proteins, have been reported.  Here, genetic, biochem., biomedical, and biotechnol. aspects of HSA are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxjvB_5YQuerVg90H21EOLACvtfcHk0liXm6hLsrrG_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls12hu7w%253D&md5=976cbd0c53b93f77bc172f909ba6682a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2011.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2011.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DFanali%26aufirst%3DG.%26aulast%3Ddi%2BMasi%26aufirst%3DA.%26aulast%3DTrezza%26aufirst%3DV.%26aulast%3DMarino%26aufirst%3DM.%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DAscenzi%26aufirst%3DP.%26atitle%3DHuman%2520Serum%2520Albumin%253A%2520From%2520Bench%2520to%2520Bedside%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2012%26volume%3D33%26spage%3D209%26epage%3D290%26doi%3D10.1016%2Fj.mam.2011.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span>; <span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span></span> <span> </span><span class="NLM_article-title">Chapter 14 – Plasma and Tissue Binding</span>. In  <i>Drug-Like Properties</i>; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">228</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2FB978-0-12-801076-1.00014-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=219-228&author=L.+Di&author=E.+H.+Kerns&author=L.+Di&author=E.+H.+Kerns&title=Drug-Like+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-801076-1.00014-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-801076-1.00014-9%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26atitle%3DChapter%252014%2520%25E2%2580%2593%2520Plasma%2520and%2520Tissue%2520Binding%26btitle%3DDrug-Like%2520Properties%26pub%3DAcademic%2520Press%26date%3D2016%26spage%3D219%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. W.</span></span> <span> </span><span class="NLM_article-title">Albumin: Biochemical Properties and Therapeutic Potential</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1219</span>, <span class="refDoi"> DOI: 10.1002/hep.20720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fhep.20720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=15915465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVSntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=1211-1219&author=G.+J.+Quinlanauthor=G.+S.+Martinauthor=T.+W.+Evans&title=Albumin%3A+Biochemical+Properties+and+Therapeutic+Potential&doi=10.1002%2Fhep.20720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin: biochemical properties and therapeutic potential</span></div><div class="casAuthors">Quinlan, Gregory J.; Martin, Greg S.; Evans, Timothy W.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1211-1219</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review highlights current thinking regarding albumin therapy in the crit. care and hepatol. setting and also discusses other potential therapeutic applications for its use based around the complex biochem. of the multifunctional plasma protein.  Potential contraindications are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVfxiwwEwerLVg90H21EOLACvtfcHk0liRMYqJ1jCLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVSntb0%253D&md5=37fd91838abb959d6db2db55ac92e8e5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fhep.20720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.20720%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DG.%2BJ.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DEvans%26aufirst%3DT.%2BW.%26atitle%3DAlbumin%253A%2520Biochemical%2520Properties%2520and%2520Therapeutic%2520Potential%26jtitle%3DHepatology%26date%3D2005%26volume%3D41%26spage%3D1211%26epage%3D1219%26doi%3D10.1002%2Fhep.20720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kragh-Hansen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, V. T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otagiri, M.</span></span> <span> </span><span class="NLM_article-title">Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1248/bpb.25.695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1248%2Fbpb.25.695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=12081132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvV2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=695-704&author=U.+Kragh-Hansenauthor=V.+T.+G.+Chuangauthor=M.+Otagiri&title=Practical+Aspects+of+the+Ligand-Binding+and+Enzymatic+Properties+of+Human+Serum+Albumin&doi=10.1248%2Fbpb.25.695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Practical aspects of the ligand-binding and enzymatic properties of human serum albumin</span></div><div class="casAuthors">Kragh-Hansen, Ulrich; Chuang, Victor Tuan Giam; Otagiri, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">695-704</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Recent work with approaches like recombinant mutants and x-ray crystallog. has given much new information about the ligand-binding properties of human serum albumin (HSA).  The information increases the understanding of this unique transport and depot protein and could give a structural basis for the possible construction of therapeutic agents with altered HSA-binding properties.  A tabulation of high-affinity binding sites for both endogenous and exogenous compds. has been made; it could be useful for the above-mentioned purpose, but it could also be of value when trying to predict potential drug interactions at the protein-binding level.  Drug displacement is not always a complication to therapy; it can be used to increase the biol. effect of a drug.  However, due to rebinding at other sites, the increase in the free concn. of a displaced ligand can be less than expected.  Drugs and drug metabolites can also interact covalently with HSA; thiol-contg. drugs often bind to the single free cysteine residue of HSA, and glucuronidated drugs react irreversibly with other residues of the protein.  Reversible binding of ligands is often stereospecific, and therefore immobilized HSA can be used to sep. drug isomers.  Albumin-contg. dialyzates are useful for extracorporeal removal of endogenous toxins and in the treatment of drug overdoses.  HSA has different types of hydrolytic activities, which also can be stereospecific.  The esterase-like property seems esp. useful in converting prodrugs to active drugs in plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrmebO3fPwI7Vg90H21EOLACvtfcHk0liRMYqJ1jCLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvV2hu7s%253D&md5=8de11b4e2c17851a6a69485437ab2cb1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1248%2Fbpb.25.695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.25.695%26sid%3Dliteratum%253Aachs%26aulast%3DKragh-Hansen%26aufirst%3DU.%26aulast%3DChuang%26aufirst%3DV.%2BT.%2BG.%26aulast%3DOtagiri%26aufirst%3DM.%26atitle%3DPractical%2520Aspects%2520of%2520the%2520Ligand-Binding%2520and%2520Enzymatic%2520Properties%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2002%26volume%3D25%26spage%3D695%26epage%3D704%26doi%3D10.1248%2Fbpb.25.695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jahanban-Esfahlan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davaran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosavi-Movahedi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dastmalchi, S.</span></span> <span> </span><span class="NLM_article-title">Investigating the Interaction of Juglone (5-Hydroxy-1, 4-Naphthoquinone) with Serum Albumins Using Spectroscopic and in Silico Methods</span>. <i>J. Iran. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1540</span>, <span class="refDoi"> DOI: 10.1007/s13738-017-1094-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1007%2Fs13738-017-1094-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFOitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=1527-1540&author=A.+Jahanban-Esfahlanauthor=S.+Davaranauthor=A.+A.+Moosavi-Movahediauthor=S.+Dastmalchi&title=Investigating+the+Interaction+of+Juglone+%285-Hydroxy-1%2C+4-Naphthoquinone%29+with+Serum+Albumins+Using+Spectroscopic+and+in+Silico+Methods&doi=10.1007%2Fs13738-017-1094-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating the interaction of juglone (5-hydroxy-1, 4-naphthoquinone) with serum albumins using spectroscopic and in silico methods</span></div><div class="casAuthors">Jahanban-Esfahlan, Ali; Davaran, Soodabeh; Moosavi-Movahedi, Ali A.; Dastmalchi, Siavoush</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Iranian Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1527-1540</span>CODEN:
                <span class="NLM_cas:coden">JICSCJ</span>;
        ISSN:<span class="NLM_cas:issn">1735-207X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The interaction between juglone at the concn. range of 10-110 μM and bovine serum albumin (BSA) or human serum albumin (HSA) at the const. concn. of 11 μM was investigated by fluorescence and UV absorption spectroscopy under physiol.-like condition.  Performing the expts. at different temps. showed that the fluorescence intensity of BSA/HSA was decreased in the presence of juglone by a static quenching mechanism due to the formation of the juglone-protein complex.  The binding const. for the interaction was in the order of 103 M-1, and the no. of binding sites for juglone on serum albumins was detd. to be equal to one.  The thermodn. parameters including enthalpy (ΔH), entropy (ΔS) and Gibb's free energy (ΔG) changes were obtained by using the van't Hoff equation.  These results indicated that van der Waals force and hydrogen bonding were the main intermol. forces stabilizing the complex in a spontaneous assocn. reaction.  Moreover, the interaction of BSA/HSA with juglone was verified by UV absorption spectra and mol. docking.  The results of synchronous fluorescence, UV-visible and CD spectra demonstrated that the binding of juglone with BSA/HSA induces min. conformational changes in the structure of albumins.  The increased binding affinity of juglone to albumin obsd. in the presence of site markers (digoxin and ibuprofen) excludes IIA and IIIA sites as the binding site of juglone.  This is partially in agreement with the results of mol. docking studies which suggests sub-domain IA of albumin as the binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprw9dqtZNbn7Vg90H21EOLACvtfcHk0liRMYqJ1jCLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFOitbo%253D&md5=be12c20f539da159534940ef84710ba4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs13738-017-1094-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13738-017-1094-0%26sid%3Dliteratum%253Aachs%26aulast%3DJahanban-Esfahlan%26aufirst%3DA.%26aulast%3DDavaran%26aufirst%3DS.%26aulast%3DMoosavi-Movahedi%26aufirst%3DA.%2BA.%26aulast%3DDastmalchi%26aufirst%3DS.%26atitle%3DInvestigating%2520the%2520Interaction%2520of%2520Juglone%2520%25285-Hydroxy-1%252C%25204-Naphthoquinone%2529%2520with%2520Serum%2520Albumins%2520Using%2520Spectroscopic%2520and%2520in%2520Silico%2520Methods%26jtitle%3DJ.%2520Iran.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D14%26spage%3D1527%26epage%3D1540%26doi%3D10.1007%2Fs13738-017-1094-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roufegarinejad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarowicz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahanban-Esfahlan, A.</span></span> <span> </span><span class="NLM_article-title">Characterizing the Interaction between Pyrogallol and Human Serum Albumin by Spectroscopic and Molecular Docking Methods</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2766</span>– <span class="NLM_lpage">2775</span>, <span class="refDoi"> DOI: 10.1080/07391102.2018.1496854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1080%2F07391102.2018.1496854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=2766-2775&author=L.+Roufegarinejadauthor=R.+Amarowiczauthor=A.+Jahanban-Esfahlan&title=Characterizing+the+Interaction+between+Pyrogallol+and+Human+Serum+Albumin+by+Spectroscopic+and+Molecular+Docking+Methods&doi=10.1080%2F07391102.2018.1496854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F07391102.2018.1496854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2018.1496854%26sid%3Dliteratum%253Aachs%26aulast%3DRoufegarinejad%26aufirst%3DL.%26aulast%3DAmarowicz%26aufirst%3DR.%26aulast%3DJahanban-Esfahlan%26aufirst%3DA.%26atitle%3DCharacterizing%2520the%2520Interaction%2520between%2520Pyrogallol%2520and%2520Human%2520Serum%2520Albumin%2520by%2520Spectroscopic%2520and%2520Molecular%2520Docking%2520Methods%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2018%26volume%3D37%26spage%3D2766%26epage%3D2775%26doi%3D10.1080%2F07391102.2018.1496854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostami-Hodjegan, A.</span></span> <span> </span><span class="NLM_article-title">Prediction of Plasma Protein Binding Displacement and Its Implications for Quantitative Assessment of Metabolic Drug-Drug Interactions from in Vitro Data</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2778</span>– <span class="NLM_lpage">2787</span>, <span class="refDoi"> DOI: 10.1002/jps.20733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fjps.20733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=16937340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSis7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=2778-2787&author=H.+Christensenauthor=M.+Bakerauthor=G.+T.+Tuckerauthor=A.+Rostami-Hodjegan&title=Prediction+of+Plasma+Protein+Binding+Displacement+and+Its+Implications+for+Quantitative+Assessment+of+Metabolic+Drug-Drug+Interactions+from+in+Vitro+Data&doi=10.1002%2Fjps.20733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of plasma protein binding displacement and its implications for quantitative assessment of metabolic drug-drug interactions from in vitro data</span></div><div class="casAuthors">Christensen, Hege; Baker, Mark; Tucker, Geoffrey T.; Rostami-Hodjegan, Amin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2778-2787</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Although displacement from plasma protein binding (dPB) is usually of little clin. significance, it should be taken into account when interpreting changes in total plasma concns. of drugs subject to metabolically based drug-drug interactions (mDDI).  The aim of this study was to develop an approach to predict changes in the free fractions (fu) of pairs of drugs that compete for plasma binding, knowing their binding affinity consts., and to consider the implications of assocd. concn.- and time-dependence of such changes with respect to drug exposure.  Exptl. fu values of valproic acid and phenytoin in the presence of ibuprofen, diflunisal, or naproxen were predicted successfully (within 0.99- to 1.36-fold) by the model.  In addn., the simulation of time-dependent changes in fu of valproic acid following administration of ibuprofen indicated different extents of dPB during 'first-pass' through the liver after oral absorption and on systemic recirculation.  To understand the impact of the time-dependent change in fu, a full physiol. based pharmacokinetic model, that accounts for concn.-time profile of displacee and displacer and their mutual effect on each other, is required.  The approach developed in this study is a first step towards the development of such a model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg7ajyBq6UI7Vg90H21EOLACvtfcHk0lhGOMJN60jAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSis7zK&md5=8890fb25b5e47b43e36f217e3865d83b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjps.20733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20733%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DH.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DTucker%26aufirst%3DG.%2BT.%26aulast%3DRostami-Hodjegan%26aufirst%3DA.%26atitle%3DPrediction%2520of%2520Plasma%2520Protein%2520Binding%2520Displacement%2520and%2520Its%2520Implications%2520for%2520Quantitative%2520Assessment%2520of%2520Metabolic%2520Drug-Drug%2520Interactions%2520from%2520in%2520Vitro%2520Data%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D2778%26epage%3D2787%26doi%3D10.1002%2Fjps.20733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birkett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudlow, G.</span></span> <span> </span><span class="NLM_article-title">Effects of Fatty Acids on Two Specific Drug Binding Sites on Human Serum Albumin</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=593269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaE1cXlvVamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1977&pages=987-992&author=D.+J.+Birkettauthor=S.+P.+Myersauthor=G.+Sudlow&title=Effects+of+Fatty+Acids+on+Two+Specific+Drug+Binding+Sites+on+Human+Serum+Albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of fatty acids on two specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Birkett, Donald J.; Myers, Shirley P.; Sudlow, Gillian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">987-92</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Two distinct binding sites, I and II, for anionic drugs on human serum albumin have previously been demonstrated using fluorescent probe techniques.  5-Dimethylaminonaphthalene-1-sulfonamide (I)  [1431-39-6] and dansylsarcosine  [1093-96-5] are specific fluorescent probes for sites I and II, resp.  The addn. of fatty acids results in differing effects at the two binding sites, and the specificity of site II is lost.  The order of potency of various fatty acids in causing these changes is oleic  [112-80-1] > stearic  [57-11-4] > linoleic  [60-33-3] ≥ palmitic acid  [57-10-3], and this is the same as the order of assocn. consts. for these fatty acids.  Thus, chain length and degree of unsatn. det. both binding affinity and the extent to which the fatty acids induce configurational adaptations in the albumin mol.  Furthermore, studies with varying ratios of oleic acid to albumin suggest that the conformational changes induced in the protein are different for each mol. of oleic acid added.  Addn. of oleic acid at a 3:1 molar ratio with albumin significantly increased the binding of warfarin  [81-81-2] and I to site I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wn45AHSv97Vg90H21EOLACvtfcHk0lhGOMJN60jAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXlvVamtg%253D%253D&md5=127ba3c3b26a9f0b6e761ee075faba32</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DMyers%26aufirst%3DS.%2BP.%26aulast%3DSudlow%26aufirst%3DG.%26atitle%3DEffects%2520of%2520Fatty%2520Acids%2520on%2520Two%2520Specific%2520Drug%2520Binding%2520Sites%2520on%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1977%26volume%3D13%26spage%3D987%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sudlow, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, D. N.</span></span> <span> </span><span class="NLM_article-title">Further Characterization of Specific Drug Binding Sites on Human Serum Albumin</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1052</span>– <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1004490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1976&pages=1052-1061&author=G.+Sudlowauthor=D.+J.+Birkettauthor=D.+N.+Wade&title=Further+Characterization+of+Specific+Drug+Binding+Sites+on+Human+Serum+Albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Sudlow, G.; Birkett, D. J.; Wade, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1052-61</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The fluorescent probes, 5-dimethylaminonaphthalene-1-sulfonamide (I) [1431-39-6] and dansylsarcosine [1093-96-5] function as specific markers for 2 distinct binding sites for anionic drugs on human serum albumin (HSA).  The binding of drugs to site I or II was detected by measuring the displacement of these probes.  The results give an indication of some of the structural features required for binding at these sites.  Stearic acid [57-11-4] binding to HSA induced different conformational changes in the albumin at sites I and II, which were detected by changes in the fluorescence and/or strength of binding of probes specific for the 2 sites.  This provides further evidence for qual. differences between the 2 sites.  The specificity of the sites for particular drugs, even at high drug to albumin ratios, was established, and the specificity and characteristics of the 2 sites on human adult and neonatal sera were shown to be similar to those on cryst. HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZMQN1NBrHM7Vg90H21EOLACvtfcHk0lhGOMJN60jAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D&md5=5286ae0da826f2764eb595b22361fe80</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudlow%26aufirst%3DG.%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DWade%26aufirst%3DD.%2BN.%26atitle%3DFurther%2520Characterization%2520of%2520Specific%2520Drug%2520Binding%2520Sites%2520on%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1976%26volume%3D12%26spage%3D1052%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kragh-Hansen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otagiri, M.</span></span> <span> </span><span class="NLM_article-title">Characterization of Site I on Human Serum Albumin: Concept about the Structure of a Drug Binding Site</span>. <i>Biochim. Biophys. Acta - Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>1295</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/0167-4838(96)00013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2F0167-4838%2896%2900013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=8695640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK28Xkt12ltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1295&publication_year=1996&pages=147-157&author=K.+Yamasakiauthor=T.+Maruyamaauthor=U.+Kragh-Hansenauthor=M.+Otagiri&title=Characterization+of+Site+I+on+Human+Serum+Albumin%3A+Concept+about+the+Structure+of+a+Drug+Binding+Site&doi=10.1016%2F0167-4838%2896%2900013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of site I on human serum albumin: concept about the structure of a drug binding site</span></div><div class="casAuthors">Yamasaki, Keishi; Maruyama, Toru; Kragh-Hansen, Ulrich; Otagiri, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1295</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-157</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) possesses at least three sites or areas for high-affinity binding of drugs.  Of these sites, site I was investigated by series of ultrafiltration and equil. dialysis expts.  Three ligands, acenocoumarol, dansyl-L-asparagine (DNSA) and Bu p-aminobenzoate (Bu p-ABE) were employed as marker ligands.  Each ligand binds to a single high-affinity site on HSA, and binding studies with different pairs of the ligands revealed independent high-affinity binding.  Preliminary displacement studies performed with the typical site I binding drugs warfarin, phenylbutazone and iodipamide showed different displacement patterns of the three marker ligands.  These studies were followed by stringent competition expts. involving all possible combinations of the three test ligands themselves and of these and the three marker ligands.  On the basis of the results obtained it seems that the acenocoumarol and DNSA binding regions correspond to the warfarin and azapropazone binding regions, resp., of site I reported by others.  The new binding region, represented by Bu p-ABE, is probably located adjacent to the acenocoumarol binding region but apart from that of DNSA.  The authors have elaborated a model for binding site I in which the authors propose novel nomenclatures, region Ia, Ib, and Ic for the acenocoumarol, DNSA and Bu p-ABE binding regions, resp.  Furthermore, the relation between these regions and the high-affinity binding sites for other drugs have been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaccaCROuBhLVg90H21EOLACvtfcHk0ljINLPW9xRjLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt12ltb4%253D&md5=7285423eae1f6679e182e3af5fd0cb7c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0167-4838%2896%2900013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4838%252896%252900013-1%26sid%3Dliteratum%253Aachs%26aulast%3DYamasaki%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DKragh-Hansen%26aufirst%3DU.%26aulast%3DOtagiri%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520Site%2520I%2520on%2520Human%2520Serum%2520Albumin%253A%2520Concept%2520about%2520the%2520Structure%2520of%2520a%2520Drug%2520Binding%2520Site%26jtitle%3DBiochim.%2520Biophys.%2520Acta%2520-%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D1996%26volume%3D1295%26spage%3D147%26epage%3D157%26doi%3D10.1016%2F0167-4838%2896%2900013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhivkova, Z.</span></span> <span> </span><span class="NLM_article-title">Studies on Drug – Human Serum Albumin Binding: The Current State of the Matter</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1830</span>, <span class="refDoi"> DOI: 10.2174/1381612821666150302113710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.2174%2F1381612821666150302113710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=25732557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1altbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1817-1830&author=Z.+Zhivkova&title=Studies+on+Drug+%E2%80%93+Human+Serum+Albumin+Binding%3A+The+Current+State+of+the+Matter&doi=10.2174%2F1381612821666150302113710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on Drug - Human Serum Albumin Binding: The Current State of the Matter</span></div><div class="casAuthors">Zhivkova, Zvetanka D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1817-1830</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human serum albumin (HSA) is the major plasma protein with vital functions acting as depot and career for many endogenous (fatty acids, bilirubin, etc.) and exogenous substances (drugs, nutrients, etc.) in the blood.  Binding to HSA controls the free, active concn. of the drug and may affect considerably the overall pharmacodynamic and pharmacokinetic profile.  Studies on drug - protein binding are important from both theor. and practical point of view as they allow better understanding of the processes underlying drug disposition and elimination and the effect of several pathol. states or co-administered drugs on drug delivery and efficacy.  The present review focuses on the current state of drug - HSA binding studies.  The major functions and consequences of drug - protein binding are described.  The X-ray structure of HSA is discussed focusing on the location and the architecture of the primary drug and fatty acids binding sites.  Some of the most commonly used methods for drug - HSA binding assay are presented together with examples for their application.  The most extensive studied topics in the area are discussed including quant. characterization of drug - HSA complexation, identification of the binding sites, stereoselectivity of drug - HSA interactions, and thermodn. characterization of the binding process.  A short section is devoted to in silico prediction of drug - HSA binding as an important step in drug design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Jbm6e8QThLVg90H21EOLACvtfcHk0ljINLPW9xRjLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1altbk%253D&md5=f14822481b5a6e075d3d33f775411c87</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1381612821666150302113710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612821666150302113710%26sid%3Dliteratum%253Aachs%26aulast%3DZhivkova%26aufirst%3DZ.%26atitle%3DStudies%2520on%2520Drug%2520%25E2%2580%2593%2520Human%2520Serum%2520Albumin%2520Binding%253A%2520The%2520Current%2520State%2520of%2520the%2520Matter%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2015%26volume%3D21%26spage%3D1817%26epage%3D1830%26doi%3D10.2174%2F1381612821666150302113710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohnert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L.-S.</span></span> <span> </span><span class="NLM_article-title">Plasma Protein Binding: From Discovery to Development</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">2953</span>– <span class="NLM_lpage">2994</span>, <span class="refDoi"> DOI: 10.1002/jps.23614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fjps.23614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=23798314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVymt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=2953-2994&author=T.+Bohnertauthor=L.-S.+Gan&title=Plasma+Protein+Binding%3A+From+Discovery+to+Development&doi=10.1002%2Fjps.23614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma protein binding: From discovery to development</span></div><div class="casAuthors">Bohnert, Tonika; Gan, Liang-Shang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2953-2994</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The importance of plasma protein binding (PPB) in modulating the effective drug concn. at pharmacol. target sites has been the topic of significant discussion and debate amongst drug development groups over the past few decades.  Free drug theory, which states that in absence of energy-dependent processes, after steady state equil. has been attained, free drug concn. in plasma is equal to free drug concn. at the pharmacol. target receptor(s) in tissues, has been used to explain pharmacokinetics/pharmacodynamics relationships in a large no. of cases.  Any sudden increase in free concn. of a drug could potentially cause toxicity and may need dose adjustment.  Free drug concn. is also helpful to est. the effective concn. of drugs that potentially can ppt. metab. (or transporter)-related drug-drug interactions.  Disease models are extensively validated in animals to progress a compd. into development.  Unbound drug concn., and therefore PPB information across species is very informative in establishing safety margins and guiding selection of First in Human (FIH) dose and human efficacious dose.  The scope of this review is to give an overview of reported role of PPB in several therapeutic areas, highlight cases where PPB changes are clin. relevant, and provide drug metab. and pharmacokinetics recommendations in discovery and development settings. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqobJp8eG98XrVg90H21EOLACvtfcHk0ljXBSmx0AeRjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVymt7c%253D&md5=d676f7490c6e0f09c8acf7cce5183b17</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjps.23614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23614%26sid%3Dliteratum%253Aachs%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DGan%26aufirst%3DL.-S.%26atitle%3DPlasma%2520Protein%2520Binding%253A%2520From%2520Discovery%2520to%2520Development%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D2953%26epage%3D2994%26doi%3D10.1002%2Fjps.23614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rolan, P.</span></span> <span> </span><span class="NLM_article-title">Plasma Protein Binding Displacement Interactions-Why Are They Still Regarded as Clinically Important?</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1994.tb04251.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1111%2Fj.1365-2125.1994.tb04251.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=8186058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK2cXivV2htL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=125-128&author=P.+Rolan&title=Plasma+Protein+Binding+Displacement+Interactions-Why+Are+They+Still+Regarded+as+Clinically+Important%3F&doi=10.1111%2Fj.1365-2125.1994.tb04251.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma protein binding displacement interactions - why are they still regarded as clinically important?</span></div><div class="casAuthors">Rolan, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-8</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">A review, with 40 refs., of drug interactions with blood plasma proteins and its clin. significance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJAyQ7NFyJ5bVg90H21EOLACvtfcHk0ljXBSmx0AeRjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXivV2htL8%253D&md5=f6285972ac0a53b94e8c1e5e0f91ff57</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1994.tb04251.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1994.tb04251.x%26sid%3Dliteratum%253Aachs%26aulast%3DRolan%26aufirst%3DP.%26atitle%3DPlasma%2520Protein%2520Binding%2520Displacement%2520Interactions-Why%2520Are%2520They%2520Still%2520Regarded%2520as%2520Clinically%2520Important%253F%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D37%26spage%3D125%26epage%3D128%26doi%3D10.1111%2Fj.1365-2125.1994.tb04251.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span> <span> </span><span class="NLM_article-title">An Examination of Protein Binding and Protein-Facilitated Uptake Relating to in Vitro-in Vivo Extrapolation</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2018.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.ejps.2018.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=30098391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2isrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2018&pages=502-514&author=C.+M.+Bowmanauthor=L.+Z.+Benet&title=An+Examination+of+Protein+Binding+and+Protein-Facilitated+Uptake+Relating+to+in+Vitro-in+Vivo+Extrapolation&doi=10.1016%2Fj.ejps.2018.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation</span></div><div class="casAuthors">Bowman, C. M.; Benet, L. Z.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">502-514</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As explained by the free drug theory, the unbound fraction of drug has long been thought to drive the efficacy of a mol.  Thus, the fraction unbound term, or fu, appears in equations for fundamental pharmacokinetic parameters such as clearance, and is used when attempting in vitro to in vivo extrapolation (IVIVE).  In recent years though, it has been noted that IVIVE does not always yield accurate predictions, and that some highly protein bound ligands have more efficient uptake than can be explained by their unbound fractions.  This review explores the evolution of fu terms included when implementing IVIVE, the concept of protein-facilitated uptake, and the mechanisms that have been proposed to account for facilitated uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOnKrgxaIxYbVg90H21EOLACvtfcHk0ljXBSmx0AeRjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2isrjK&md5=72e0905a27915ab3710cfbacd127ecff</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2018.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2018.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DC.%2BM.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26atitle%3DAn%2520Examination%2520of%2520Protein%2520Binding%2520and%2520Protein-Facilitated%2520Uptake%2520Relating%2520to%2520in%2520Vitro-in%2520Vivo%2520Extrapolation%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2018%26volume%3D123%26spage%3D502%26epage%3D514%26doi%3D10.1016%2Fj.ejps.2018.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parton, T.</span></span> <span> </span><span class="NLM_article-title">Kinetic Determinants of Hepatic Clearance: Plasma Protein Binding and Hepatic Uptake</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1110</span>– <span class="NLM_lpage">1134</span>, <span class="refDoi"> DOI: 10.1080/00498250701658296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1080%2F00498250701658296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=17968739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ahu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=1110-1134&author=M.+Bakerauthor=T.+Parton&title=Kinetic+Determinants+of+Hepatic+Clearance%3A+Plasma+Protein+Binding+and+Hepatic+Uptake&doi=10.1080%2F00498250701658296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake</span></div><div class="casAuthors">Baker, M.; Parton, T.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10/11</span>),
    <span class="NLM_cas:pages">1110-1134</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Hepatic clearance prediction, using scaled data obtained from hepatocytes and microsomes, often under-predicts the eventual obsd. clearance.  This occurs commonly where the compd. is highly bound and/or a sinusoidal transporter substrate.  The authors' own lab. observations and those reported in the literature indicate that consideration of transporter effects in vitro is not sufficient to provide a direct, quant. est. of hepatic clearance in vivo.  The physiol. of contributing processes was reviewed and the processes were compiled into a kinetic model of compd. disposition for a hepatocyte compartment.  The model has variables describing the kinetic effects of plasma protein binding, sinusoidal uptake, passive permeability, and cellular disposition.  Parameters were detd. exptl. requiring, in some instances, assays less familiar or routine to Drug metab. and pharmacokinetics (DMPK) labs.  The model accurately fitted data for the hepatic disposition of a UCB-proprietary compd. that did not undergo metab. but was a substrate for protein binding and sinusoidal uptake.  On addn. of bovine serum albumin to the assay, the uptake kinetics approximated neither those for the free fraction nor the total concn.  However, the model accurately predicted the intermediate obsd. kinetics and illustrated the kinetic effects of plasma protein binding and the complex interplay between various competing and collaborating processes.  Through the use of simulations the model illustrated the influence of different combinations and influences of hepatic kinetic processes.  Possible causes behind the extn. of highly bound compds. were identified as (1) low compd. permeability facilitating active uptake and (2) high permeability facilitating the role of intracellular metab.  In almost all circumstances koff is not low enough (<1 s-1) to limit the extn. of plasma protein bound compds.; however, kon still exerts an effect through competition with the uptake process.  Crucially the model indicated the complex nature of the combined processes, whose broad range of effects on hepatic disposition could only be accurately detd. with a kinetic model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrla35qcclCT7Vg90H21EOLACvtfcHk0li-WduFGgY58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ahu7vO&md5=a8462484f955caae8dad03be95375cb1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F00498250701658296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250701658296%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DParton%26aufirst%3DT.%26atitle%3DKinetic%2520Determinants%2520of%2520Hepatic%2520Clearance%253A%2520Plasma%2520Protein%2520Binding%2520and%2520Hepatic%2520Uptake%26jtitle%3DXenobiotica%26date%3D2007%26volume%3D37%26spage%3D1110%26epage%3D1134%26doi%3D10.1080%2F00498250701658296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranter, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. L.</span></span> <span> </span><span class="NLM_article-title">Determination of Drug–Plasma Protein Binding Kinetics and Equilibria by Chromatographic Profiling: Exemplification of the Method Using l–Tryptophan and Albumin</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1021/ac010643c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac010643c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFalsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2002&pages=446-452&author=A.+M.+Talbertauthor=G.+E.+Tranterauthor=E.+Holmesauthor=P.+L.+Francis&title=Determination+of+Drug%E2%80%93Plasma+Protein+Binding+Kinetics+and+Equilibria+by+Chromatographic+Profiling%3A+Exemplification+of+the+Method+Using+l%E2%80%93Tryptophan+and+Albumin&doi=10.1021%2Fac010643c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of Drug-Plasma Protein Binding Kinetics and Equilibria by Chromatographic Profiling: Exemplification of the Method Using L-Tryptophan and Albumin</span></div><div class="casAuthors">Talbert, Ann M.; Tranter, George E.; Holmes, Elaine; Francis, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">446-452</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-plasma protein binding may greatly influence the bioavailability and metab. of a plasma-borne drug, the bound form being partially protected from the metabolic fate of the unbound drug. Traditionally, equil. values (e.g., percentage binding) for drug-protein binding have been measured to rationalize in vivo phenomena. However, such studies overlook the influence of kinetics.  A rapid method of simultaneously detg. kinetic rate consts. and equil. consts. from chromatog. profiles has been developed, based on the use of immobilized protein columns and HPLC.  By measuring the chromatog. profiles (the position and width) of a retained and an unretained compd. one can directly det. both the rate and equil. consts.  Results are presented for the binding of L-tryptophan to human serum albumin to exemplify the method.  The assocn. equil. const. (Ka) and the assocn. and dissocn. rate consts. (ka and kd, resp.) were thereby measured in an aq. pH 7.4 environment at 37° as 0.84 104 M-1, 5.8 104 M-1 s-1, and 6.9 s-1, resp.  These compare favorably with previously published results.  The described method may be used in quant. structure-property relation-based rational drug discovery or for the rationalization of drug pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZXDhb5GpharVg90H21EOLACvtfcHk0li-WduFGgY58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFalsLY%253D&md5=a972e1bf6e0ad4c8d2e9315d191935d4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fac010643c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac010643c%26sid%3Dliteratum%253Aachs%26aulast%3DTalbert%26aufirst%3DA.%2BM.%26aulast%3DTranter%26aufirst%3DG.%2BE.%26aulast%3DHolmes%26aufirst%3DE.%26aulast%3DFrancis%26aufirst%3DP.%2BL.%26atitle%3DDetermination%2520of%2520Drug%25E2%2580%2593Plasma%2520Protein%2520Binding%2520Kinetics%2520and%2520Equilibria%2520by%2520Chromatographic%2520Profiling%253A%2520Exemplification%2520of%2520the%2520Method%2520Using%2520l%25E2%2580%2593Tryptophan%2520and%2520Albumin%26jtitle%3DAnal.%2520Chem.%26date%3D2002%26volume%3D74%26spage%3D446%26epage%3D452%26doi%3D10.1021%2Fac010643c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svennebring, A.</span></span> <span> </span><span class="NLM_article-title">The Connection Between Plasma Protein Binding and Acute Toxicity as Determined by the LD 50 Value</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1002/ddr.21286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fddr.21286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=26686875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCqsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2016&pages=3-11&author=A.+Svennebring&title=The+Connection+Between+Plasma+Protein+Binding+and+Acute+Toxicity+as+Determined+by+the+LD+50+Value&doi=10.1002%2Fddr.21286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The connection Between Plasma Protein Binding and Acute Toxicity as Determined by the LD50 Value</span></div><div class="casAuthors">Svennebring, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-11</span>CODEN:
                <span class="NLM_cas:coden">DDREDK</span>;
        ISSN:<span class="NLM_cas:issn">0272-4391</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Preclin. Research A dataset of three drug classes (acids, bases, and neutrals) with LD50 values in mice was analyzed to investigate a possible connection between high plasma protein binding and acute toxicity.  Initially, it was found that high plasma protein binding was assocd. with toxicity for acids and neutrals, but after compensating for differences in lipophilicity, plasma protein binding was found not to be assocd. with toxicity.  The therapeutic index established by the quotient between mouse LD50 and the defined daily dose was unaffected by both lipophilicity and plasma protein binding.  Drug Dev Res. © 2015 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ALTHnW5jQrVg90H21EOLACvtfcHk0li-WduFGgY58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCqsLnK&md5=44ed3909d32b40bd84144fe3980e9d84</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fddr.21286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.21286%26sid%3Dliteratum%253Aachs%26aulast%3DSvennebring%26aufirst%3DA.%26atitle%3DThe%2520Connection%2520Between%2520Plasma%2520Protein%2520Binding%2520and%2520Acute%2520Toxicity%2520as%2520Determined%2520by%2520the%2520LD%252050%2520Value%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2016%26volume%3D77%26spage%3D3%26epage%3D11%26doi%3D10.1002%2Fddr.21286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, V.</span>; <span class="NLM_string-name">Vachharajani, N.</span></span> <span> </span><span class="NLM_article-title">Protein Binding in Drug Discovery and Development</span>. In  <i>Evaluation of Drug Candidates for Preclinical Development</i>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ, USA</span>, <span class="NLM_year">2010</span>; Vol.  <span class="NLM_volume">13</span>, pp  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">167</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=135-167&author=V.+Ramanathan&author=N.+Vachharajani&title=Evaluation+of+Drug+Candidates+for+Preclinical+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DV.%26atitle%3DProtein%2520Binding%2520in%2520Drug%2520Discovery%2520and%2520Development%26btitle%3DEvaluation%2520of%2520Drug%2520Candidates%2520for%2520Preclinical%2520Development%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2010%26volume%3D13%26spage%3D135%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laakso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pusecker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner-Redeker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delrat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, P.</span></span> <span> </span><span class="NLM_article-title">Bioanalysis for Plasma Protein Binding Studies in Drug Discovery and Drug Development: Views and Recommendations of the European Bioanalysis Forum</span>. <i>Bioanalysis</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.4155/bio.13.338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.4155%2Fbio.13.338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=24620809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktV2nt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=673-682&author=B.+Buscherauthor=S.+Laaksoauthor=H.+Mascherauthor=K.+Puseckerauthor=M.+Doigauthor=L.+Dillenauthor=W.+Wagner-Redekerauthor=T.+Pfeiferauthor=P.+Delratauthor=P.+Timmerman&title=Bioanalysis+for+Plasma+Protein+Binding+Studies+in+Drug+Discovery+and+Drug+Development%3A+Views+and+Recommendations+of+the+European+Bioanalysis+Forum&doi=10.4155%2Fbio.13.338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum</span></div><div class="casAuthors">Buscher, Brigitte; Laakso, Sirpa; Mascher, Hermann; Pusecker, Klaus; Doig, Mira; Dillen, Lieve; Wagner-Redeker, Winfried; Pfeifer, Thomas; Delrat, Pascal; Timmerman, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Bioanalysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">673-682</span>CODEN:
                <span class="NLM_cas:coden">BIOAB4</span>;
        ISSN:<span class="NLM_cas:issn">1757-6180</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Plasma protein binding (PPB) is an important parameter for a drug's efficacy and safety that needs to be investigated during each drug-development program.  Even though regulatory guidance exists to study the extent of PPB before initiating clin. studies, there are no detailed instructions on how to perform and validate such studies.  To explore how PPB studies involving bioanal. are currently executed in the industry, the European Bioanal. Forum (EBF) has conducted three surveys among their member companies: PPB studies in drug discovery (Part I); in vitro PPB studies in drug development (Part II); and in vivo PPB studies in drug development.  This paper reflects the outcome of the three surveys, which, together with the team discussions, formed the basis of the EBF recommendation.  The EBF recommends a tiered approach to the design of PPB studies and the bioanal. of PPB samples: 'PPB screening' expts. in (early) drug discovery vs. qualified/validated procedures in drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgJVlWvZ1xvbVg90H21EOLACvtfcHk0lhW26Mm4Vj7uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktV2nt74%253D&md5=7a0b1f87dcaa6ac4477b43ed7d8c2b30</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Fbio.13.338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fbio.13.338%26sid%3Dliteratum%253Aachs%26aulast%3DBuscher%26aufirst%3DB.%26aulast%3DLaakso%26aufirst%3DS.%26aulast%3DMascher%26aufirst%3DH.%26aulast%3DPusecker%26aufirst%3DK.%26aulast%3DDoig%26aufirst%3DM.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DWagner-Redeker%26aufirst%3DW.%26aulast%3DPfeifer%26aufirst%3DT.%26aulast%3DDelrat%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DP.%26atitle%3DBioanalysis%2520for%2520Plasma%2520Protein%2520Binding%2520Studies%2520in%2520Drug%2520Discovery%2520and%2520Drug%2520Development%253A%2520Views%2520and%2520Recommendations%2520of%2520the%2520European%2520Bioanalysis%2520Forum%26jtitle%3DBioanalysis%26date%3D2014%26volume%3D6%26spage%3D673%26epage%3D682%26doi%3D10.4155%2Fbio.13.338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronzetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baljinnyam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span> <span> </span><span class="NLM_article-title">Testing for Drug-Human Serum Albumin Binding Using Fluorescent Probes and Other Methods</span>. <i>Expert Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.1080/17460441.2018.1534824</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1080%2F17460441.2018.1534824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=30320522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWiu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1005-1014&author=M.+Ronzettiauthor=B.+Baljinnyamauthor=A.+Yasgarauthor=A.+Simeonov&title=Testing+for+Drug-Human+Serum+Albumin+Binding+Using+Fluorescent+Probes+and+Other+Methods&doi=10.1080%2F17460441.2018.1534824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Testing for drug-human serum albumin binding using fluorescent probes and other methods</span></div><div class="casAuthors">Ronzetti, Michael; Baljinnyam, Bolormaa; Yasgar, Adam; Simeonov, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1005-1014</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug plasma protein binding remains highly relevant to research and drug development, making the assessment and profiling of compd. affinity to plasma proteins essential to drug discovery efforts.  Although there are a no. of fully-characterized methods, they lack the throughput to handle large nos. of compds.  As the evaluation of adsorption, distribution, metab., and excretion is addressed earlier in the drug development timeline, the need for higher-throughput methods has grown.  This review will highlight recent developments on methods for profiling drug plasma binding, with an emphasis on fluorescent probes and emerging high-throughput methodologies.  There have been a no. of high-throughput assays developed in recent years to meet the scaled up demands for compd. profiling.  Ultimately, the selection of assay technol. relies on a no. of factors, such as capabilities of the lab. and the breadth and amt. of data required.  Fluorescent probe displacement assays are highly flexible and amenable to high-throughput screening, easily scaling up to handle large compd. libraries.  Recent developments in fluorescence technologies, such as homogenous time-resolved fluorescence and probes utilizing the aggregation-induced emission effect, have improved the sensitivity of these assays.  Other technologies, such as microscale thermophoresis and quant. structure-activity relationship modeling, are gaining popularity as alternative techniques for drug plasma protein binding characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovzgGcjI27gbVg90H21EOLACvtfcHk0lhW26Mm4Vj7uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWiu7zN&md5=1733f12699a2921d3fcfd9cab1b488d3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F17460441.2018.1534824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2018.1534824%26sid%3Dliteratum%253Aachs%26aulast%3DRonzetti%26aufirst%3DM.%26aulast%3DBaljinnyam%26aufirst%3DB.%26aulast%3DYasgar%26aufirst%3DA.%26aulast%3DSimeonov%26aufirst%3DA.%26atitle%3DTesting%2520for%2520Drug-Human%2520Serum%2520Albumin%2520Binding%2520Using%2520Fluorescent%2520Probes%2520and%2520Other%2520Methods%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discov.%26date%3D2018%26volume%3D13%26spage%3D1005%26epage%3D1014%26doi%3D10.1080%2F17460441.2018.1534824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebille, B.</span></span> <span> </span><span class="NLM_article-title">Methods of Drug Protein Binding Determinations</span>. <i>Fundam. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">151s</span>– <span class="NLM_lpage">161s</span>, <span class="refDoi"> DOI: 10.1111/j.1472-8206.1990.tb00073.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1111%2Fj.1472-8206.1990.tb00073.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=2093626" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=151s-161s&author=B.+Sebille&title=Methods+of+Drug+Protein+Binding+Determinations&doi=10.1111%2Fj.1472-8206.1990.tb00073.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.1990.tb00073.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.1990.tb00073.x%26sid%3Dliteratum%253Aachs%26aulast%3DSebille%26aufirst%3DB.%26atitle%3DMethods%2520of%2520Drug%2520Protein%2520Binding%2520Determinations%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1990%26volume%3D4%26spage%3D151s%26epage%3D161s%26doi%3D10.1111%2Fj.1472-8206.1990.tb00073.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehngren, M.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Screening of Protein Binding by Equilibrium Dialysis Combined with Liquid Chromatography and Mass Spectrometry</span>. <i>J. Chromatogr. A</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1102</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.chroma.2005.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.chroma.2005.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=16266710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlagsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1102&publication_year=2006&pages=125-134&author=H.+Wanauthor=M.+Rehngren&title=High-Throughput+Screening+of+Protein+Binding+by+Equilibrium+Dialysis+Combined+with+Liquid+Chromatography+and+Mass+Spectrometry&doi=10.1016%2Fj.chroma.2005.10.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry</span></div><div class="casAuthors">Wan, Hong; Rehngren, Mikael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography A</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1102</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">125-134</span>CODEN:
                <span class="NLM_cas:coden">JCRAEY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new approach for screening plasma protein binding is presented.  The method is based on equil. dialysis combined with rapid generic LC-MS bioanal. by using a sample pooling approach enabling high-throughput screening of protein binding in the drug discovery phase.  The method is evaluated by a comparison of measured unbound free fractions fu (%) between single and pooled compds. for a test set of structurally diverse compds. with a wide range of unbound fractions.  Test compds. include 1 acidic and 10 basic drug stds. along with 36 new chem. entities.  A good correlation (R2 > 0.95) of fu (%) between the single and pooled compds. is found, suggesting that at least 10 compds. can be simultaneously measured with acceptable accuracy.  A simplified drug-protein binding model is applied to calc. the fu (%) of drugs at various drug and protein concns. and this is applied to elucidate the applicability of the sample pooling approach from a theor. standpoint.  Moreover, pH shifts in the plasma were obsd. after dialysis when using different types of buffers and the impact of that on the fu is illustrated in assocn. with their physicochem. properties, in particular the ionization state of compds. by the profile of effective mobility as a function of pH.  A new buffer is proposed being able to minimize the pH shift of plasma during the dialysis.  In addn., the application of the proposed buffer does not necessarily require adjusting plasma pH before the dialysis and utilizing a CO2 incubator during the dialysis.  The effect of the ionic strengths of different buffers on MS signals is investigated with regard to ion suppression.  The sample pooling method not only significantly reduces the plasma vol. required but also the no. of bioanal. samples as compared to the single compd. measurements by a conventional approach.  The new proposed approach is esp. beneficial for measuring in vitro protein binding in matrixes such as mouse plasma where plasma is available only in limited amts.  The current new development will facilitate the drug discovery process by more rapidly assessing the protein binding potential of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM94QtsMLoELVg90H21EOLACvtfcHk0ljUhqninBBILw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlagsrzI&md5=53274b3e87826d1be0ac15d9ba758c08</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2005.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2005.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DRehngren%26aufirst%3DM.%26atitle%3DHigh-Throughput%2520Screening%2520of%2520Protein%2520Binding%2520by%2520Equilibrium%2520Dialysis%2520Combined%2520with%2520Liquid%2520Chromatography%2520and%2520Mass%2520Spectrometry%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D2006%26volume%3D1102%26spage%3D125%26epage%3D134%26doi%3D10.1016%2Fj.chroma.2005.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, S.</span></span> <span> </span><span class="NLM_article-title">Comparison of Ultrafiltration Devices for Assessing Theophylline Protein Binding</span>. <i>Ther. Drug Monit.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1097/00007691-199007000-00017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1097%2F00007691-199007000-00017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=2396314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Crt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1990&pages=398-403&author=J.+Blanchardauthor=S.+Harvey&title=Comparison+of+Ultrafiltration+Devices+for+Assessing+Theophylline+Protein+Binding&doi=10.1097%2F00007691-199007000-00017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of ultrafiltration devices for assessing theophylline protein binding</span></div><div class="casAuthors">Blanchard, James; Harvey, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Drug Monitoring</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">398-403</span>CODEN:
                <span class="NLM_cas:coden">TDMODV</span>;
        ISSN:<span class="NLM_cas:issn">0163-4356</span>.
    </div><div class="casAbstract">The ability of two com. available ultrafiltration devices to assess the protein binding of theophylline was compared using human serum albumin in pH 7.4 buffer at 37°.  The devices compared were the Millipore-MC filter units (Catalog no. UFC3LGC00) and the Amicon Centrifree Micropartition System; both rely on centrifugal force to sep. the unbound and bound mols.  The results from each device were essentially identical provided that the Millipore units were centrifuged using conditions that would not allow heat buildup to occur and thereby cause a decrease in the binding.  This problem could be minimized if the Millipore units were available in a low-binding 30,000 dalton cutoff membrane instead of the 10,000 dalton membrane currently available.  The use of the Millipore 30,000 dalton cutoff polysulfone membrane (UFC3TTK00) reduced the centrifugation time necessary to obtain a sufficient vol. of ultrafiltrate for assay, thereby minimizing the possibility of heat generation.  Furthermore, the binding of theophylline to this device was low and comparable to the binding to the Centrifree devices.  Because this low degree of membrane binding may not hold for other drugs, it would be suggested that a Millipore unit supplied with a low-binding, 30,000 dalton cutoff membrane could provide binding data with an efficacy comparable to that achieved with the Centrifree devices.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzy5v26IoOZ7Vg90H21EOLACvtfcHk0ljUhqninBBILw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Crt7w%253D&md5=d53280d514227bbdef921755b2de6de2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1097%2F00007691-199007000-00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007691-199007000-00017%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DHarvey%26aufirst%3DS.%26atitle%3DComparison%2520of%2520Ultrafiltration%2520Devices%2520for%2520Assessing%2520Theophylline%2520Protein%2520Binding%26jtitle%3DTher.%2520Drug%2520Monit.%26date%3D1990%26volume%3D12%26spage%3D398%26epage%3D403%26doi%3D10.1097%2F00007691-199007000-00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J. L.</span>; <span class="NLM_string-name">Lary, J. W.</span>; <span class="NLM_string-name">Moody, T. P.</span>; <span class="NLM_string-name">Laue, T. M.</span></span> <span> </span><span class="NLM_article-title">Analytical Ultracentrifugation: Sedimentation Velocity and Sedimentation Equilibrium</span>. In  <i>Methods in Cell Biology</i>; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2008</span>; Vol.  <span class="NLM_volume">84</span>, pp  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">179</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=143-179&author=J.+L.+Cole&author=J.+W.+Lary&author=T.+P.+Moody&author=T.+M.+Laue&title=Methods+in+Cell+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DJ.%2BL.%26atitle%3DAnalytical%2520Ultracentrifugation%253A%2520Sedimentation%2520Velocity%2520and%2520Sedimentation%2520Equilibrium%26btitle%3DMethods%2520in%2520Cell%2520Biology%26pub%3DElsevier%26date%3D2008%26volume%3D84%26spage%3D143%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergström, F.</span></span> <span> </span><span class="NLM_article-title">High Throughput Screening of Drug-Protein Binding in Drug Discovery</span>. <i>J. Liq. Chromatogr. Relat. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1080/10826070701190989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1080%2F10826070701190989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVOhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=681-700&author=H.+Wanauthor=F.+Bergstr%C3%B6m&title=High+Throughput+Screening+of+Drug-Protein+Binding+in+Drug+Discovery&doi=10.1080%2F10826070701190989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput screening of drug-protein binding in drug discovery</span></div><div class="casAuthors">Wan, Hong; Bergstroem, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liquid Chromatography & Related Technologies</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">681-700</span>CODEN:
                <span class="NLM_cas:coden">JLCTFC</span>;
        ISSN:<span class="NLM_cas:issn">1082-6076</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Characterization of drug-protein binding is essential, since it has profound effects on pharmacokinetic and pharmacodynamic parameters of new chem. entities.  Although the traditional equil. dialysis method is well established and widely used for drug-protein binding measurement, this assay suffers from its low throughput.  Recent efforts were made in developing and implementing high throughput assays for drug-protein screening in drug discovery.  The present review highlights high-throughput assays, as well as potential new approaches for drug-protein binding screening in drug discovery.  These primarily include automated 96-well plate, sample pooling based equil. dialysis combined with LCMS, immobilized HSA column HPLC, and electrodriven techniques such as frontal anal. combined with capillary electrophoresis (FACE), and affinity capillary electrophoresis (ACE).  Fundamental drug-protein binding models are also discussed to (1) compare and discriminate HSA (human serum albumin) and AGP (alpha 1-acid glycoprotein) binding with regard to the whole plasma protein binding; and (2) elucidate the applicability of high throughput screening (HTS) from the viewpoint of a simplified binding model.  Some strategies and recommendations are proposed in dealing with applications of high throughput assays in different situations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_xre3PNsNMbVg90H21EOLACvtfcHk0ljUhqninBBILw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVOhtbg%253D&md5=5eb753c9ec9142c2a3d89a3a266dfacf</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1080%2F10826070701190989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10826070701190989%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DF.%26atitle%3DHigh%2520Throughput%2520Screening%2520of%2520Drug-Protein%2520Binding%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Liq.%2520Chromatogr.%2520Relat.%2520Technol.%26date%3D2007%26volume%3D30%26spage%3D681%26epage%3D700%26doi%3D10.1080%2F10826070701190989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-Q.</span></span> <span> </span><span class="NLM_article-title">Rapid Screening of Drug-Protein Binding Using High-Performance Affinity Chromatography with Columns Containing Immobilized Human Serum Albumin</span>. <i>J. Anal. Methods Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1155/2013/439039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1155%2F2013%2F439039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-7&author=Y.-F.+Liauthor=X.-Q.+Zhangauthor=W.-Y.+Huauthor=Z.+Liauthor=P.-X.+Liuauthor=Z.-Q.+Zhang&title=Rapid+Screening+of+Drug-Protein+Binding+Using+High-Performance+Affinity+Chromatography+with+Columns+Containing+Immobilized+Human+Serum+Albumin&doi=10.1155%2F2013%2F439039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1155%2F2013%2F439039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F439039%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.-F.%26aulast%3DZhang%26aufirst%3DX.-Q.%26aulast%3DHu%26aufirst%3DW.-Y.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DP.-X.%26aulast%3DZhang%26aufirst%3DZ.-Q.%26atitle%3DRapid%2520Screening%2520of%2520Drug-Protein%2520Binding%2520Using%2520High-Performance%2520Affinity%2520Chromatography%2520with%2520Columns%2520Containing%2520Immobilized%2520Human%2520Serum%2520Albumin%26jtitle%3DJ.%2520Anal.%2520Methods%2520Chem.%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D7%26doi%3D10.1155%2F2013%2F439039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noctor, T. A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Perez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainer, I. W.</span></span> <span> </span><span class="NLM_article-title">Use of a Human Serum Albumin-Based Stationary Phase for High-Performance Liquid Chromatography as a Tool for the Rapid Determination of Drug–Plasma Protein Binding</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1002/jps.2600820629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fjps.2600820629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=8331550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK3sXkvVGhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1993&pages=675-676&author=T.+A.+G.+Noctorauthor=M.+J.+Diaz-Perezauthor=I.+W.+Wainer&title=Use+of+a+Human+Serum+Albumin-Based+Stationary+Phase+for+High-Performance+Liquid+Chromatography+as+a+Tool+for+the+Rapid+Determination+of+Drug%E2%80%93Plasma+Protein+Binding&doi=10.1002%2Fjps.2600820629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a human serum albumin-based stationary phase for high-performance liquid chromatography as a tool for the rapid determination of drug-plasma protein binding</span></div><div class="casAuthors">Noctor, Terence A. G.; Diaz-Perez, Maria J.; Wainer, Irving W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-6</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">The present investigation evaluated HPLC on a chiral stationary phase (CSP) based on human serum albumins (HSA) for rapid and precise detn. of the extent to which a drug binds to albumin.  Three series of solutes were examd.: a group of 19 1,4-benzodiazepines, a group of 9 coumarins and a series of 24 structurally related triazole derivs.  The percentage of binding of each compd. to HSA (4 g/100 mL) in buffer soln. (100 mM, pH 7.4) was detd. by ultrafiltration (Centrifree) after incubation for 2-3 h at room temp.  The compds. were quantitated photometrically.  In each case, control expts. were performed to ensure that the compd. under study did not adsorb to the ultrafiltration assembly.  Significant and variable amts. of a UV-absorptive material from the ultrafiltration membrane appeared in the ultrafiltrate and interfered with solute anal.  The percentage of solute bound to HSA, as detd. above, was correlated with the retention of the compd. on the HSA CSP (Chiral-Protein 2), as represented by capacity factors (k').  Because the solutes examd. exhibited a very large range of levels of binding to HSA, HSA CSPs of different sizes and different mobile phases were used.  The triazole derivs. were found to exhibit very low levels of binding to HSA and subsequently to be retained in very small amts. on the HSA CSP.  These solutes were therefore chromatographed on a 15-cm HSA column with a mobile phase composed of a simple phosphate buffer (100 mM, pH 6.90) without an org. modifier.  The coumarins showed very high levels of binding to HSA; therefore, a 5-cm HSA column with a mobile phase of sodium phosphate (100 mM, pH 6.90):propan-1-ol (95:5 [vol./vol.]) was used.  For the benzodiazepines, a 15-cm column with the same mobile phase compn. as that used for the coumarins was used.  For the compds. examd., the extent of HSA binding correlated better with the expression k'/(k' + 1) than with k'.  This factor is derived from the fundamental definition of k' as the ratio of solute in the stationary phase to that in the mobile phase and is therefore an expression of the fraction of solute actually adsorbed to the immobilized protein.  Plots of k'/(k' + 1) against percentage of solute bound to HSA are presented.  These studies show that retention of a solute on the HSA CSP is clearly related to its binding affinity for the free protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXYRcOMv9rBbVg90H21EOLACvtfcHk0ljEivFKJvwgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvVGhtbg%253D&md5=8f9d55337a700c1244017d0e43894d09</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600820629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600820629%26sid%3Dliteratum%253Aachs%26aulast%3DNoctor%26aufirst%3DT.%2BA.%2BG.%26aulast%3DDiaz-Perez%26aufirst%3DM.%2BJ.%26aulast%3DWainer%26aufirst%3DI.%2BW.%26atitle%3DUse%2520of%2520a%2520Human%2520Serum%2520Albumin-Based%2520Stationary%2520Phase%2520for%2520High-Performance%2520Liquid%2520Chromatography%2520as%2520a%2520Tool%2520for%2520the%2520Rapid%2520Determination%2520of%2520Drug%25E2%2580%2593Plasma%2520Protein%2520Binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1993%26volume%3D82%26spage%3D675%26epage%3D676%26doi%3D10.1002%2Fjps.2600820629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Binding of Imipramine to Plasma Proteins: Effect of Hyperlipoproteinemia</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1002/cpt1979253316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fcpt1979253316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=761443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaE1MXhvFOgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1979&pages=316-321&author=A.+Danonauthor=Z.+Chen&title=Binding+of+Imipramine+to+Plasma+Proteins%3A+Effect+of+Hyperlipoproteinemia&doi=10.1002%2Fcpt1979253316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of imipramine to plasma proteins:  effect of hyperlipoproteinemia</span></div><div class="casAuthors">Danon, Abraham; Chen, Zehava</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-21</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">Imipramine (I)  [50-49-7] was highly bound to lipoproteins and to other plasma proteins.  The binding to the lipoproteins was higher in hyperlipoproteinemic patients than in normal subjects and correlated with both plasma cholesterol  [57-88-5] and triglyceride levels.  The overall percent binding of I was higher in hyperlipoproteinemic patients than in normal subjects.  The varying degree of binding of I to plasma proteins as a result of varying lipoprotein concns., as well as the special nature of the binding to lipoproteins, may be of kinetic and clin. significance in hyperlipoproteinemic individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJn2eBR1SVoLVg90H21EOLACvtfcHk0ljEivFKJvwgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhvFOgtL4%253D&md5=133fa1abb69eb26fae30d6e9b92e4e23</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcpt1979253316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt1979253316%26sid%3Dliteratum%253Aachs%26aulast%3DDanon%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DBinding%2520of%2520Imipramine%2520to%2520Plasma%2520Proteins%253A%2520Effect%2520of%2520Hyperlipoproteinemia%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1979%26volume%3D25%26spage%3D316%26epage%3D321%26doi%3D10.1002%2Fcpt1979253316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larive, C. K.</span></span> <span> </span><span class="NLM_article-title">Measuring Ligand-Protein Binding Using NMR Diffusion Experiments</span>. <i>Concepts Magn. Reson. Part A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>20A</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1002/cmr.a.10094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fcmr.a.10094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20A&publication_year=2004&pages=24-41&author=L.+H.+Lucasauthor=C.+K.+Larive&title=Measuring+Ligand-Protein+Binding+Using+NMR+Diffusion+Experiments&doi=10.1002%2Fcmr.a.10094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring ligand-protein binding using NMR diffusion experiments</span></div><div class="casAuthors">Lucas, Laura H.; Larive, Cynthia K.</div><div class="citationInfo"><span class="NLM_cas:title">Concepts in Magnetic Resonance, Part A</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">20A</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-41</span>CODEN:
                <span class="NLM_cas:coden">CMRPC2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Characterization of ligand-protein interactions is important because many biol. important processes are mediated by the binding of a small mol. to an enzyme or cell-surface receptor.  Pulsed-field gradient NMR (PFG-NMR) spectroscopy measurements of diffusion coeffs. permit noninvasive, quant. anal. of binding over a broad range of dissocn. consts. and ligand:protein concn. ratios.  An arsenal of specific and selective PFG-NMR methods has been developed by exploiting differential behaviors of small mol. ligands and macromol. proteins.  A discussion of several PFG-NMR methods and their relevant applications reveals the anal. value of using PFG-NMR diffusion measurements for studying ligand-protein binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK1JhVnpSLFLVg90H21EOLACvtfcHk0ljEivFKJvwgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVCjsrc%253D&md5=0ea7637a42793d336c008e3fac5744fe</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcmr.a.10094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmr.a.10094%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DL.%2BH.%26aulast%3DLarive%26aufirst%3DC.%2BK.%26atitle%3DMeasuring%2520Ligand-Protein%2520Binding%2520Using%2520NMR%2520Diffusion%2520Experiments%26jtitle%3DConcepts%2520Magn.%2520Reson.%2520Part%2520A.%26date%3D2004%26volume%3D20A%26spage%3D24%26epage%3D41%26doi%3D10.1002%2Fcmr.a.10094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaimo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsale, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicero, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span> <span> </span><span class="NLM_article-title">A Novel Method Using Nuclear Magnetic Resonance for Plasma Protein Binding Assessment in Drug Discovery Programs</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2019.01.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.jpba.2019.01.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=30738240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC1MXis1Wksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2019&pages=21-29&author=M.+Galloauthor=S.+Matteucciauthor=N.+Alaimoauthor=E.+Pittiauthor=M.+V.+Orsaleauthor=V.+Summaauthor=D.+O.+Ciceroauthor=E.+Monteagudo&title=A+Novel+Method+Using+Nuclear+Magnetic+Resonance+for+Plasma+Protein+Binding+Assessment+in+Drug+Discovery+Programs&doi=10.1016%2Fj.jpba.2019.01.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A novel method using nuclear magnetic resonance for plasma protein binding assessment in drug discovery programs</span></div><div class="casAuthors">Gallo, Mariana; Matteucci, Sara; Alaimo, Nadine; Pitti, Erica; Orsale, Maria V.; Summa, Vincenzo; Cicero, Daniel O.; Monteagudo, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new methodol. based on NMR was developed to det. plasma protein binding (PPB) of drug candidates in drug discovery programs.  A strong correlation was found between the attenuation of NMR signals of diverse drugs in the presence of different plasma concns. and their fraction bound (fb) reported in the literature.  Based on these results, a protocol for a rapid calcn. of fb of small mols. was established.  The advantage of using plasma instead of purified recombinant proteins and the possibility of pool anal. to increase throughput were also evaluated.  This novel methodol. proved to be very versatile, cost-effective, fast and suitable for automation.  As a plus, it contemporarily provides a quality check and soly. of the compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoCa_PAOMXyLVg90H21EOLACvtfcHk0lgR8LhpUCgpFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXis1Wksr4%253D&md5=616d2e8af44c5169588cc5599eb6105f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2019.01.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2019.01.049%26sid%3Dliteratum%253Aachs%26aulast%3DGallo%26aufirst%3DM.%26aulast%3DMatteucci%26aufirst%3DS.%26aulast%3DAlaimo%26aufirst%3DN.%26aulast%3DPitti%26aufirst%3DE.%26aulast%3DOrsale%26aufirst%3DM.%2BV.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DCicero%26aufirst%3DD.%2BO.%26aulast%3DMonteagudo%26aufirst%3DE.%26atitle%3DA%2520Novel%2520Method%2520Using%2520Nuclear%2520Magnetic%2520Resonance%2520for%2520Plasma%2520Protein%2520Binding%2520Assessment%2520in%2520Drug%2520Discovery%2520Programs%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2019%26volume%3D167%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.jpba.2019.01.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meehan, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span> <span> </span><span class="NLM_article-title">A New Drug Binding Subsite on Human Serum Albumin and Drug–Drug Interaction Studied by X-Ray Crystallography</span>. <i>J. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.jsb.2007.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.jsb.2007.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=18258455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksleju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2008&pages=40-49&author=L.+Zhuauthor=F.+Yangauthor=L.+Chenauthor=E.+J.+Meehanauthor=M.+Huang&title=A+New+Drug+Binding+Subsite+on+Human+Serum+Albumin+and+Drug%E2%80%93Drug+Interaction+Studied+by+X-Ray+Crystallography&doi=10.1016%2Fj.jsb.2007.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography</span></div><div class="casAuthors">Zhu, Lili; Yang, Feng; Chen, Liqing; Meehan, Edward J.; Huang, Mingdong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Structural Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-49</span>CODEN:
                <span class="NLM_cas:coden">JSBIEM</span>;
        ISSN:<span class="NLM_cas:issn">1047-8477</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">3'-Azido-3'-deoxythymidine (AZT) is the first clin. effective drug for the treatment of human immunodeficiency virus infection.  The drug interaction with human serum albumin (HSA) has been an important component in understanding its mechanism of action, esp. in drug distribution and in drug-drug interaction on HSA in the case of multi-drug therapy.  We present here crystal structures of a ternary HSA-Myr-AZT complex and a quaternary HSA-Myr-AZT-SAL complex (Myr, myristate; SAL, salicylic acid).  From this study, a new drug binding subsite on HSA Sudlow site 1 was identified.  The presence of fatty acid is needed for the creation of this subsite due to fatty acid induced conformational changes of HSA.  Thus, the Sudlow site 1 of HSA can be divided into three non-overlapped subsites: a SAL subsite, an indomethacin subsite and an AZT subsite.  Binding of a drug to HSA often influences simultaneous binding of other drugs.  From the HSA-Myr-AZT-SAL complex structure, we obsd. the coexistence of two drugs (AZT and SAL) in Sudlow site 1 and the competition between these two drugs in subdomain IB.  These results provide new structural information on HSA-drug interaction and drug-drug interaction on HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr02e6NtI1kY7Vg90H21EOLACvtfcHk0lgR8LhpUCgpFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksleju7g%253D&md5=b5bb4a6a96bbfa8614c3e2fbe2e00c94</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2007.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2007.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMeehan%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DM.%26atitle%3DA%2520New%2520Drug%2520Binding%2520Subsite%2520on%2520Human%2520Serum%2520Albumin%2520and%2520Drug%25E2%2580%2593Drug%2520Interaction%2520Studied%2520by%2520X-Ray%2520Crystallography%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2008%26volume%3D162%26spage%3D40%26epage%3D49%26doi%3D10.1016%2Fj.jsb.2007.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. A.</span></span> <span> </span><span class="NLM_article-title">Capillary Electrophoresis Technologies for Screening in Drug Discovery</span>. <i>Drug Discov. Today Technol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1016/j.ddtec.2005.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.ddtec.2005.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=24981845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKrtLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=171-178&author=H.+Wanauthor=R.+A.+Thompson&title=Capillary+Electrophoresis+Technologies+for+Screening+in+Drug+Discovery&doi=10.1016%2Fj.ddtec.2005.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Capillary electrophoresis technologies for screening in drug discovery</span></div><div class="casAuthors">Wan, Hong; Thompson, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-178</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The high sepn. efficiency of capillary electrophoresis (CE), combined with the high selectivity and sensitivity of mass spectrometry (MS) detection offers the potential of unique resolving power and high-throughput capacity to the anal. and structural identification of complex mixts.  Recent advances in CE-MS interfaces and com. available 96-capillary instruments have made the implementation of routine CE methods for drug screening feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8caFTtvPpRbVg90H21EOLACvtfcHk0li0DhFl3h5DRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKrtLnL&md5=76359049fc141fe3ea6716647da7962e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2005.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2005.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26atitle%3DCapillary%2520Electrophoresis%2520Technologies%2520for%2520Screening%2520in%2520Drug%2520Discovery%26jtitle%3DDrug%2520Discov.%2520Today%2520Technol.%26date%3D2005%26volume%3D2%26spage%3D171%26epage%3D178%26doi%3D10.1016%2Fj.ddtec.2005.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambrinidis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallianatou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantili-Kakoulidou, A.</span></span> <span> </span><span class="NLM_article-title">In Vitro, in Silico and Integrated Strategies for the Estimation of Plasma Protein Binding. A Review</span>. <i>Adv. Drug Delivery Rev</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2015.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.addr.2015.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=25819487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslCltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2015&pages=27-45&author=G.+Lambrinidisauthor=T.+Vallianatouauthor=A.+Tsantili-Kakoulidou&title=In+Vitro%2C+in+Silico+and+Integrated+Strategies+for+the+Estimation+of+Plasma+Protein+Binding.+A+Review&doi=10.1016%2Fj.addr.2015.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review</span></div><div class="casAuthors">Lambrinidis, George; Vallianatou, Theodosia; Tsantili-Kakoulidou, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-45</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Plasma protein binding (PPB) strongly affects drug distribution and pharmacokinetic behavior with consequences in overall pharmacol. action.  Extended plasma protein binding may be assocd. with drug safety issues and several adverse effects, like low clearance, low brain penetration, drug-drug interactions, loss of efficacy, while influencing the fate of enantiomers and diastereoisomers by stereoselective binding within the body.  Therefore in holistic drug design approaches, where ADME(T) properties are considered in parallel with target affinity, considerable efforts are focused in early estn. of PPB mainly in regard to human serum albumin (HSA), which is the most abundant and most important plasma protein.  The second crit. serum protein α1-acid glycoprotein (AGP), although often underscored, plays also an important and complicated role in clin. therapy and thus the last years it has been studied thoroughly too.In the present review, after an overview of the principles of HSA and AGP binding as well as the structure topol. of the proteins, the current trends and perspectives in the field of PPB predictions are presented and discussed considering both HSA and AGP binding.  Since however for the latter protein systematic studies have started only the last years, the review focuses mainly to HSA.  One part of the review highlights the challenge to develop rapid techniques for HSA and AGP binding simulation and their performance in assessment of PPB.  The second part focuses on in silico approaches to predict HSA and AGP binding, analyzing and evaluating structure-based and ligand-based methods, as well as combination of both methods in the aim to exploit the different information and overcome the limitations of each individual approach.  Ligand-based methods use the Quant. Structure-Activity Relationships (QSAR) methodol. to establish quantitate models for the prediction of binding consts. from mol. descriptors, while they provide only indirect information on binding mechanism.  Efforts for the establishment of global models, automated workflows and web-based platforms for PPB predictions are presented and discussed.  Structure-based methods relying on the crystal structures of drug-protein complexes provide detailed information on the underlying mechanism but are usually restricted to specific compds.  They are useful to identify the specific binding site while they may be important in investigating drug-drug interactions, related to PPB.  Moreover, chemometrics or structure-based modeling may be supported by exptl. data a promising integrated alternative strategy for ADME(T) properties optimization.  In the case of PPB the use of mol. modeling combined with bioanal. techniques is frequently used for the investigation of AGP binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO5Jya4dWQ6LVg90H21EOLACvtfcHk0li0DhFl3h5DRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslCltbo%253D&md5=06b12cb016d725b42c3f59af08919f4e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2015.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2015.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DLambrinidis%26aufirst%3DG.%26aulast%3DVallianatou%26aufirst%3DT.%26aulast%3DTsantili-Kakoulidou%26aufirst%3DA.%26atitle%3DIn%2520Vitro%252C%2520in%2520Silico%2520and%2520Integrated%2520Strategies%2520for%2520the%2520Estimation%2520of%2520Plasma%2520Protein%2520Binding.%2520A%2520Review%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev%26date%3D2015%26volume%3D86%26spage%3D27%26epage%3D45%26doi%3D10.1016%2Fj.addr.2015.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, M. H.</span></span> <span> </span><span class="NLM_article-title">An Inexpensive, In-House-Made, Microdialysis Device for Measuring Drug–Protein Binding</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00316</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00316" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOjurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=279-282&author=Z.+M.+Herbstauthor=S.+Shibataauthor=E.+Fanauthor=M.+H.+Gelb&title=An+Inexpensive%2C+In-House-Made%2C+Microdialysis+Device+for+Measuring+Drug%E2%80%93Protein+Binding&doi=10.1021%2Facsmedchemlett.7b00316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">An Inexpensive, In-House-Made, Microdialysis Device for Measuring Drug-Protein Binding</span></div><div class="casAuthors">Herbst, Zackary M.; Shibata, Sayaka; Fan, Erkang; Gelb, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An inexpensive, inhouse made microdialysis device is described that is suitable for measuring the binding of small mols. including drug candidates to serum proteins or other macromols.  The device is based on the std. equil. dialysis method to measure the fraction of low mol. wt. compd. bound to proteins.  It is constructed from a std. polypropylene 96-well plate, dialysis tubing, and low viscosity epoxy resin.  The device can be readily prepd. for a small fraction of the cost of a com., multichamber microdialysis device.  Drug-protein binding results are provided, which validates the device.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTjiSTHRb7orVg90H21EOLACvtfcHk0ljTZwdUfC3UPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOjurzF&md5=9a612b4666217cd6356c44679e4f0bda</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00316%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DZ.%2BM.%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DAn%2520Inexpensive%252C%2520In-House-Made%252C%2520Microdialysis%2520Device%2520for%2520Measuring%2520Drug%25E2%2580%2593Protein%2520Binding%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D279%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.7b00316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kieltyka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drexler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Application of Cassette Ultracentrifugation Using Non-Labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding Determination</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_fpage">1036</span>, <span class="refDoi"> DOI: 10.1016/S0022-3549(15)00177-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2FS0022-3549%2815%2900177-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=26886323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=1036&author=K.+Kieltykaauthor=B.+McAuliffeauthor=C.+Cianciauthor=D.+M.+Drexlerauthor=W.+Shouauthor=J.+Zhang&title=Application+of+Cassette+Ultracentrifugation+Using+Non-Labeled+Compounds+and+Liquid+Chromatography-Tandem+Mass+Spectrometry+Analysis+for+High-Throughput+Protein+Binding+Determination&doi=10.1016%2FS0022-3549%2815%2900177-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Cassette Ultracentrifugation Using Non-labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding Determination</span></div><div class="casAuthors">Kieltyka, Kasia; McAuliffe, Brian; Cianci, Christopher; Drexler, Dieter M.; Shou, Wilson; Zhang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1036-1042</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Membrane-based devices typically used for serum protein binding detn. are not fully applicable to highly lipophilic compds. because of nonspecific binding to the device membrane.  Ultracentrifugation, however, completely eliminates the issue by using a membrane-free approach, although its wide application has been limited.  This lack of utilization is mainly attributed to 2 factors: the high cost in acquiring and handling of radiolabeled compds. and low assay throughput owing to the difficulties in process automation.  To overcome these challenges, we report a high-throughput workflow by cassette ultracentrifugation of nonradiolabeled compds. followed by liq. chromatog.-tandem mass spectrometry (LC-MS/MS) anal.  Twenty compds. with diverse physicochem. and protein binding properties were selected for the evaluation of the workflow.  To streamline the working process, approaches of matrix balancing for all the samples for LC-MS/MS anal. and detg. free fraction without anal. calibration curves were adopted.  Both the discrete ultracentrifugation of individual compds. and cassette ultracentrifugation of all the test compds. followed by simultaneous LC-MS/MS anal. exhibited a linear correlation with literature values, demonstrating resp. the validity of the ultracentrifugation process and the cassette approach.  The cassette ultracentrifugation using nonradiolabeled compds. followed by LC-MS/MS anal. has greatly facilitated its application for high-throughput protein binding screening in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrntwsG-p7rDLVg90H21EOLACvtfcHk0ljTZwdUfC3UPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnu7rI&md5=4f0784b86c5b895763870c40aebc6db0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0022-3549%2815%2900177-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3549%252815%252900177-X%26sid%3Dliteratum%253Aachs%26aulast%3DKieltyka%26aufirst%3DK.%26aulast%3DMcAuliffe%26aufirst%3DB.%26aulast%3DCianci%26aufirst%3DC.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26aulast%3DShou%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520Cassette%2520Ultracentrifugation%2520Using%2520Non-Labeled%2520Compounds%2520and%2520Liquid%2520Chromatography-Tandem%2520Mass%2520Spectrometry%2520Analysis%2520for%2520High-Throughput%2520Protein%2520Binding%2520Determination%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26spage%3D1036%26doi%3D10.1016%2FS0022-3549%2815%2900177-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, L. E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas-Hernández, C.</span></span> <span> </span><span class="NLM_article-title">Spectrophotometric Determination of the PKa, Isosbestic Point and Equation of Absorbance vs. PH for a Universal PH Indicator</span>. <i>Am. J. Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>05</i></span>,  <span class="NLM_fpage">1290</span>– <span class="NLM_lpage">1301</span>, <span class="refDoi"> DOI: 10.4236/ajac.2014.517135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.4236%2Fajac.2014.517135" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=05&publication_year=2014&pages=1290-1301&author=L.+E.+V.+Salgadoauthor=C.+Vargas-Hern%C3%A1ndez&title=Spectrophotometric+Determination+of+the+PKa%2C+Isosbestic+Point+and+Equation+of+Absorbance+vs.+PH+for+a+Universal+PH+Indicator&doi=10.4236%2Fajac.2014.517135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.4236%2Fajac.2014.517135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fajac.2014.517135%26sid%3Dliteratum%253Aachs%26aulast%3DSalgado%26aufirst%3DL.%2BE.%2BV.%26aulast%3DVargas-Hern%25C3%25A1ndez%26aufirst%3DC.%26atitle%3DSpectrophotometric%2520Determination%2520of%2520the%2520PKa%252C%2520Isosbestic%2520Point%2520and%2520Equation%2520of%2520Absorbance%2520vs.%2520PH%2520for%2520a%2520Universal%2520PH%2520Indicator%26jtitle%3DAm.%2520J.%2520Anal.%2520Chem.%26date%3D2014%26volume%3D05%26spage%3D1290%26epage%3D1301%26doi%3D10.4236%2Fajac.2014.517135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Connors, K. A.</span></span> <span> </span><span class="NLM_article-title">Optical Absorption Spectroscopy</span>. In  <i>Binding Constants: The Measurement of Molecular Complex Stability</i>; <span class="NLM_publisher-name">Wiley-Interscience</span>, <span class="NLM_year">1987</span>; pp  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">187</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1987&pages=141-187&author=K.+A.+Connors&title=Binding+Constants%3A+The+Measurement+of+Molecular+Complex+Stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DConnors%26aufirst%3DK.%2BA.%26atitle%3DOptical%2520Absorption%2520Spectroscopy%26btitle%3DBinding%2520Constants%253A%2520The%2520Measurement%2520of%2520Molecular%2520Complex%2520Stability%26pub%3DWiley-Interscience%26date%3D1987%26spage%3D141%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span> <i>Goodman and Gilman’s The Pharmacological
Basis of Therapeutics,
10th ed.</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardman, J. G.</span>, <span class="NLM_string-name">Limbird, L. E.</span>, <span class="NLM_string-name">Gilman, A. G.</span></span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+G.+Hardman&author=L.+E.+Limbird&author=A.+G.+Gilman&title=Goodman+and+Gilman%E2%80%99s+The+Pharmacological%0ABasis+of+Therapeutics%2C%0A10th+ed."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGoodman%2520and%2520Gilman%25E2%2580%2599s%2520The%2520Pharmacological%250ABasis%2520of%2520Therapeutics%252C%250A10th%2520ed.%26aulast%3DHardman%26aufirst%3DJ.%2BG.%26pub%3DMcGraw-Hill%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span> <span> </span><span class="NLM_article-title">Compilation of 222 Drugs’ Plasma Protein Binding Data and Guidance for Study Designs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">485</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.drudis.2011.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=22210121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslygsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=475-485&author=F.+Zhangauthor=J.+Xueauthor=J.+Shaoauthor=L.+Jia&title=Compilation+of+222+Drugs%E2%80%99+Plasma+Protein+Binding+Data+and+Guidance+for+Study+Designs&doi=10.1016%2Fj.drudis.2011.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Compilation of 222 drugs' plasma protein binding data and guidance for study designs</span></div><div class="casAuthors">Zhang, Fengling; Xue, Jinpin; Shao, Jingwei; Jia, Li</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">475-485</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The binding of a drug to plasma protein reduces free drug in the blood circulation that would otherwise be available for penetration into tissues to reach the therapeutic target or the kidney for elimination.  Therefore, the binding event affects drug elimination from the body, efficacy, duration of action and toxicity.  Co-administration of other drugs, food and pathol. conditions of patients can significantly change percentage binding of the drug and result in serious consequences.  Here, we present the largest and newest information on plasma protein binding for 222 drugs, of which 50% show 90-100% binding, a range that could be considered as a favorable element for future lead selection.  We also provide crit. and comprehensive evaluations on the methods and techniques established to det. plasma protein binding, pinpoint advantages and pitfalls of individual approaches, and offer detailed guidance for exptl. designs, including ultrafiltration, equil. dialysis, ultracentrifugation, charcoal adsorption, high-performance affinity chromatog., high-performance frontal anal., solid-phase microextn. and in vivo microdialysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTcTLPiF2eoLVg90H21EOLACvtfcHk0ljTZwdUfC3UPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslygsbg%253D&md5=3de93a27ff20a113a4ef0724961ab6bc</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DL.%26atitle%3DCompilation%2520of%2520222%2520Drugs%25E2%2580%2599%2520Plasma%2520Protein%2520Binding%2520Data%2520and%2520Guidance%2520for%2520Study%2520Designs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26spage%3D475%26epage%3D485%26doi%3D10.1016%2Fj.drudis.2011.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, J.</span></span> <span> </span><span class="NLM_article-title">Measurement of Drug–Protein Binding by Immobilized Human Serum Albumin-HPLC and Comparison with Ultrafiltration</span>. <i>J. Chromatogr., B</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>834</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.jchromb.2006.02.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.jchromb.2006.02.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=16567134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFOgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=834&publication_year=2006&pages=108-116&author=S.+S.+Singhauthor=J.+Mehta&title=Measurement+of+Drug%E2%80%93Protein+Binding+by+Immobilized+Human+Serum+Albumin-HPLC+and+Comparison+with+Ultrafiltration&doi=10.1016%2Fj.jchromb.2006.02.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration</span></div><div class="casAuthors">Singh, Sonu Sundd; Mehta, Jitendra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">834</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">108-116</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An HPLC method employing CHIRAL-I (150 mm × 3 mm), 5 μm column from Chrom.Tech., immobilized with human serum albumin (HSA), was used to det. in vitro protein binding of several compds.  Exptl. obtained plasma protein data exhibited good correlation with the reported values.  The method was compared with the conventional ultrafiltration technique and both yielded similar results.  Proprietary compds. that could not be analyzed by ultrafiltration due to high non-specific binding to filter membrane were successfully analyzed by HSA-HPLC method.  On the other hand, two proprietary compds. did not elute from HSA column due to strong binding, but were successfully analyzed by ultra filtration.  This proves that both the techniques have their own merits and demerits and should be exploited judiciously as per the requirement.  The plasma protein binding studies conducted on four gyrase inhibitors in rat and human plasma exhibited no interspecies difference via ultra filtration method.  Further, it was also obsd. that the protein binding obtained for the four gyrase inhibitors by HSA-HPLC method was not only similar to that obtained by ultra filtration in human plasma but was also in accordance with ex vivo and in vitro protein binding obtained for rat plasma after ultra filtration because these compds. predominantly bind to HSA.  The binding of several compds. to α1-acid glycoprotein (AGP), another important plasma protein, was also examd. using AGP immobilized column.  However, the data could not be relied upon since some antibacterials and non-steroidal anti-inflammatory drugs (NSAIDS), which are known to predominantly bind to HSA, were also found to bind to AGP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIksVQwwJ-ObVg90H21EOLACvtfcHk0lgdYEJxOz3NPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFOgsbw%253D&md5=92a665ddf0314ab9a3c1114d80789a93</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2006.02.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2006.02.053%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BS.%26aulast%3DMehta%26aufirst%3DJ.%26atitle%3DMeasurement%2520of%2520Drug%25E2%2580%2593Protein%2520Binding%2520by%2520Immobilized%2520Human%2520Serum%2520Albumin-HPLC%2520and%2520Comparison%2520with%2520Ultrafiltration%26jtitle%3DJ.%2520Chromatogr.%252C%2520B%26date%3D2006%26volume%3D834%26spage%3D108%26epage%3D116%26doi%3D10.1016%2Fj.jchromb.2006.02.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunhuck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, D. P.</span></span> <span> </span><span class="NLM_article-title">Fast Gradient HPLC Method to Determine Compounds Binding to Human Serum Albumin. Relationships with Octanol/Water and Immobilized Artificial Membrane Lipophilicity</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">2236</span>– <span class="NLM_lpage">2248</span>, <span class="refDoi"> DOI: 10.1002/jps.10494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1002%2Fjps.10494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=14603509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=2236-2248&author=K.+Valkoauthor=S.+Nunhuckauthor=C.+Bevanauthor=M.+H.+Abrahamauthor=D.+P.+Reynolds&title=Fast+Gradient+HPLC+Method+to+Determine+Compounds+Binding+to+Human+Serum+Albumin.+Relationships+with+Octanol%2FWater+and+Immobilized+Artificial+Membrane+Lipophilicity&doi=10.1002%2Fjps.10494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity</span></div><div class="casAuthors">Valko, Klara; Nunhuck, Shenaz; Bevan, Chris; Abraham, Michael H.; Reynolds, Derek P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2236-2248</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A fast gradient HPLC method (cycle time 15 min) has been developed to det. Human Serum Albumin (HSA) binding of discovery compds. using chem. bonded protein stationary phases.  The HSA binding values were derived from the gradient retention times that were converted to the logarithm of the equil. consts. (logK HSA) using data from a calibration set of mols.  The method has been validated using literature plasma protein binding data of 68 known drug mols.  The method is fully automated, and has been used for lead optimization in more than 20 company projects.  The HSA binding data obtained for more than 4000 compds. were suitable to set up global and project specific quant. structure binding relationships that helped compd. design in early drug discovery.  The obtained HSA binding of known drug mols. were compared to the Immobilizd Artificial Membrane binding data (CHI IAM) obtained by our previously described HPLC-based method.  The solvation equation approach has been used to characterize the normal binding ability of HSA, and this relationship shows that compd. lipophilicity is a significant factor.  It was found that the selectivity of the "baseline" lipophilicity governing HSA binding, membrane interaction, and octanol/water partition are very similar.  However, the effect of the presence of pos. or neg. charges have very different effects.  It was found that neg. charged compds. bind more strongly to HSA than it would be expected from the lipophilicity of the ionized species at pH 7.4.  Several compds. showed stronger HSA binding than can be expected from their lipophilicity alone, and comparison between predicted and exptl. binding affinity allows the identification of compds. that have good complementarities with any of the known binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr1LUBLdv-t7Vg90H21EOLACvtfcHk0lgdYEJxOz3NPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCrs7Y%253D&md5=14eb1e0f0ad616846a2b5d1428133fa9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjps.10494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10494%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DReynolds%26aufirst%3DD.%2BP.%26atitle%3DFast%2520Gradient%2520HPLC%2520Method%2520to%2520Determine%2520Compounds%2520Binding%2520to%2520Human%2520Serum%2520Albumin.%2520Relationships%2520with%2520Octanol%252FWater%2520and%2520Immobilized%2520Artificial%2520Membrane%2520Lipophilicity%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D2236%26epage%3D2248%26doi%3D10.1002%2Fjps.10494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollósy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valkó, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunhuck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span> <span> </span><span class="NLM_article-title">Estimation of Volume of Distribution in Humans from High Throughput HPLC-Based Measurements of Human Serum Albumin Binding and Immobilized Artificial Membrane Partitioning</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6958</span>– <span class="NLM_lpage">6971</span>, <span class="refDoi"> DOI: 10.1021/jm050957i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050957i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ClurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6958-6971&author=F.+Holl%C3%B3syauthor=K.+Valk%C3%B3author=A.+Herseyauthor=S.+Nunhuckauthor=G.+K%C3%A9riauthor=C.+Bevan&title=Estimation+of+Volume+of+Distribution+in+Humans+from+High+Throughput+HPLC-Based+Measurements+of+Human+Serum+Albumin+Binding+and+Immobilized+Artificial+Membrane+Partitioning&doi=10.1021%2Fjm050957i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of Volume of Distribution in Humans from High Throughput HPLC-Based Measurements of Human Serum Albumin Binding and Immobilized Artificial Membrane Partitioning</span></div><div class="casAuthors">Hollosy, Ferenc; Valko, Klara; Hersey, Anne; Nunhuck, Shenaz; Keri, Gyoergy; Bevan, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6958-6971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The vol. of distribution (VD) in humans of 179 known drug mols. (acids, bases, and neutrals) has been modeled using two biomimetic-binding measurements.  The phospholipid binding (log K (IAM)) and the plasma protein binding (log K (HSA)) have been calcd. from gradient HPLC retention times on immobilized artificial membrane (IAM) and on human serum albumin (HSA) columns, resp.  The log VD values showed good correlation with the compds.' relative binding to IAM and HSA as follows: log VD = 0.44 log K (IAM) - 0.22 log K (HSA) - 0.66; n = 179, r2 = 0.76, s = 0.33, and F = 272.  It was also obsd. that pos. charged mols. bind relatively more to IAM, while neg. charged ones bind more to HSA, in line with the empirical observation that bases tend to have a larger vol. of distribution than acids.  These results suggest that with the help of these two simple high throughput HPLC-based biomimetic binding measurements an important in vivo drug disposition property can be estd. for use in early drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBHWlrSQHQUbVg90H21EOLACvtfcHk0lgdYEJxOz3NPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ClurfK&md5=e19a0a058e052287cdca97c2125f9da4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm050957i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050957i%26sid%3Dliteratum%253Aachs%26aulast%3DHoll%25C3%25B3sy%26aufirst%3DF.%26aulast%3DValk%25C3%25B3%26aufirst%3DK.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DBevan%26aufirst%3DC.%26atitle%3DEstimation%2520of%2520Volume%2520of%2520Distribution%2520in%2520Humans%2520from%2520High%2520Throughput%2520HPLC-Based%2520Measurements%2520of%2520Human%2520Serum%2520Albumin%2520Binding%2520and%2520Immobilized%2520Artificial%2520Membrane%2520Partitioning%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6958%26epage%3D6971%26doi%3D10.1021%2Fjm050957i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Non-Steroidal Anti-Inflammatory Drug Diclofenac Binding to Human Serum Albumin</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1178</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1111%2Fcbdd.12583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=25958880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVSksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2015&pages=1178-1184&author=Y.+Zhangauthor=P.+Leeauthor=S.+Liangauthor=Z.+Zhouauthor=X.+Wuauthor=F.+Yangauthor=H.+Liang&title=Structural+Basis+of+Non-Steroidal+Anti-Inflammatory+Drug+Diclofenac+Binding+to+Human+Serum+Albumin&doi=10.1111%2Fcbdd.12583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Non-Steroidal Anti-Inflammatory Drug Diclofenac Binding to Human Serum Albumin</span></div><div class="casAuthors">Zhang, Yao; Lee, Philbert; Liang, Shichu; Zhou, Zuping; Wu, Xiaoyang; Yang, Feng; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1178-1184</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) is the most abundant protein in plasma, which plays a central role in drug pharmacokinetics because most compds. bound to HSA in blood circulation.  To understand binding characterization of non-steroidal anti-inflammatory drugs to HSA, we resolved the structure of diclofenac and HSA complex by X-ray crystallog.  HSA-palmitic acid-diclofenac structure reveals two distinct binding sites for three diclofenac in HSA.  One diclofenac is located at the IB subdomain, and its carboxylate group projects toward polar environment, forming hydrogen bond with one water mol.  The other two diclofenac mols. cobind in big hydrophobic cavity of the IIA subdomain without interactive assocn.  Among them, one binds in main chamber of big hydrophobic cavity, and its carboxylate group forms hydrogen bonds with Lys199 and Arg218, as well as one water mol., whereas another diclofenac binds in side chamber, its carboxylate group projects out cavity, forming hydrogen bond with Ser480.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPjF2KhYkcI7Vg90H21EOLACvtfcHk0ljuPU5B5jtS4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVSksrg%253D&md5=7c653f32321cc32aacefc24b0ff4a6fc</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12583%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DStructural%2520Basis%2520of%2520Non-Steroidal%2520Anti-Inflammatory%2520Drug%2520Diclofenac%2520Binding%2520to%2520Human%2520Serum%2520Albumin%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2015%26volume%3D86%26spage%3D1178%26epage%3D1184%26doi%3D10.1111%2Fcbdd.12583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghuman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunszain, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petitpas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otagiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of the Drug-Binding Specificity of Human Serum Albumin</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.07.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2Fj.jmb.2005.07.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=16169013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=38-52&author=J.+Ghumanauthor=P.+A.+Zunszainauthor=I.+Petitpasauthor=A.+A.+Bhattacharyaauthor=M.+Otagiriauthor=S.+Curry&title=Structural+Basis+of+the+Drug-Binding+Specificity+of+Human+Serum+Albumin&doi=10.1016%2Fj.jmb.2005.07.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Drug-binding Specificity of Human Serum Albumin</span></div><div class="casAuthors">Ghuman, Jamie; Zunszain, Patricia A.; Petitpas, Isabelle; Bhattacharya, Ananyo A.; Otagiri, Masaki; Curry, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-52</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) is an abundant plasma protein that binds a remarkably wide range of drugs, thereby restricting their free, active concns.  The problem of overcoming the binding affinity of lead compds. for HSA represents a major challenge in drug development.  Crystallog. anal. of 17 different complexes of HSA with a wide variety of drugs and small-mol. toxins reveals the precise architecture of the two primary drug-binding sites on the protein, identifying residues that are key determinants of binding specificity and illuminating the capacity of both pockets for flexible accommodation.  Numerous secondary binding sites for drugs distributed across the protein have also been identified.  The binding of fatty acids, the primary physiol. ligand for the protein, is shown to alter the polarity and increase the vol. of drug site 1.  These results clarify the interpretation of accumulated drug binding data and provide a valuable template for design efforts to modulate the interaction with HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyKWUfReJZ-bVg90H21EOLACvtfcHk0ljuPU5B5jtS4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ&md5=d82105920c360292329bf509667df42f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.07.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.07.075%26sid%3Dliteratum%253Aachs%26aulast%3DGhuman%26aufirst%3DJ.%26aulast%3DZunszain%26aufirst%3DP.%2BA.%26aulast%3DPetitpas%26aufirst%3DI.%26aulast%3DBhattacharya%26aufirst%3DA.%2BA.%26aulast%3DOtagiri%26aufirst%3DM.%26aulast%3DCurry%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520of%2520the%2520Drug-Binding%2520Specificity%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D38%26epage%3D52%26doi%3D10.1016%2Fj.jmb.2005.07.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Multiwavelength Spectrophotometric Determination of Acid Dissociation Constants of Ionizable Drugs</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/S0731-7085(98)00010-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2FS0731-7085%2898%2900010-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=9682153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFWhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=699-712&author=R.+I.+Allenauthor=K.+J.+Boxauthor=J.+E.+A.+Comerauthor=C.+Peakeauthor=K.+Y.+Tam&title=Multiwavelength+Spectrophotometric+Determination+of+Acid+Dissociation+Constants+of+Ionizable+Drugs&doi=10.1016%2FS0731-7085%2898%2900010-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs</span></div><div class="casAuthors">Allen, R. I.; Box, K. J.; Comer, J. E. A.; Peake, C.; Tam, K. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4,5</span>),
    <span class="NLM_cas:pages">699-712</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A multiwavelength spectrophotometry was used to det. acid dissocn. consts. (pKa) of sparingly sol. drugs.  UV absorption spectra of the drug solns. were acquired using a versatile device based on a fiber optic dip probe, a light source, and a photodiode array (PDA) detector, while the pH and the ionic strength of the chem. system was manipulated by a com. available titrator.  Target factor anal. (TFA) was applied to deduce the pKa values from the multiwavelength UV absorption data recorded at different pH values.  We call this multiwavelength approach the WApH technique because the pKa values are detd. from changes in Wavelength and Absorbance as a function of pH (WApH).  The WApH technique is exemplified by using pure niflumic acid, nitrazepam, pyridoxine, quinine, and terbutaline.  The WApH pKa values obtained agree well with those derived from pH-metric titrns.  The WApH technique is able to deduce pKa values with high accuracy even if the absorption spectra of the reacting species are very similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqckQEYX9u_PLVg90H21EOLACvtfcHk0ljuPU5B5jtS4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFWhtrw%253D&md5=5a1b3d3d724ac3991dc14e571ac92834</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2898%2900010-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252898%252900010-7%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DR.%2BI.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DComer%26aufirst%3DJ.%2BE.%2BA.%26aulast%3DPeake%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DMultiwavelength%2520Spectrophotometric%2520Determination%2520of%2520Acid%2520Dissociation%2520Constants%2520of%2520Ionizable%2520Drugs%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1998%26volume%3D17%26spage%3D699%26epage%3D712%26doi%3D10.1016%2FS0731-7085%2898%2900010-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takács-Novák, K.</span></span> <span> </span><span class="NLM_article-title">Multi-Wavelength Spectrophotometric Determination of Acid Dissociation Constants: A Validation Study</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>434</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1016/S0003-2670(01)00810-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1016%2FS0003-2670%2801%2900810-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt12nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2001&pages=157-167&author=K.+Y.+Tamauthor=K.+Tak%C3%A1cs-Nov%C3%A1k&title=Multi-Wavelength+Spectrophotometric+Determination+of+Acid+Dissociation+Constants%3A+A+Validation+Study&doi=10.1016%2FS0003-2670%2801%2900810-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Multiwavelength spectrophotometric determination of acid dissociation constants: a validation study</span></div><div class="casAuthors">Tam, K. Y.; Takacs-Novak, K.</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The pKa values of 25 structurally diverse drug compds. including mono-, di- and tri-protic mols. were detd. by a recently developed multi-wavelength spectrophotometric technique, called dip-probe absorption spectroscopy (D-PAS), and the traditional spectrophotometric titrn.  All expts. were performed at 25.0 ± 0.5° in an ionic strength of 0.15 M KCl in two labs. (Semmelweis and Sirius), to evaluate the reproducibility and reliability of the spectrophotometric techniques for pKa detn.  It was found that the pKa values detd. by the D-PAS technique are in excellent agreement with values measured by the traditional spectrophotometric method (av. deviation=0.08 units) and are consistent with the literature data where available.  It was demonstrated that the D-PAS approach is a simple, precise and easy-to-use method for pKa detn. of drug mols. with ionizable group(s) in proximity to chromophore(s).  The advantages and limitations of spectrophotometric pKa detn. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtqUXyzEqEh7Vg90H21EOLACvtfcHk0lhVrgx8fKjfiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt12nt7w%253D&md5=c601c8e99f5bc15e40047fc9c7bfca71</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0003-2670%2801%2900810-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-2670%252801%252900810-8%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DK.%2BY.%26aulast%3DTak%25C3%25A1cs-Nov%25C3%25A1k%26aufirst%3DK.%26atitle%3DMulti-Wavelength%2520Spectrophotometric%2520Determination%2520of%2520Acid%2520Dissociation%2520Constants%253A%2520A%2520Validation%2520Study%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2001%26volume%3D434%26spage%3D157%26epage%3D167%26doi%3D10.1016%2FS0003-2670%2801%2900810-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madhavi
Sastry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+Madhavi%0ASastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+Ligand+Preparation%3A+Parameters%2C+Protocols%2C+and+Influence+on+Virtual+Screening+Enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0lhVrgx8fKjfiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520Ligand%2520Preparation%253A%2520Parameters%252C%2520Protocols%252C%2520and%2520Influence%2520on%2520Virtual%2520Screening%2520Enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span> <i>Schrödinger Release 2018–4: Protein
Preparation Wizard</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2018%E2%80%934%3A+Protein%0APreparation+Wizard%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202018%25E2%2580%25934%253A%2520Protein%250APreparation%2520Wizard%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span> <i>Schrödinger Release 2018–4: LigPrep</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2018%E2%80%934%3A+LigPrep%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202018%25E2%2580%25934%253A%2520LigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lhDXcMNN_vqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+Precision+Glide%3A+Docking+and+Scoring+Incorporating+a+Model+of+Hydrophobic+Enclosure+for+Protein-Ligand+Complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lhDXcMNN_vqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520Precision%2520Glide%253A%2520Docking%2520and%2520Scoring%2520Incorporating%2520a%2520Model%2520of%2520Hydrophobic%2520Enclosure%2520for%2520Protein-Ligand%2520Complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span> <i>Schrödinger Release 2018–4: Glide</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2018%E2%80%934%3A+Glide%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202018%25E2%2580%25934%253A%2520Glide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z69" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z69','PDB','4Z69'); return false;">PDB: 4Z69</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXE','PDB','2BXE'); return false;">PDB: 2BXE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXC','PDB','2BXC'); return false;">PDB: 2BXC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BXD','PDB','2BXD'); return false;">PDB: 2BXD</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i28"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00046">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11050"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00046?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00046</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Results of UV-pH titrations in the presence and absence of HSA, results of HSA-binding measurements by RED and biomimetic chromatography (CHIRALPAK HSA column), comparison of the HPLC systems used for HPLC-HSA measurements, and synthesis and structural confirmation (NMR and HRMS) of diflunisal ethyl ester and <i>C</i>-methyl phenylbutazone (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of different APIs (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_liveslides.mp4">jm0c00046_liveslides.mp4 (6.01 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_001.pdf">jm0c00046_si_001.pdf (510.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00046/suppl_file/jm0c00046_si_002.csv">jm0c00046_si_002.csv (6.18 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00046&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00046%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00046" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999853bdf72290","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
